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The papers presented in this thesis describe the development of
methods for the estimation of adrenaline, noradrenaline, dopamine,
5-hydroxytryptamine and some of their metabolites and the application
of such estimations to some problems of biological interest. The
major part of the thesis is concerned with the metabolism of these
amines in the mammalian central nervous system. The papers are
presented in three groups.
The first group is made up of papers in which the estimation of
5-hydroxytryptamine (5-HT) or its metabolite 5-hydroxy-indol-3-yl
acetic acid (5-HIAA) was measured.
1. On the question of the occurrence and metabolism of 5-hydroxy-
tryptamine and related indole compounds in mammalian semen. By T. Mann,
R. P. Seamark and D. F. Sharman. Br. J. Pharmac. Chemother. VJ_, 208 -
217, 1961.
In this paper it was shown conclusively that the semen of man, bull,
boar, ram and dog contains little or no 5-hydroxytryptamine.
2. Drug-induced changes in the concentration of 5-0R indolyl compounds
in cerebrospinal fluid and caudate nucleus. By G. W. Ashcroft and
D. P. Sharman. Br. J. Pharmac. Chemother. J_9, 153 - 160, 1962.
Because of an earlier observation by Ashcroft and Sharman (Nature,
Lond.,186, 1050 - 1051, 1960) that the cerebrospinal fluid of depressed
patients contained a lower concentration of 5~hydroxyindolyl compounds
than normal, the effect of reserpine, a drug known to reduce the
concentration of 5-hydroxytryptamine in the brain, on the concentration
of such compounds in the cerebrospinal fluid of the dog was examined.
It was found that the concentration of 5-hydroxyindolyl compounds in
the cerebrospinal fluid was increased after reserpine.
3. The effect of a-methyldopa on the metabolism of 5-hydroxy-
tryptamine in rat brain. By D. P. Sharman and S. E. Smith. J.
Neurochem. 9., 403 - 406, 1962.
In this paper, the concentration of 5-HIM in the "brain was used as
an index of the rate at which 5-HT was released in this tissue after
a-methyldopa, an inhibitor of the formation of 5-HT,was given to rats.
4. The action of 2-aminotetralin (p-tetrahydronaphthylamine) on the
metabolism of 5-hydroxytryptamine in the brain of the mouse.
By D. Robinson and D. P. Sharman. Br. J. Pharmac. Chemother. 29,
335 - 341, 1967.
2-Aminotetralin causes a reduction in the concentration of 5-
hydroxyindol-5-ylacetic acid in the brain of the mouse (paper 12).
The possible causes of this effect were' examined.
The second group consists mainly of papers which describe the
development of methods of estimating dopamine and its acid metabolites
3,4-dihydroxyphenylacetic acid (DOPAC) and 4-hydroxy-3-methoxyphenyl
acetic acid (homovanillic acid; HVA), their application to several
problems, chiefly to a study of the rate of utilisation of dopamine
in the brain and also the effect of drugs on the metabolism of
this amine.
5. Chemical and physiological changes produced by arterial infusion
of dihydroxyphenylalanine into one cerebral hemisphere of the cat.
By R. Dagirmanjian, R. Laverty, P. Mantegazzini, D. P. Sharman and
M. Yogt. J. Neurochem. JO, 177 - 182, 1963.
The infusion of 3»4-dihydroxyphenylalanine (DOPA) into one
carotid artery of the cat can cause arousal of the brain on the side
of the infusion. It was shown that this unilateral arousal is
accompanied by an increase in the concentration of dopamine in the
caudate nucleus, hypothalamus and midbrain reticular formation on
the same side of the brain.
6. The subcellular localisation of dopamine and acetylcholine in the
dog caudate nucleus. By R. Laverty, I. A. Michaelson, D.P. Sharman and
Y. P.-Whittaker. Rr. J. Pharmac. Chemother. 21. 482 - 490, 1963.
7. Localisation of acetylcholine, 5-hydroxytryptamine and noradrenaline
within subcellular particles derived from guinea-pig subcortical brain
tissue. By I. A. Michaelson, V. P. Whittaker, R. Laverty and
D. F. Sharman. Biochem. Pharmacol. 12, 1450 - 1453, 19^5•
These two papers describe the estimation of noradrenaline, dopamine,
5-hydroxytryptamine and acetylcholine in particles obtained by sub¬
cellular fractionation of brain tissues. The first shows that
dopamine is associated with a particle that is similar to,but distinguish¬
able from, that with which acetylcholine is associated. The second paper
demonstrates that the storage sites within subcellular particles for
acetylcholine and those for noradrenaline and 5-Lydroxytryptamine
are different.
8. A fluorimetric method for the estimation of 4-hydroxy-3-methoxy-
phenylacetic acid (homovanillic acid) and its identification in brain
tissue. By D. F. Sharman. Br. J. Pharmac. Chemother. 20, 204 - 213, 1963.
9. The estimation of small quantities of 3,4-dihydroxyphenylethylamine
in tissues. By R. Laverty and D. F. Sharman, Br. J. Pharmac. Chemother.
24, 538 - 548, 1965.
10. Modification by drugs of the metabolism of 3,4-dihydroxyphenyl¬
ethylamine, noradrenaline and 5-hydroxytryptamine in the brain.
By R. Laverty and D. F. Sharman. Br. J. Pharmac. Chemother. 24,
759 - 772, 1965.
11. The effect of drugs on the homovanillic acid content of the corpus
striatum of some rodents. By A. V. Juorio, D. F. Sharman and T. Trajkov.
Br. J. Pharmac. Chemother. 26, 385 - 392, 1966.
12. Changes in the metabolism of 3,4-dihydroxyphenylethylamine
(dopamine) in the striatum of the mouse induced by drugs. By D. F. Sharman,
Br. J. Pharmac. Chemother. 28, 153 - 163» 1966.
13. A discussion of the modes of action of drugs which increase the
concentration of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic
acid) in the striatum of the mouse. By D. F, Sharman. Br. J. Pharmac.
Chemother. 30, 620 - 626, 1967.
14. Homovanillic acid and dihydroxyphenylacetic acid in the striatum
of monkeys with brain lesions. By D. F. Sharman, L. J. Poirier,
G. F. Murphy and T. L. Sourkes. Can. J. Physiol. Pharmacol. 45* 57 -
62, 1967.
15. Release by tubocurarine of dopamine and homovanillic acid from
the superfused caudate nucleus. By P. J. Portig, D. F. Sharman and
Marthe Vogt. J. Physiol. Lond. 194. 565 - 572, 1968.
16. The effect of tropolone on the formation of 3,4-dihydroxyphenyl-
acetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the brain of
the mouse. By G. F. Murphy, D. Robinson and D. F. Sharman. Br. J.
Pharmac. Chemother. _3<5, 107 - 115* 1969-
17. Turnover of amines using probenecid to block the egress of
metabolites. By D. F. Sharman. Metabolism of brain amines. Edited
by G. Hooper, Macmillan, London, pp. 34 - 37? 19^9•
These papers form the main part of the thesis and attempt to relate
the concentration of HVA in the central nervous system to the rate at
which dopamine is utilised in this tissue. The locus of the metabolism
of dopamine in the central nervous system is discussed.
The papers in the third group are concerned with noradrenaline
or its glycol metabolites.
18. Noradrenaline content in the heart and spleen of the mouse under
normal conditions and after administration of some drugs.
By D. F. Sharman, S. Vanov and Marthe Vogt. Br. J. Pharmac. Chemother.
12, 527 - 533, 1962.
This study was made to investigate a report of what appeared to be
unusual behaviour of the tissue catecholamines in the mouse. The method
used to estimate the noradrenaline was designed to incorporate as many
controls as was possible to ensure that correct estimates were obtained.
The earlier report could not be confirmed.
19. Iontophoretic release of adrenaline noradrenaline and 5-Hydroxy-
tryptamine from micropipettes. By K. Krnjevic, R. Laverty and D. P.
Sharman. Br. J. Pharmac. Chemother. _20, 491 - 496, 1963-
Pluorimetric methods were used to measure the relation between the
release of these amines and the electrical charge applied to micro¬
pipettes used for the iontophoretic application of drugs to single
neurones.
20. The action of 2,4,5-trihydroxyphenylethylamine on the storage and
release of noradrenaline. By R. Laverty, D. P. Sharman and Marthe Yogt.
Br. J. Pharmac. Chemother. 24, 549 - 560, 1965*
2,4,5-Trihydroxyphenylethylamine causes a rapid and long lasting
depletion of noradrenaline from the mouse heart. A new method was
developed for the estimation of the former amine and was used to show
that it did not persist in the tissue or was tightly bound in the tissue.
21. The noradrenaline content of the caudate nucleus of the rabbit.
By D. P. Sharman and Marthe Vogt. J. Neurochem. 12, 62, 1965*
This short paper illustrates a frequently reported erroneous result
when a commonly used fluorimetric method for the estimation of nor¬
adrenaline is applied to those brain tissues which contain very little
of this amine.
22. Gas chromatographic evidence for the presence of glycol metabolites
of catecholamines in brain tissue. By D. P. Sharman. J. Physiol. Lond.
200, 35 - 35P, 1969.
23. Glycol metabolites of noradrenaline in brain tissue.
By D. F. Sharman. Accepted for publication by Br. J. Pharmac.
Chemother. 1969•
The application of gas liquid chromatography and electron capture
detection to the estimation of glycol metabolites of noradrenaline in
the brain is described. The possibility of using a similar technique
for the estimation of noradrenaline and normetanephrine is discussed.
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The content of 5-hydroxytryptamine was examined in the semen of man, bull, ram,
boar and dog. Spectrophotofluorimetric and chromatographic analysis of extracts
prepared by several methods has shown that the semen contains only minute quantities
of 5-hydroxytryptamine, if any. One cannot attribute to 5-hydroxytryptamine the
uterus-stimulating effect which the human seminal plasma is known to exert.
Tryptophan, although present in the seminal plasma, is not converted to 5-hydroxy¬
tryptamine on incubation of semen. 5-Hydroxytryptophan is oxidatively deaminated,
but not decarboxylated, by spermatozoa. 5-Hydroxytryptamine itself, like tryptamine
and tyramine, is not deaminated by either whole semen or washed suspensions of
ram spermatozoa.
Among the pharmacodynamic effects of the mammalian seminal plasma is a
strong stimulation of smooth-muscle organs such as the uterus and the intestine.
This oxytocic activity of semen was investigated in the past by many authors,
including Kurzrok & Lieb (1930), Cockrill, Miller & Kurzrok (1935), Goldblatt
(1933, 1935a, b), von Euler (1934a, b ; 1935, 1936, 1939, 1949), Vandelli (1943),
Asplund (1947a, b), Karlson (1949) and Bergstrom (1949); the general conclusion
reached was that the uterine-stimulating property of semen, particularly in man,
is probably due to the combined action of several constituents of the seminal plasma,
such as choline, prostaglandin and histamine. The early literature has been
reviewed in some detail by Mann (1954). Seminal prostaglandin has since been
purified and is now believed to be produced, at least in man and ram, by the seminal
vesicles and not by the prostate gland (Eliasson, 1959). Two crystalline compounds,
both possessing the properties of nitrogen-free unsaturated fatty-acids, have been
separated from prostaglandin preparations of vesicular origin; one of these,
" prostaglandin E," was shown to exert, in addition to the smooth-muscle stimulat¬
ing action, a depressant effect on blood pressure of the rabbit, while the other,
"
prostaglandin F," was found to be devoid of action on blood pressure (Bergstrom,
Eliasson, Euler & Sjovall, 1959 ; Bergstrom, Duner, Euler, Pernow & Sjovall, 1959).
Several authors have also considered the possibility that the " oxytocic activity "
of semen is due, at least partly, to 5-hydroxytryptamine, which is known to induce
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strong uterine contractions, either when applied to the isolated uterus of the rat
(Erspamer, 1952) or injected into a living dog (Abrahams & Pickford, 1956). The
evidence, however, for the presence of this substance in mammalian semen has so
far been confusing and contradictory. Thus, whereas according to Katsh (1959)
human seminal plasma contains as much as 135 «g/ml., Hawker, Roberts &
Walmsley (1960) could not find 5-hydroxytryptamine either in human or in ram
semen.
On the other hand, a recent investigation of the secretory function of male
accessory organs in the spiny dogfish, Squalus acanthias, has revealed the surprising
fact that, in this viviparous elasmobranch fish, one of the accessory organs, the
so-called clasper siphon, produces a secretion which is extremely rich in 5-hydroxy-
tryptamine (Mann, 1960). The presence of as much as 7% of 5-hydroxytryptamine
in a secretion which forms part of the seminal plasma in the spiny dogfish suggests
that in this animal 5-hydroxytryptamine may be involved in the process of reproduc¬
tion, - either by facilitating the ejaculation of semen in the male or perhaps by
eliciting contractions of the reproductive tract in the female and thus aiding sperm
ascent in the oviducts. Another recent observation relevant to the function of
5-hydroxytryptamine in reproduction concerns certain insects. It was shown that
the secretion of the opaque accessory gland in the male of Rhodnius prolixus, as
well as the secretion of similar glands, the utriculi majores, in the cockroach
Periplaneta americana, contain a substance which causes contractions of the insects'
oviducts. The active principle is destroyed by monoamine oxidase and o-diphenol
oxidase, and is probably an odihydroxyindolalkylamine related to 5-hydroxytrypt-
amine (Davey, 1960).
We have attempted to clarify the question concerning the presence of 5-hydroxy-
tryptamine and related compounds in mammalian semen, and to provide more
information on the relation of 5-hydroxytryptamine to the " oxytocic activity " of
semen.
METHODS
Semen. Semen from rams, bulls and boars was collected by means of the artificial vagina.
Dog semen provided by Dr D. Bartlett was collected by the massage technique. Human
semen from donors at the Fertility Clinic was made available by Dr H. A. Davidson. The
semen samples intended for determination of 5-hydroxytryptamine were kept in solid carbon
dioxide until deproteinized. In addition to whole boar semen, analyses of 5-hydroxytryptamine
were also carried out on the seminal gel and the epididymal seminal plasma of this species.
For measurements of respiration, fresh ram semen was used, either whole or after separation
into spermatozoa and seminal plasma.
Spectrophotofluorimetric determination of 5-hydroxytryptamine. This was carried out in
the Aminco-Bowman spectrophotofluorimeter on extracts prepared by one of the following
three procedures: (1) The sample was deproteinized with zinc sulphate and sodium hydroxide ;
deproteinization was usually carried out by adding to the sample 1 vol. water, followed by 1 vol. of
10% zinc sulphate (Zn.SO4.H2O) and 0.2 vol. of 10% sodium hydroxide; on occasions when
the centrifuged extract was not completely clear, small additional amounts of the deproteiniz-
ing agents had to be added ; to 2 ml. of the protein-free filtrate was added 1 ml. concentrated
hydrochloric acid containing ascorbic acid (0.1 mg/1 ml.); the solution was placed in a quartz
cuvette for spectrophotofluorimetric analysis. (2) The sample was extracted by the method
of Bogdanski, Pletscher, Brodie & Udenfriend (1956). (3) The sample was treated with 4 vol.
acetone and the resultant precipitate and supernatant solution processed further as described
by Katsh (1959).
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Chromatographic identification of 5-hydroxytryptamine and related indole compounds. Both
descending and ascending one- and two-dimensional paper partition chromatography was
used. The solvent systems, (i) butanol + acetic acid, (ii) isopropanol +ammonia, (iii) aqueous
potassium chloride, and (iv) butanol + pyridine, were used as recommended by Jepson (1960).
The developed chromatograms were dried at 25° C in an air oven, all fluorescent areas noted,
and an ultra-violet contact photograph taken, using a Hanovia " Chromatolite " lamp and
Kodak Duostat 13 reflex paper. The following location reagents, used either singly or in
sequence, were applied: acid ninhydrin, ninhydrin pyridine, Ehrlich's reagent, diazotized
sulphanilic acid (Jepson, 1960), 5 n hydrochloric acid (Sharman, 1960), and potassium
dichromate formaldehyde (Shepherd & West, 1953).
Metabolic studies. Oxygen uptake was determined in Barcroft differential manometers
filled with air, at 37° C. Ammonia formation was followed by treating the samples with a
saturated solution of sodium borate and subjecting the mixtures to steam-distillation in vacuo,
at a temperature not exceeding 25° C, in the apparatus of Parnas & Heller (1924). Monoamine
oxidase activity was determined by measuring O2 uptake and ammonia formation as well as
by the colorimetric method of Green & Haughton (1961).
Chemicals. The chemicals were of the analytical or microanalytical reagent grade:
5-Hydroxytryptamine creatinine sulphate (Sigma Chem. Co.; May & Baker); dl-tryptophan





This was carried out on a series of extracts prepared from human, ram, bull and
boar semen by deproteinization with zinc hydroxide, and the supernatant then
rendered 3 N with respect to hydrochloric acid. When these extracts were examined
in the spectrophotofluorimeter using a Chance OY 4 filter in the fluorescent light
path, a distinct fluorescence was observed with an activation maximum at 295 m«
and a fluorescence maximum at 525 mp.. This fluorescence maximum, however,
was shown to be an artefact, due to the transmission characteristics of the filter,
since, when the determinations were repeated with the filter omitted, the wavelengths
for maximal activation and fluorescence of the seminal extracts were 295 m/x and
430 m,u, respectively. On the instrument used, 5-hydroxytryptamine, in common
with other 5-hydroxyindolyl derivatives, showed a fluorescence in 3 N HC1,
characterized by an activation maximum at 285 m« and a fluorescence maximum
at 540 m/i. Thus the seminal constituent which fluoresced with a maximum at
430 m,u could not be identical with 5-hydroxytryptamine, even though its activation
peak of 295 m/j, is close to that of 5-hydroxytryptamine.
In the light of this observation, subsequent fluorimetric analyses of the seminal
extracts were made using an activation wavelength of 285 m/i and a fluorescence
wavelength of 540 m,u, and calibrating each time the observed fluorescence against
one produced by a standard solution of pure 5-hydroxytryptamine. When this was
done the following results were obtained, the 5-hydroxytryptamine content being
expressed in ng/2 ml. extract: three different samples of human semen, 0 to 5 ;
ram semen, 0; ram seminal plasma, 0; two different samples of bull semen, 0 and
60 ; boar semen (separated from the gel), 250 ; boar seminal gel, 0 ; boar epididymal
seminal plasma, 0.
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As can be seen, the fluorescence values were of an exceedingly low order in all
species. Moreover, these values represent not only the maximum fluorescence
attributable to 5-hydroxytryptamine, but include, in all probability, the fluorescence
due to some other substances which are present in semen.
Experiment no. 2
For the detection of trace amounts of 5-hydroxytryptamine in semen, an experi¬
ment was carried out on two 1.5 ml. samples of human semen, to one of which
5 ,«g 5-hydroxytryptamine was added before deproteinization. Both samples were
extracted with butanol according to Bogdanski et al. (1956), and the purified and
acidified extracts used to determine the activation scans with fluorescence at 540 rnu,
as well as the fluorescence scans with activation at 280 m,u. The results of these
determinations are recorded in Fig. 1, which shows the characteristic fluorescence
Fig. 1. Activation and fluorescence spectra of extracts from human semen: (1) extract from 1-5 ml.
human semen; (2) extract from 1-5 ml. human semen to which 5 /<g 5-hydroxytryptamine was
added; and (3) reagent blank.
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due to added 5-hydroxytryptamine and the lack of fluorescence in the sample
without 5-hydroxytryptamine. These results clearly indicate that the content of
5-hydroxytryptamine in human semen is either negligible or nil.
Experiment no. 3
The fluorimetric analyses of human, bull, boar and ram semen were repeated,
using larger quantities of semen and the extraction procedure of Bogdanski et al.
(1956) which allows the preparation of more concentrated extracts. In addition,
dog semen was examined by the same method. In each instance two measurements
were taken: (i) of the wavelengths of maximal activation and fluorescence of the
seminal extracts; and (ii) of the " 5-hydroxytryptamine equivalent" of any
fluorescence present, determined at the activation wavelength of 285 m/x, and the
fluorescence wavelength of 540 mp. The results were as follows.
Human semen. 9 ml. representing pooled ejaculates from four donors; two
normal, one completely azoospermic, and one with sperm density less than 10,000
cells/ju.1.; final volume of the hydrochloric acid extract, 5 ml. When examined
in the spectrophotofluorimeter, the extract exhibited a characteristically strong
fluorescence with an activation maximum of 295 mp and a fluorescence maximum at
430 mu ; 2 ml. of the hydrochloric acid extract, when examined at the 285 and
540 mp wavelength, corresponded to a content of 540 ng " 5-hydroxytryptamine
equivalent," that is, 150 ng/ml. semen.
Bull semen. 13 ml. obtained from two bulls. The acid extract exhibited the
typical 295/430 mp fluorescence. The "5-hydroxytryptamine equivalent" content
was 1,000 ng (1 ,ug)/ml. semen.
Ram semen. 15 ml. representing pooled ejaculates from ten rams. The acid
extract exhibited the typical 295/430 mp fluorescence. The " 5-hydroxytryptamine
equivalent" was 500 ng/ml. semen.
Boar semen. Out of a total ejaculate of 270 ml., a 15 ml. sample was used for
extraction. The extract showed the typical 295 / 430 m/x fluorescence, and contained
a "5-hydroxytryptamine equivalent" of 50 ng/ml. semen.
Dog semen. 15 ml. representing two ejaculates. The extract prepared from dog
semen clearly showed the blue fluorescence previously observed in human, bull, ram
and boar semen, namely, at the 295 and 430 rap wavelengths. It contained a " 5-
hydroxytryptamine equivalent" of 150 ng/ml. semen.
The general conclusion to be drawn from experiment no. 3 is that there is very
little 5-hydroxytryptamine, if any, in the semen of man, boar, ram, bull and dog.
This was confirmed by the following experiment.
Experiment no. 4
Both the activation and fluorescence scans were determined using side by side
the hydrochloric acid extracts obtained from human and canine semen, and a
similarly prepared extract from the nucleus caudatus of the dog brain, of which the
5-hydroxytryptamine content had previously been determined and found to be
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0.3 jig/g tissue. The results of this experiment are recorded in Fig. 2. In the left
part of this figure the activation scan of the extract from dog semen is compared
with that obtained from the nucleus caudatus. There is only a small difference
in the maximum activation wavelength (295 mp and 285 m/x, respectively). In
the right part of Fig. 2, the fluorescence scan of human semen is contrasted with
that of the dog nucleus caudatus; here it is obvious that the peak characteristic of
5-hydroxytryptamine (540 m/x) is entirely absent in the semen.
Activation Fluorescence
Fig. 2. Activation and fluorescence spectra of extracts from dog semen (DS), human semen (HS)
and the nucleus caudatus of the dog brain (DB). The amplification used in recording the
fluorescence scan of the extract from human semen (HS) was reduced to enable the record to
cover the same wavelength range as that obtained with the nucleus caudatus extract (DB). If
HS had contained 1 /xg 5-hydroxytryptamine, a peak of the same size as that shown by DB would
have been observed.
214 T. MANN, R. F. SEAMARK and D. F. SHARMAN
Chromatographic observations on fresh semen
Several attempts were made to detect 5-hydroxytryptamine by chromatography
in concentrated extracts from either whole semen or freshly prepared washed sperm
suspensions and seminal plasma of man, bull, ram, boar and dog. The chromato-
grams were examined by the various methods already cited, but no evidence was
obtained for the occurrence of 5-hydroxytryptamine.
In order to repeat the observation of Katsh on the presence of 5-hydroxytryptamine
in human semen, two separate experiments were carried out, with 3 ml. and 12 ml.
human seminal plasma, following closely the acetone extraction procedure. These
experiments, too, failed to yield positive evidence for the presence of 5-hydroxy-
tryptamine in human seminal plasma. It may be added that chromatograms
developed with the various systems used revealed several substances reacting with
one or another of the spraying reagents. However, no indole compounds other than
tryptophan, no substituted tryptamine derivatives such as 5-hydroxytryptamine, nor
any phenolic indole compounds were detected. Similarly, we obtained negative
results with human semen using different deproteinization and extraction procedures
(Udenfriend, Weissbach & Brodie, 1958).
We did not succeed in demonstrating 5-hydroxytryptamine chromatographically
in bull, ram, boar and dog semen by any of the methods applied in this work.
Metabolism of 5-hydroxytryptamine and other indole compounds in semen
A series of chromatographic analyses was performed on ram semen, washed sperm
and seminal plasma, which had been incubated in the presence of added 5-hydroxy¬
tryptamine or certain other related compounds, to find out whether 5-hydroxy-
tryptamine itself is metabolized in semen, and also to explore the possibility that
it might be formed in semen as the result of the metabolic breakdown of substances
such as tryptophan and 5-hydroxytryptophan. Most of these experiments were
combined with measurements of the oxygen uptake and ammonia evolution during
the incubations.
5-Hydroxytryptamine. The experimental samples contained 5 mg 5-hydroxy¬
tryptamine creatinine sulphate dissolved in 1 ml. Ringer-phosphate, and 2 ml. of
either a washed sperm suspension (109 cells) in Ringer or 2 ml. of correspondingly
diluted whole semen ; aerobic incubations were done in Barcroft manometers for
periods ranging from 1 to 4 hr at 37° C. Under these conditions the addition of
5-hydroxytryptamine had no detectable effect on the rate of oxygen uptake, and
there was no rise in free ammonia. After deproteinization with barium hydroxide
and zinc sulphate (1.5 ml. incubation mixture+ 0.5 ml. 0.3 n barium hydroxide
+ 0.5 ml. 5% zinc sulphate (ZnS04.7H20)), 50 to 100 /d. aliquots of the protein-free
filtrates were analysed by paper chromatography in various solvents. However,
as' a result of the aerobic incubation there was no evidence that either washed
spermatozoa or whole semen produced any change in the 5-hydroxytryptamine
content. In particular, there was no formation of 5-hydroxyindole acetic acid as
an oxidative breakdown product of 5-hydroxytryptamine.
Tryptophan. The oxidative deamination of tryptophan by bull spermatozoa has
been the subject of a study by Tosic & Walton (1950) and Tosic (1951), who have
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pointed out that the formation of hydrogen peroxide during the oxidative
deamination of aromatic amino-acids is responsible for the gradual decline in the
oxygen uptake of incubated sperm mixtures. Using the same conditions as in the
experiments with 5-hydroxytryptamine, we found that whole ram semen and washed
ram spermatozoa can deaminate dl-tryptophan aerobically ; moreover, whilst the
same amount of ammonia was produced in the presence as in the absence of pure
catalase, the rate of oxygen consumption was much higher with catalase present,
owing to the decomposition of the toxic hydrogen peroxide. Chromatographic
analyses of the incubation mixtures of dl-tryptophan and either whole semen or
washed sperm suspensions showed that ram spermatozoa metabolize tryptophan
aerobically, but not anaerobically, to several products. The major product was
identified chromatographically as indoleacetic acid. The identification rested on
the use of both descending and ascending chromatography in butanol + acetic acid
(Rp 0.88 and 0.92, respectively), as well as in two other solvents, namely, isopropanol
+ ammonia (Rp 0.28) and potassium chloride (Rp 0.60). No tryptamine, 5-hydroxy-
tryptophan or 5-hydroxytryptamine was detected.
5-Hydroxytryptophan. Mixtures of sperm and 5-hydroxytryptophan were
incubated under the same conditions as in experiments with 5-hydroxytryptamine
and tryptophan, in the presence and absence of catalase. A small amount of
ammonia was formed, but there was no evidence of decarboxylation of 5-hydroxy-
tryptophan to 5-hydroxytryptamine.
Tryptamine and tyramine. No ammonia formation occurred when a solution
containing 5 mg tryptamine was incubated aerobically for 3 hr at 37° C, with either
a suspension of washed spermatozoa (109 cells/2 ml. Ringer) or a sample of
correspondingly diluted whole ram semen. When the experiment was repeated
using tyramine instead of tryptamine, only a trace of ammonia was produced. These
experiments provided a good indication that the monoamine oxidase activity of
ram semen must be low. Supporting evidence for this view was obtained in the
following manner. Tyramine oxidation was examined by the more sensitive
procedure of Green & Haughton (1961), which depends on trapping with semi-
carbazide the aldehyde formed during the enzymic oxidation of tyramine, and
converting the semicarbazone into the corresponding 2:4 dinitrophenylhydrazone.
The light absorption of the orange-coloured alkaline solution of the dinitrophenyl¬
hydrazone was determined in the Unicam spectrophotometer at 450 m/x. Aerobic
incubation for 2 hr at 37° C of a mixture (4 ml.) containing 1 ml. whole semen, 1 ml.
0.5 m semicarbazide solution (pH 7.4), 0.4 ml. 0.1 m solution of tyramine hydro¬
chloride (pH 7.4), and 1.6 ml. Ringer phosphate produced less than 1/25 of the
amount of semicarbazone which had been formed, under identical experimental
conditions, by a preparation of mitochondria from 1 g of rat liver.
discussion
It was thought at one time that spermatozoa deposited at ejaculation in the vagina
or cervix rely on their own motility in order to traverse the uterus and reach the
oviducts. More recently, however, when measurements were made of the time
interval required for some spermatozoa, at any rate, to arrive at the site of fertili-
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zation, this proved to be remarkably short, in some species no more than a few
minutes. This and subsequent work has shown that ejaculated spermatozoa are
propelled to their final destination in the oviducts not so much by their own
movements as by the concomitant uterine contractions.
The mechanism responsible for the increase in uterine motility following
copulation and sexual stimulation is still under investigation. Some investigators
attribute it mainly to the release of oxytocin by the pituitary gland ; others believe
that semen itself may provide, at least partly, the required stimulus in the form of
pharmacologically active constituents. Similarly, the chemical identity of the various
"
oxytocic " substances in semen is still under dispute, as shown by the perusal of
recent literature (Mann, 1954 ; Eliasson, 1959 ; Hawker et al., 1960).
The possibility that 5-hydroxytryptamine is one of these substances has been
examined. The present study does not support the claim that mammalian semen
has a high content of 5-hydroxytryptamine ; our spectrophotofluorimetric as well
as chromatographic analyses have shown that the amine is either altogether absent
from the semen of man, bull, boar, ram and dog, or present only in minute quantities.
5-Hydroxytryptamine may, perhaps, appear in human semen in measurable
quantities in special circumstances. One need only recall the well-known effect
which 5-hydroxytryptamine contained in certain foods exerts on the excretion of
indole derivatives in the human urine. Certain other substances administered orally
can pass unchanged into the seminal plasma ; for instance, when ergothioneine, a
normal constituent of the seminal plasma, is fed to a boar the administered compound
is found unchanged in the ejaculated semen (Heath, Rimington, Glover, Mann &
Leone, 1953). The fact remains that 5-hydroxytryptamine is not a normal constituent
of seminal plasma, either in man or in ram, bull, boar and dog. It is therefore
unlikely that the uterine-stimulating property of semen depends upon the presence
therein of 5-hydroxytryptamine.
An indole compound which is a normal constituent of mammalian seminal plasma
is tryptophan. This amino-acid, however, and the closely related 5-hydroxytrypto¬
phan, do not appear to undergo any appreciable decarboxylation in semen.
5-Hydroxytryptamine itself, and related amines such as tryptamine and tyramine,
when added to semen, are also relatively stable, as shown by incubation experiments
carried out with whole ejaculated semen or washed sperm suspensions.
This research was carried out on behalf of the Agricultural Research Council. We are
indebted for help to Dr J. H. Gaddum, F.R.S., and Dp M. Vogt, F.R.S. One of us (R.F. S.)
is indebted to the University of Adelaide for the Barr Smith Travelling Scholarship.
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The effects of reserpine and imipramine on the concentration of indolyl compounds
bearing an OR group in position 5 (5-OR indolyl compounds) in the cerebrospinal
fluid and the caudate nucleus of the dog have been studied. Reserpine was shown
to produce an increase in the concentration of these compounds in the cerebrospinal
fluid. In the caudate nucleus reserpine produced a fall in the concentration of the
basic 5-OR indolyl compounds accompanied by an equivalent increase in the concen¬
tration of acidic 5-OR indolyl compounds. No significant change in the concentration
of 5-OR indolyl compounds in the cerebrospinal fluid was observed after treatment
with imipramine.
In a previous publication (Ashcroft & Sharman, 1960) it was reported that there
was a difference in the concentration of 5-hydroxyindolyl compounds in the cere¬
brospinal fluid of patients suffering from depressive psychoses and patients with
neurological diseases. The present investigation on dogs was carried out to test
the possibility that changes in the metabolism of 5-hydroxytryptamine in the body
might be reflected in changes in the cerebrospinal fluid level of indolyl compounds
bearing an OR group in position 5. Sharman (1960) has shown that many indolyl
compounds bearing an OR group in position 5, where R is a hydrogen atom, or an
aryl or alkyl group, and unsubstituted in the 2 position of the indole nucleus, show
the fluorescence in 3n hydrochloric acid attributed to 5-hydroxyindolyl compounds
by Udenfriend, Bogdanski & Weissbach (1955) and demonstrated for (V-acetyl-5-
methoxytryptamine by Axelrod & Weissbach (1961). It is possible that traces of
indolyl compounds bearing an OR group in position 5 other than 5-hydroxytrypt¬
amine or 5-hydroxyindol-3-ylacetic acid are present in the cerebrospinal fluid.
Because of this it was decided to refer to the substances estimated in this investiga¬
tion as 5-OR indolyl compounds.
* Present address: Department of Pharmacology, University of Edinburgh.
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METHODS
All-glass apparatus was used for the chemical procedures. It was found that the use of
rubber stoppers led to interference with the fluorescence estimations. De-ionized water was
used throughout. Samples of cerebrospinal fluid (approximately 2.5 ml.) were collected into
glass-stoppered tubes, each containing 5 mg ascorbic acid to prevent oxidation.
Estimation of the total 5-OR indolyl compounds in cerebrospinal fluid
A measured portion (2.0 to 2.5 ml.) of cerebrospinal fluid was placed in a glass-stoppered,
graduated test-tube. To the sample was added 0.5 ml. of a 10% (w/v) solution of zinc sulphate
(Analar grade, recrystallized from water and dried) and the contents of the tube mixed by
inversion. After the addition of 0.1 ml. of a 10% (w/v) solution of sodium hydroxide the
contents of the tube were again mixed by inversion. To 2.0 ml. of the clear supernatant fluid,
obtained after centrifuging for 10 min at 2,500 r.p.m., was added 1.0 ml. of concentrated
hydrochloric acid containing 0.05% (w/v) ascorbic acid. The fluorescence of this solution at a
wavelength of 550 my, when activated with ultra-violet light of wavelength 295 m/i, was
measured in an Aminco-Bowman spectrophotofluorometer.
Estimation of 5-OR indolyl compounds in brain tissue
(a) Total 5-OR indolyl compounds. The weighed tissue was homogenized in 0.1 n hydro¬
chloric acid (2 ml./g tissue). The homogenate was then diluted to 10 ml./g tissue with water.
A 5 ml. portion of the diluted homogenate was deproteinized using 1.0 ml. of a 10%
solution of zinc sulphate and 0.2 ml. of a 10% solution of sodium hydroxide in a manner
similar to that described for cerebrospinal fluid ; 1.0 ml. of concentrated hydrochloric acid con¬
taining ascorbic acid was added to 2.0 ml. of the clear supernatant obtained after centrifuging
at 2,500 r.p.m. for 10 min. The fluorescence of this solution (activation wavelength 295 my ;
fluorescence wavelength 550 m/i) was measured.
(b) Basic 5-OR indolyl compounds. A portion of the supernatant fluid obtained after the
protein precipitation was extracted into butanol and estimated fluorimetrically by the method
described for 5-hydroxytryptamine by Bogdanski, Pletscher, Brodie & Udenfriend (1956).
(c) Acidic 5-OR indolyl compounds. These were estimated by a modification of the method
described for 5-hydroxyindol-3-ylacetic acid by Udenfriend, Titus & Weissbach (1955). A 2.0
ml. portion of the clear supernatant fluid obtained after protein precipitation was adjusted to
a />H of between 1 and 2 (indicator paper) with concentrated hydrochloric acid. The solution
was saturated with sodium chloride and then shaken for 1 min with 10 ml. of diethyl ether,
which had been stored previously over a saturated aqueous solution of sodium sulphite.
The two phases were separated completely by centrifuging for 30 sec and the ether layer
was transferred to a tube containing 1.0 ml. of 0.5 m sodium phosphate buffer pR 7.0. The
mixture was shaken for 1 min and then the two phases were allowed to separate. A measured
portion (0.8 ml.) of the aqueous layer was diluted to 1.0 ml. with water and 0.5 ml. of
concentrated hydrochloric acid containing ascorbic acid was added. The fluorescence of this
solution (activation wavelength 295 m«, fluorescence wavelength 550 my) was measured. The
fluorescence in the estimation of total, basic and acidic 5-OR indolyl compounds was measured
against and expressed as ng of 5-hydroxyindol-3-ylacetic acid.
Collection of the cerebrospinal fluid
Three procedures were employed for the collection of cerebrospinal fluid.
(1) Adult dogs were anaesthetized with ether followed by intravenous chloralose (70 mg/kg
body weight). The head of the animal was securely fixed to allow the percutaneous introduc¬
tion of a 19-gauge hypodermic needle into the cisterna magna. The needle was then secured
in a rigid clamp. A narrow-bore manometer, into which some of the cerebrospinal fluid was
allowed to escape, was connected to the needle via a three-way tap and gave a record of the
pressure. The pressure, in mm cerebrospinal fluid, was read every 15 min. A first 2.0 to
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2.5 ml. sample of cerebrospinal fluid was collected by allowing the fluid to drip from the tap
into the collection tube ; further samples were only taken when the cerebrospinal fluid pressure
had recovered from the fall due to sampling and had reached about 70 mm cerebrospinal
fluid. This was usually a little below the initial cerebrospinal fluid pressure. In some cases
the cerebrospinal fluid pressure was slow in recovering to this value, and it was found that
the intravenous injection of 0.9%w/v saline accelerated recovery.
(2) A 19-gauge hypodermic needle was introduced into the cisterna magna of an anaesthetized
dog as described in the preceding section.
Two ml. of cerebrospinal fluid was allowed to drip from the needle. Drugs were then
injected intravenously and 2 hr later as much cerebrospinal fluid as possible was drained off
in consecutive 2.0 ml. samples.
(3) A third procedure was adopted in order to examine the chronic effect of imipramine
hydrochloride on the concentration of 5-OR indolyl compounds in the cerebrospinal fluid and
to study the day-to-day variation in normal dogs.
Adult dogs were anaesthetized by an intravenous injection of thiopentone. A 19-gauge
hypodermic needle was introduced percutaneously into the cisterna magna and 2 ml. of cere¬
brospinal fluid was withdrawn into a syringe. It was possible to repeat this procedure once
daily, taking aseptic precautions throughout.
Collection of brain tissue
At the end of each experiment the dog was bled out and the brain removed. The caudate
nuclei were dissected out, frozen and stored at —17° C until analysed. The caudate nucleus
was selected because this tissue has a high content of 5-OR indolyl compounds and the
dissection is easily reproducible.
RESULTS
The estimates of total 5-OR indolyl compounds in the cerebrospinal fluid of
normal dogs and the effect produced by an intravenous injection of reserpine (2 mg /
kg body weight) are shown in Table 1. They were obtained using the first method of
cerebrospinal fluid collection. The values indicate that the increase in the cerebro-
Table 1
EFFECT OF RESERPINE ON THE CONCENTRATION OF TOTAL 5-OR INDOLYL
COMPOUNDS IN THE CEREBROSPINAL FLUID (a)
(Cerebrospinal fluid collected by method 1)
Concentrations expressed as ng 5-hydroxyindol-3-ylacetic acid/ml. cerebrospinal fluid
Concentration of total 5-OR indolyl compounds in
cerebrospinal fluid
Cerebrospinal fluid sample no.: 1 2 3 4 . 5 6
Control dogs 1 46 92 85 94 83 —
2 59 71 83 96 94 92
3 36 38 74 125 102 —
Reserpine
(2 mg/kg) injected intra¬ 1 49 87 72 108 168 161
venously after sample 2 2 33 71 135 197 — —
spinal fluid concentration of 5-OR indolyl compounds after an intravenous injection
of reserpine was greater than the increase observed to occur in successive samples
taken from control animals. There was, however, no common time-course to these
experiments. The time intervals between the collection of samples varied between
30 and 120 min. The second method of cerebrospinal fluid collection was intro¬
duced to standardize the timing in each experiment and to attempt to show more
clearly whether there was an increase of 5-OR indolyl compounds in the cerebro-
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Table 2
EFFECT OF RESERPINE ON THE CONCENTRATION OF TOTAL 5-OR INDOLYL
COMPOUNDS IN THE CEREBROSPINAL FLUID (b)
(Cerebrospinal fluid collected by method 2)
Concentrations expressed as ng 5-hydroxyindol-3-ylacetic acid/ml. cerebrospinal fluid
Concentration of total 5-OR indolyl Concentration
compounds in cerebrospinal fluid of total 5-OR
■ indolyl
Cone, in consecutive samples compounds in
taken 2 hr after initial sample caudate
Initial . ■ . nucleus
conc. 1 2 3 (ng/g)
Control dogs 66 61 43 55 775
45 48 ' 49 55 705
Reserpine 34 70 102 127 810
(2 mg/kg) intravenously 66 72 88 145 725
after initial sample 54 101 125 147 805
spinal fluid after reserpine. The results obtained with this procedure are shown in
Table 2. They show that 2 hr after a dose of reserpine the concentration of 5-OR
indolyl compounds in the cerebrospinal fluid of 3 dogs had risen to approximately
twice the concentration observed in control animals. It is also shown that the level
of the 5-OR indolyl compounds in the caudate nucleus had not fallen 2 hr after the
injection of reserpine. In another experiment in which reserpine had been
administered to two dogs over a period of 4 days (0.5 mg/kg body weight on day 1
and 0.25 mg/kg body weight on days 3 and 4), it was found that on the fifth day the
concentration of 5-OR indolyl compounds in the caudate nuclei (Table 3) had fallen
Table 3
EFFECT OF CHRONIC ADMINISTRATION OF RESERPINE ON THE CONCENTRATION
OF TOTAL 5-OR INDOLYL COMPOUNDS IN THE CEREBROSPINAL FLUID AND THE
CAUDATE NUCLEUS
Concentrations expressed as ng 5-hydroxyindol-3-ylacetic acid/ml. cerebrospinal fluid or ng
5-hydroxyindol-3-ylacetic acid/g tissue
Concentration of total 5-OR indolyl compounds
on 5th day after initial reserpine administration
Reserpine Cerebrospinal fluid samples
administered » . Caudate
over 4 days 1 2 3 4 nucleus
Dog 1 46 84 105 — 282
Dog 2 98 83 83 89 - 262
Control dog 39 63 51 80 1,020
to less than half of the control values shown in Tables 2 and 3. This experiment
also gave information on the concentration of 5-OR indolyl compounds in. the cere¬
brospinal fluid after chronic reserpine administration. Consecutive 2 ml. samples
of cerebrospinal fluid were obtained from each animal under ether anaesthesia. The
results are shown in Table 3, and show that after the chronic administration of
reserpine the concentration of 5-OR indolyl compounds in the cerebrospinal fluid
is at a normal or slightly elevated level despite the greatly reduced concentration
in the tissues.
The absence of a fall in the concentration of 5-OR indolyl compounds in the
caudate nucleus 2 hr after an injection of reserpine suggested further investigation.
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It has been shown (Paasonen & Vogt, 1956) that there is a fall in the concentration
of 5-hydroxytryptamine in the caudate nucleus of the dog 4.5 hr after an injection
of reserpine in a dose of 0.5 mg/kg. Brodie (1958) demonstrated that in the rabbit
a dose of 1 mg/kg of reserpine will deplete 75% of the 5-hydroxytryptamine in the
brain in 30 min. Recently, Brodie, Finger, Orlans, Quinn & Sulser (1960) have
reported that stress will inhibit the release of 5-hydroxytryptamine from the brain
after the administration of reserpine. The possibility that the stress of anaesthesia
and subsequent operations was preventing the release of 5-hydroxytryptamine in
the foregoing experiments was therefore investigated.
Two dogs were trained for seven days to lie quietly while the preparations for an
intravenous injection were carried out. On the eighth day they were injected intra¬
venously with reserpine (2 mg/kg body weight). Within 30 min the animals were
exhibiting effects of the reserpine such as tremor, vomiting and in one case circling
movements. These symptoms disappeared after 15 min and the animals became
sedated. 2.5 hr after the injection of reserpine the animals were anaesthetized and
killed. The concentration of total 5-OR indolyl compounds in the caudate nuclei
of these two animals was 740 ng/g and 755 ng/g. This result demonstrated that
the concentration of 5-OR indolyl compounds in the caudate nucleus of the dog
Table 4
CONCENTRATION OF 5-OR INDOLYL COMPOUNDS IN THE CAUDATE NUCLEUS
OF THE DOG
Concentrations expressed as ng 5-hydroxyindol-3-ylacetic acid/g tissue
Total 5-OR Acidic 5-OR Basic 5-OR
indolyl compds indolyl compds indolyl compds
Control dogs 610 184 485
845 285 631
2 hr after reserpine 650 478 172
(2 mg/kg intravenously) 670 557 189
does not fall 2.5 hr after the injection of reserpine despite the fact that the reserpine
had an obvious effect on the behaviour of the animal, and that any " stress " was
avoided.
Sharman (1960) has shown that a substance behaving like 5-hydroxyindol-3-
ylacetic acid can be extracted from dog brain tissue, and a second explanation was
that 5-hydroxyindol-3-ylacetic acid, formed by the action of monoamine oxidase
on the 5-hydroxytryptamine released by reserpine, was remaining in the brain tissue.
The following experiment was carried out on four litter-mate puppies. Two of
the dogs were injected intravenously with reserpine (2 mg/kg body weight). After
2 hr the animals were anaesthetized, bled out and the caudate nuclei removed and
analysed for total, acidic, and basic 5-OR indolyl compounds. The caudate nuclei
from the two control dogs were analysed in a similar way. The results obtained
are shown in Table 4. They show that an acidic indolyl compound, presumably
5-hydroxyindol-3-ylacetic acid, is increased by about as much as the 5-hydroxy¬
tryptamine is reduced after reserpine; the formation of this metabolite and its
persistence in the tissue explain the absence of a reduction in the total 5-OR
indolyl compounds 2 hr after reserpine.
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Effect of imipramine on the concentration of 5-OR indolyl compounds in the
cerebrospinal fluid
Marshall, Stirling, Tait & Todrick (1960) have demonstrated that imipramine
produced a fall in the concentration of 5-hydroxytryptamine in the blood platelets
in man. A reduction to about 50% of control levels was observed after this drug
had been administered daily for 5 days. Costa (1960) has observed that imipramine
will increase the 5-hydroxytryptamine content of several organs in the rat within
5 hr after the administration of the drug.
The effect of imipramine on the level of 5-OR indolyl compounds in the cerebro¬
spinal fluid was examined. Preliminary experiments in which cerebrospinal fluid
was collected by method 2 did not indicate acute changes in the level of 5-OR
indolyl compounds in the cerebrospinal fluid after a single dose of imipramine.
The chronic effect of this drug on concentration of 5-OR indolyl compounds in
cerebrospinal fluid was investigated using the third method of collection in which
daily samples of cerebrospinal fluid were obtained from anaesthetized dogs. Control
samples of cerebrospinal fluid were collected on four successive days from three
dogs and on two successive days from one dog. After an interval of three days
Table 5
EFFECT OF IMIPRAMINE ON THE CONCENTRATION OF TOTAL 5-OR INDOLYL
COMPOUNDS IN THE CEREBROSPINAL FLUID
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two of the animals were injected intramuscularly with imipramine, twice daily,
starting with 2 doses of 100 mg on the first day of injection, and increasing the
doses on subsequent days by 50 mg per day to twice 250 mg on the fourth day
of injection. One animal was then found to be suffering from gross oedema at the
site of the injections, and was anaesthetized, bled out and the caudate nuclei dissected
out from the brain. The other dog was therefore given the last dose by mouth. It
was killed the following day. On each day during the experiment approximately
2 ml. of cerebrospinal fluid was obtained from each of these animals and also from
the two control dogs. The results of this experiment are shown in Table 5. They
show that there is only a small day-to-day variation in the concentration of 5-OR
indolyl compounds in the cerebrospinal fluid of normal dogs. Bleeding into the
cerebrospinal fluid occurred in one of the animals (no. 3) which was receiving
imipramine. The cerebrospinal fluid on subsequent days was xanthochromic and
the concentration of total 5-OR indolyl compound rose sharply probably because
of the release of 5-hydroxytryptamine from blood platelets during clotting at the
site of the bleeding. The observations on the remaining animal which had been
treated with imipramine do not indicate any change in the concentration of total
5-OR indolyl compounds in the cerebrospinal fluid as a result of the administration
of this drug. Imipramine did not produce a definite change in the concentration
of total 5-OR indolyl compounds in the caudate nuclei in this experiment.
DISCUSSION
The experiments described here have shown that changes in the concentration
of total 5-OR indolyl compounds in the cerebrospinal fluid can reflect changes in
the metabolism of 5-hydroxytryptamine such as those occurring after the administra¬
tion of reserpine. The changes in 5-hydroxytryptamine metabolism which were
presumed to occur after imipramine were not reflected by any change in the cere¬
brospinal fluid level of 5-OR indolyl compounds.
The change in metabolism of 5-hydroxytryptamine after a single injection of a
large dose of reserpine is very great and it is possible that smaller changes might
not be obvious when the acute experimental methods described here are employed.
The demonstration that the release of the metabolites of 5-hydroxytryptamine is a
slow process led to the conclusion that the chronic experiment would be more useful
in the detection of small changes in the metabolism of 5-hydroxytryptamine, provided
that the change persisted for some time. Relatively small chronic changes should
be detectable because the day-to-day variation in the concentration of total 5-OR
indolyl compounds in the cerebrospinal fluid of normal animals is small. It is not
possible to determine from these experiments the origin of the 5-OR indolyl com¬
pound or compounds appearing in the cerebrospinal fluid after reserpine treatment.
The observations on the total, acidic and basic 5-OR indolyl compounds in the
caudate nucleus show that a better evaluation of the metabolism of these compounds
in the tissues can be obtained by estimating all fractions. The main acidic 5-OR
indolyl compound in brain is 5-hydroxyindol-3-ylacetic acid (Sharman, 1960)
and the main basic compound is 5-hydroxytryptamine (Bogdanski et al., 1956).
There is the possibility that other acidic and basic compounds are present in the
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brain. 5-Methoxyindol-3-ylacetic acid has been isolated from the pineal gland by
Lerner, Case, Biemann, Heinzelman, Szmuszkovicz, Anthony & Krivis (1959), and
other 5-OR indolyl derivatives such as lV-acetyl-5-methoxytryptamine have also been
isolated (Lerner, Case & Heinzelman, 1959). Because the methods used here would
not distinguish all of these compounds it was found preferable to describe the
substances by the general term of 5-OR indolyl compounds.
This work was carried out during the tenure by G. W. A. of a Medical Research Council
Fellowship for training in clinical research.
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Administration to mice and guinea pigs of a-methyl-dihydroxyphenylalanine
(a-methyldopa), an inhibitor of dihydroxyphenylalanine (dopa) decarboxylase and
5-hydroxytryptophan decarboxylase, has been shown to reduce the concentration of
5-hydroxytryptamine (5-HT) in the brain (Smith, 1960). This has been confirmed by
other workers using these and other species, and it has since been found that depletion
of the noradrenaline in the brain also occurs (Kuntzman, Costa, Gessa, Hirsch
and Brodie, 1961). There is a difference in the behaviour of the 5-HT and the
noradrenaline levels after administration of a-methyldopa; whereas 5-HT con¬
centrations remain low for a few hours only, noradrenaline levels remain low for
several days (Hess, Ozaki and Udenfriend, 1960). These findings indicate that 5-HT
and noradrenaline are either depleted by different mechanisms, or that there is a
difference in the rate of restoration of the stores of the two amines; or both may be
true. It seems likely that 5-HT depletion results from inhibition of 5-hydroxytrypto-
phan decarboxylase, because the time course of the depletion coincides roughly with
the presence of the a-methyldopa in the brain (Murphy and Sourkes, 1959). There
is no such correlation in the case of noradrenaline depletion and it has been suggested
that noradrenaline is released from its binding sites in the brain by a-methyldopa or
by its metabolites (Carlsson, 1961).
The following investigations were made to find out whether evidence could be
obtained of the release of stored 5-HT after administration of a-methyldopa. Evidence
that release of 5-HT in the body can be detected by an increase in the concentration
of 5-hydroxyindolylacetic acid in the urine has been presented by Shore, Silver
and Brodie (1955). Ashcroft and Sharman (1961) have shown that there is also an
increase in the acidic 5-OR indolyl compounds (where R is hydrogen, an alkyl or an
aryl group), presumably of 5-hydroxyindolylacetic acid, in the brain of the dog,
after an injection of reserpine. The possibility that a-methyldopa might produce a
similar increase in the acidic 5-OR indolyl compounds in the brain was therefore
studied.
METHODS
Groups of female albino rats were given intraperitoneal injections of saline or a-methyldopa
(400 mg/kg) and killed at intervals thereafter. The cerebellum and a large portion of the cerebral
cortex were removed from the brain and an extract of the remaining tissue was prepared by depro-
teinising a dilute acid homogenate with zinc sulphate and sodium hydroxide. A portion of this
solution was made 3 n with respect to hydrochloric acid and the fluorescence was measured in an
Aminco-Bowman spectrophotofluorometer. (Activation wavelength 285 mfluorescence wavelength
540 m/i. Uncorrected instrumental values.) This gives an estimate of the concentration of total 5-OR
indolyl compounds present in the tissue. The basic 5-OR indolyl compounds were extracted from a
portion of the deproteinised solution by the method described for 5-HT (Bogdanski, Pletscher,
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Brodie and Udenfriend, 1956). The extraction of acidic 5-OR indolyl compounds was carried out
by the method described for 5-hydroxyindolylacetic acid (Udenfriend, Titus and Weissbach, 1955).
The fiuorimetric estimation of both the acidic and basic fractions was similar to that described for
the total 5-OR indolyl compounds.
RESULTS AND DISCUSSION
Any difference between the measured total and the total obtained by summation
of the two fractions would represent neutral and amphoteric 5-OR indolyl compounds
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Fig. 1.—Rat brain 5-OR indolyl compounds after administration of a-methyldopa
(400 mg/kg) at zero time. • Total 5-OR indoles. ▲ — A Basic fraction.
O—O Acidic fraction. Points are means of 8 results. Vertical lines represent s.e.m.
Absence of a vertical line indicates that the standard error is smaller than the symbol
used.
The results were calculated as /rm-moles of 5-OR indolyl compounds per g brain.
It can be seen (Fig. 1) that the concentrations of total, basic and acidic 5-OR indolyl
compounds decreased progressively with time after injection of a-methyldopa.
There is no evidence of the release of 5-HT because, in spite of a large decrease
in the basic fraction, the concentration of the acidic fraction did not increase as it
did after reserpine (Ashcroft and Sharman, 1961).. The acidic fraction diminished
continuously suggesting that the utilization of the stored 5-HT was falling con¬
tinuously. There was a significant difference between the measured total and the
sum total of the basic and acidic fractions at 2 hr (P < 0-05) and 3 hr (P < 0-01)
after treatment. This indicates accumulation of a very small amount of a neutral
or amphoteric 5-OR indolyl compound, possibly 5-hydroxytryptophan. Cooper
and Melcer (1961) suggest that the brain derives its supply of 5-hydroxytryptophan
from the circulation. If this uptake were inhibited by a-methyldopa, this would
lead to a diminished amount of 5-HT in the tissue, but not to an accumulation of
5-hydroxytryptophan such as one might expect to occur if inhibition of dopa decar¬
boxylase were the sole action of the drug.
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Further interference by a-methyldopa with the metabolism of the 5-OR indolyl
series of compounds could occur if a-methyldopa or its metabolites interfered with
monoamine oxidase. The possible inhibitory actions of a-methyldopa, a-methyl-m-
tyrosine (another decarboxylase inhibitor), a-methyldopamine, a-methyl-m-tyramine
(their decarboxylated derivatives), Cobefrine and metaraminol (the /3-hydroxylated
amine derivatives) on rat brain monoamine oxidase were investigated manometrically
using 5-HT as substrate. Results of these experiments (Table 1) show that the amino
acids themselves had no inhibitory effect, the /3-hydroxylated amines had very little
effect, but both a-methyldopamine and a-methyl-m-tyramine showed some inhibitory
activity. These results are consistent with the predictions made by Blaschko (1940)
for this type of compound.
Theoretically therefore, the decarboxylation metabolite could interfere with the
metabolism of 5-HT by inhibiting monoamine oxidase, although the concentration
required appears to be large. Any such inhibition would limit the decrease in the
basic fraction and cause a decrease in the acidic 5-OR indolyl fraction. Such changes
were observed between 2 hr and 3 hr after treatment with a-methyldopa, but they are
not necessarily due to inhibition of monoamine oxidase.
It is apparent that a-methyldopa could influence the metabolism of 5-HT in the
brain in four ways:—•
1. Inhibition of the decarboxylation of 5-hydroxytryptophan.
2. Inhibition of monoamine oxidase by a-methyldopamine, a metabolite of
a-methyldopa.
3. Inhibition of uptake of 5-hydroxytryptophan.
4. Displacement or release of 5-HT by a-methyldopa or its metabolites.
Table 1.—Inhibition of rat brain homogenate
monoamine oxidase by various compounds*
Inhibitor Concentration % Inhibition
a-Methyldopa 5 X 10~3 m 0
a-Methyl-m-tyrosine 5 X 10~3 m 0
a-Methyldopamine 5 X 10-4 m 32
5 X 10-3 m 76
a-Methyl-/»-tyram ine 5 X 10"4 M 27
5 X 10~3 m 68
Cobefrine 5 X 10"3 m 14
metaraminol 5 X 10~3 M 13
* Manometric investigations using 5 x 10~3 m-5-hydroxy-
tryptamine as substrate.
Whereas mechanism 1 would be sufficient to explain the results obtained in this
work, a contribution by mechanisms 2 and 3 is not ruled out. The evidence is against
the liberation of 5-HT (mechanism 4) because no increase in the concentration of
acidic 5-OR indolyl compounds was observed.
SUMMARY
The effect of a-methyldopa on the metabolism of 5-HT in the brain of the rat has
been studied. No evidence was obtained to suggest that this drug causes an increased
release of 5-HT in the brain. Other ways in which the metabolism of 5-HT might be
affected by this drug are considered.
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It has been shown that the administration of 2-amino-tetralin (/3-tetrahydronaphthyl-
amine) to the mouse results in a decrease in the concentration of 5-hydroxyindol-3-ylacetic
acid, an acid metabolite of 5-hydroxytryptamine, in the brain (Sharman, 1966). This
report attempts to explain the mechanism by which this change is brought about.
METHODS
All chemicals and reagents were of analytical reagent quality.
The following drugs were used: L-a-methyl-3,4-dihydroxyphenylalanine (a-methyldopa), Merck,
Sharp and Dohme. 2-Amino-tetralin hydrochloride (2-amino-l,2,3,4-tetrahydronaphthalene
hydrochloride; /3-tetrahydronaphthylamine hydrochloride), Dr. Theodor Schuchardt G.m.b.H.
Pheniprazine (JB 516; /3-phenylisopropylhydrazine hydrochloride), Lakeside Laboratories Inc.
L-tryptophan, Hopkins & Williams Limited.
Drugs were injected intraperitoneally dissolved in 0.9% sodium chloride solution except for
L-tryptophan which was triturated in 0.9% sodium chloride in an agate mortar to yield a very fine
suspension of the amino acid (Ashcroft, Eccleston & Crawford, 1965).
Male albino mice, 20-35 g wt. were used throughout. The tissue used for analysis was obtained
as follows: the animals were stunned, decapitated and the brains taken out and placed on a glass
plate in an ice bath. Olfactory bulbs, cerebellum, medulla and pons were removed, and the
remaining brain tissue from three mice was combined for each estimation. The tissue was homo¬
genised in 2 vol. of 0.1 N-hydrochloric acid together with 5-10 mg ascorbic acid in a Griffith pattern
glass tissue grinder and the homogenate diluted with 1 vol. of water. One millilitre of 16% zinc
sulphate (ZnS0i.7H20) and 0.1 ml. 20% sodium hydroxide were added and the homogenate was
centrifuged for 5 min at 3,500 rev/min. The supernatant fluid was filtered to remove floating fatty
material and the precipitate washed with water. After centrifuging, the washings were also filtered
and combined with the first supernatant fluid. The total volume was 6 ml. Of this, 4 ml. was
used to estimate 5-hydroxyindol-3-ylacetic acid and 2 ml. was used to estimate 5-hydroxytryptamine.
5-Hydroxyindol-3-ylacetic acid was estimated fluorimetrically as acidic 5-OR indolyl compounds
(Ashcroft & Sharman, 1962). 5-Hydroxytryptamine was estimated, in principle, as described by
Bogdanski, Pletscher, Brodie & Udenfriend (1956).
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The results are shown in Fig. 2. Tryptophan given in doses of 100 mg/kg and 400
mg/kg caused a significant increase in the concentration of 5-hydroxyindol-3-ylacetic
acid (P<0.01) but only the larger dose of the amino acid produced a small but significant
(P<0.01) increase in 5-hydroxytryptamine. The administration of 2-amino-tetralin in
combination with tryptophan reduced the increase in 5-hydroxyindol-3-ylacetic acid. In
addition there was now a significant increase (P<0.01) in 5-hydroxytryptamine above
control values with both doses of tryptophan.
The effect of pheniprazine and a-methyldopa
The effect of the monoamine oxidase inhibitor pheniprazine (2 mg/kg and 5 mg/kg)
and of a-methyldopa (400 mg/kg), alone and combined, on the concentrations of
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Fig. 3. The effect of pheniprazine and a-methyl-S^-dihydroxyphenylalanine on the concentrations
of 5-hydroxyindol-3-ylacetic acid and 5-hydroxytryptamine in the brain of the mouse.
A = control; B = pheniprazine (2 mg/kg); C=pheniprazine (5 mg/kg); D = <x-methyldopa
(400 mg/kg); E=a-methyldopa (400 mg/kg) and pheniprazine (5 mg/kg). Results are given
as means+ s.e.m. expressed as a percentage of the mean control value. The observations were
made 2 hr after the administration of the drugs.
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shown in Fig. 3. Like 2-amino-tetralin (Fig. 1) pheniprazine lowered the tissue content
of 5-hydroxyindol-3-ylacetic acid, but produced a significant accumulation of
5-hydroxytryptamine, which did not occur after 2-amino-tetralin. When doses of
a-methyldopa and of pheniprazine, which alone produced equal falls in the concentration
of 5-hydroxyindol-3-ylacetic acid, were combined the effects on the acid were additive
(Fig. 3). The same combination of drugs also had additive effects on the tissue content
of 5-hydroxytryptamine, the rise produced by pheniprazine and the fall caused by
ff-methyldopa cancelling each other out. This was not observed when 2-amino-tetralin
and ff-methyldopa were combined.
DISCUSSION
5-Hydroxyindol-3-ylacetic acid is formed from 5-hydroxytryptamine by the action of
the enzymes monoamine oxidase and aldehyde dehydrogenase. The simplest explanation
for a decrease in this acid metabolite after 2-amino-tetralin would be inhibition of these
enzymes. However, the fall in the concentration of 5-hydroxyindol-3-ylacetic acid in
the brain should then be accompanied by an increase in 5-hydroxytryptamine. The
administration of the known monoamine oxidase inhibitor pheniprazine caused a signi-
cant increase in the concentration of 5-hydroxytryptamine even with a dose that produced
a fall in the concentration of 5-hydroxyindol-3-ylacetic acid smaller than that seen after
2-amino-tetralin. However, no increase in the amine was seen after 2-amino-tetralin.
That the effect of 2-amino-tetralin is due to inhibition of the enzyme aldehyde dehydro¬
genase is unlikely since it has been shown that the formation of homovanillic acid, an
acid metabolite of dopamine is, in fact, accelerated in the mouse brain by the administra¬
tion of 2-amino-tetralin (Sharman, 1966). The evidence thus suggests that the enzymic
processes by which 5-hydroxytryptamine is oxidized to 5-hydroxyindol-3-ylacetic acid
are unaffected by 2-amino-tetralin.
Ashcroft et al. (1965) and Eccleston, Ashcroft & Crawford (1965) have shown how
tryptophan loading of animals can be used to study the intermediate metabolism of
5-hydroxyindole compounds in tissues. The present results with tryptophan loading
suggest that the ability to synthesize 5-hydroxytryptamine in the brain is not arrested
by 2-amino-tetralin since there is an increased level of 5-hydroxytryptamine when both
tryptophan and 2-amino-tetralin are given together. The reduced formation of
5-hydroxyindol-3-ylacetic acid, however, suggests that some step in the conversion of
5-hydroxytryptamine to 5-hydroxyindol-3-ylacetic acid is impaired by the administration
of 2-amino-tetralin.
A possible point in this conversion which might be affected is the rate of release and
transport of the amine to a site where it can be metabolized to the acid. The rate at
which an amine is being used in the brain can be studied by blocking its synthesis and
measuring the rate of its disappearance from the tissue. a-Methyldopa blocks the
synthesis of 5-hydroxytryptamine in the brain (Smith, 1960). The present experiments
show that the rate of fall of 5-hydroxytryptamine after a-methyldopa is unaffected
by the simultaneous administration of 2-amino-tetralin, and thus it would appear that
the rate of release of 5-hydroxytryptamine from its storage sites is proceeding at a
normal rate.
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Yet this need not be so when 2-amino-tetralin is given alone. Assuming this com¬
pound inhibited the release of 5-hydroxytryptamine, one would not only have expected
that the decrease in tissue 5-hydroxytryptamine following the administration of a-methyl-
dopa would be checked by 2-amino-tetralin, but also that there would have been a
larger fall in tissue 5-hydroxyindol-3-ylacetic acid when the two drugs were given
together.
No such additive effects would be expected, however, if the release of 5-hydroxytrypta¬
mine by 2-amino-tetralin were inhibited by a reflex response which counteracts or
balances a direct effect of the drug on some other neural mechanism. Such a reflex
response may not be elicited in the presence of o-methyldopa because the release of
5-hydroxytryptamine is already sufficiently lowered by inhibition of synthesis. Thus
the effect of a combination of the two drugs on the concentration of 5-hydroxytryptamine
would not be additive.
The effects of 2-amino-tetralin on the metabolism of monoamines in the brain are not
the same in different species of animals. Juorio & Vogt (unpublished) have shown that in the
rat this drug produces changes similar to those seen in the mouse, whereas in the pigeon
the levels of both dopamine and 5-hydroxytryptamine and their acid metabolites were
depressed.
SUMMARY
1. The administration of 2-amino-tetralin (/3-tetrahydronaphthylamine) to the mouse
causes a fall in the concentration of 5-hydroxyindol-3-ylacetic acid in the brain without
changing the concentration of 5-hydroxytryptamine.
2. A comparison of the effect of 2-amino-tetralin with the fall in 5-hydroxyindol-3-
ylacetic acid and the increase in 5-hydroxytryptamine produced by pheniprazine, a known
inhibitor of monoamine oxidase, shows that the change in 5-hydroxyindol-3-ylacetic acid
caused by 2-amino-tetralin is not a result of inhibition of this enzyme.
3. The effect of 2-amino-tetralin on the cerebral concentrations of 5-hydroxyindol-3-
ylacetic acid and 5-hydroxytryptamine in mice given a loading dose of tryptophan
suggested that it is a slowing rate of utilization of 5-hydroxytryptamine that plays the
major role in causing the reduction of 5-hydroxyindol-3-ylacetic acid. However, when
the synthesis of 5-hydroxytryptamine was inhibited by «-methyl-3,-4-dihydroxyphenylala-
nine the administration of 2-amino-tetralin did not appear to reduce the rate at which
5-hydroxytryptamine disappeared from the brain.
4. It is suggested that the effect of 2-amino-tetralin on the cerebral metabolism of
5-hydroxytryptamine in the mouse might be an indirect effect of the drug. Because the
inhibition of synthesis of 5-hydroxytryptamine by «-methyl-3,4-dihydroxyphenylalanine
brings about a reduction in the rate of utilization of the amine, the effects of a combina¬
tion of these two drugs need not be additive.
The authors would like to thank Miss R. Dickinson for her help with this work and Dr. M. Vogt,
F.R.S., for her advice and encouragement. We are grateful to the following for their generous gifts
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Mantegazzini and Glasser (1960) have shown that injection of dihydroxyphenyl-
alanine (DOPA) J into an external cartoid artery of a cerveau isole preparation of the cat
caused arousal, whereas the intravenous injection of the same amount had no such
effect. The injection into the cartoid artery of dopamine, the amine formed in the body
from DOPA by decarboxylation, did not produce arousal. It is known that dopamine
does not readily penetrate the blood-brain barrier, whereas DOPA passes more easily.
The conclusion drawn by Mantegazzini and Glasser was that either DOPA itself, or
one of its metabolites formed in the brain, were responsible for the arousal. The present
experiments were undertaken in order to try and trace the chemical changes produced
in the brain by the arterial infusion of DOPA. The technique was modified in such a
way that the DOPA was trapped essentially in one half of the brain; thus it became
possible to detect any changes resulting from the infusion by a comparison of the
chemical composition of the two sides.
METHODS
A preliminary series of experiments was done on cats anaesthetized with pentobarbitone sodium.
With this technique no information can be obtained from the electroencephalogram, since the anaes¬
thetic causes a persistent sleep pattern, but chemical estimations can be carried out. In the main
experiments the cerveau isole was prepared by the method of Mantegazzini and Ferrara (1960).
Under ether anaesthesia a hole of about 1 cm2 was drilled in the skull just anterior to the occipital
protuberance. The brain was then transected by means of a spatula oriented stereotaxically so as to
cut in a plane inclined at 45° and passing dorsally through the inferior colhculi and ventrally through
the midbrain just anterior to the border of the pons. After this transection the EEG shows a pattern of
sleep "spindles" and the pupils are maximally constricted.
The arterial infusion of DOPA was made through fine polythene tubing tied into the right lingual
artery, the tip of the tubing lying at the junction of the lingual and carotid arteries. A ligature around
the lingual artery fixing the tip of the catheter very near this junction ensured that none of the infused
fluid escaped into branches of the lingual artery instead of entering the carotid blood stream. The
tubing was filled with heparinized saline and firmly clamped to avoid blood entering it and a clot
forming before the infusion was started. By infusing a 0-5 % solution of DOPA at a rate of only about
0-1 ml/min any interference with the circulation to the brain was avoided. The drug was mainly
distributed to the side of the infusion since the infusion was too slow to cause any local rise in pressure.
Before infusing the DOPA a test injection was made of a single dose of a few ,ttg adrenaline; pupillary
dilation restricted to the side of the injection indicated that there was little or no mixing of the blood
supply to the iris.
* Rilcer Fellow,
f Beit Memorial Fellow.
% Abbreviation used: DOPA, dihydroxyphenylalanine.
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The electroencephalograms were obtained by inserting metal screws into two small drill holes made
symmetrically in the skull above the parietal cortex and connecting these to an Ediswan EEG recorder.
One or more hr were allowed to elapse between the brain transection and the first recordings. As soon
as control recordings had been made, infusion of DOPA was begun and pupils and EEG observed.
The experiments were normally terminated when changes had occurred on the side of the infusion;
this usually required no less than 15 min. When no difference between the two sides was observed,
the infusion was stopped after 45 min and the brain excised. It was cut in the midline and each side
analysed separately. In one series ofexperiments, dopamine was estimated in the caudate nuclei, and
noradrenaline in the hypothalamus. In the remaining experiments dopamine was not only estimated in
the caudate nuclei but also in the tissue containing the reticular formation. When the preparation was
a cerveau isole. the regions examined were hypothalamus, mesencephalic central grey, and tegmentum.
When the brain had not been transected, the region containing the upper part of the bulbar reticular
formation was included in the pooled tissues. In these experiments noradrenaline was not estimated.
Dopamine estimations. The tissue was quickly weighed and homogenized in twice its weight of
0-1 n-HCI to which either a little ascorbic acid or a few crystals of potassium metabisulphite (K2S2Os)
had been added. The homogenate was diluted with water to five times its volume and the protein
precipitated with an equal volume of 0-8 m-HC104. Removal of the perchloric acid and adsorption of
the dopamine to a column of Dowex 50-X 8 was then carried out as described by Bertler, Carlsson,
Rosengren and Waldeck (1958). The column was washed with 6-10 ml 0-4 n-HCI to remove any
DOPA and noradrenaline, and the dopamineeluted with 6 or 8 ml 2n-HC1. Estimation of the dopamine
was carried out fluorimetrically after condensation with ethylene diamine according to the procedure
of Weil-Malherbe and Bone (1952, 1957). Recovery of dopamine added to a sample of the original
homogenate was determined in every experiment, and correct development of fluorescence was ascer¬
tained by estimating the fluorescence produced by a known amount of dopamine added to a fraction
of the final eluate. Recoveries amounted to about 70 % when the higher concentrations in the caudate
nucleus were estimated, and to approximately 35 % from the hypothalamus and midbrain where the
concentration is very near the threshold of the method: when the size of the column was increased,
and a new batch of resin employed, recovery of the small amounts rose to that of the larger quantities.
Noradrenaline estimations. The majority of the estimations were done by bioassay on the pithed
rat's blood pressure after chromatography on paper in a phenol-HCl system (Vogt, 1952, 1953, 1954;
Muscholl and Vogt, 1957). Some of the control experiments, however, were done by fluorimetry,
and the procedure adopted was identical with that described by Sharman, Vanov and Vogt (1962). It
consisted essentially in the adsorption to the resin Dowex 50-X 8 (Bertler et al., 1958) followed by
elution and fluorimetric estimation of the trihydroxyindole derivative of noradrenaline (von Euler
and Floding, 1955; von Euler and Lishajko, 1961). In ten such experiments, in which DOPA had
not been given, the hypothalamus or midbrain of one hemisphere was analysed by fluorimetry, that of
the other by bioassay. In seven of these parallel estimations the concentrations found, after correction
for recovery, were within 13 % of each other. In the three remaining instances, the result of the
chemical estimation was 42, 50, and 75 % respectively above that of the biological assay. Since the
aberrant figures were all obtained on one day, there was probably some uncontrolled factor operating
on this particular occasion. However, attempts at using the fluorimetric estimation for experiments in
which DOPA had been infused gave values which were much higher than those obtained by bioassay,
and it was concluded that enough DOPA was retained in the column and eluted with the noradrenalint
to render the method unsuitable.
RESULTS
A first group of five experiments (Table 1) in which DOPA was given into the righl
lingual artery was carried out on cats under pentobarbitone. It gave preliminary infor¬
mation on the changes in catecholamines produced in the brain. The dopamine of the
caudate nucleus was higher on the side of the infusion, but the rise was large in only two
experiments. The concentration on the contralateral side was within the normal limits
shown in three control experiments (Nos. 7-9), in which cats were either only anaes¬
thetized or given an infusion of saline into the right lingual artery. The hypothalamic
noradrenaline concentration was a little higher on the side of the DOPA infusion, but
the largest increase of 36 % was at the very limit of the discrimination of the method of
assay. Noradrenaline concentrations in the midbrain were not significantly different
on the two sides.
Table 2 summarizes the next series of experiments in which the brain had beei
transected and EEG records were taken. In all cats there was some mydriasis on the
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Table 1.-—Cats in pentobarbitone anaesthesia
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« • • , , Noradrenaline
DOPA infused Dopamine m caudate nucleus
Cat; , «— , , • , in hypothalamus in 'midbrain'")"
No. mg min L R % rise L R % rise L R
1 15 30 11-3 14-3 27 11 1-5 36
2 20 42 8-1 19-7 145 — — —
3 15 33 ■—• —• — 1-3 1-6 23
4 15 30 11-5 12-9 12 11 1-5 36 0-17 016
5 15 31 9-5 150 58 0-9 10 6 008 0-12
7 0 Exsanguinated 6-9 6-8 1-5* 1-4 0-12 0-12*
under chloro¬
form
8 0 Pentobarbi¬ 11-6 1-3* 1-2
tone anaes¬
thesia





Catecholamine concentrations C«g/g fresh tissue) in different parts of the brain after an infusion of
dihydroxyphenylalanine (DOPA) into the right lingual artery. The figures have not been corrected for
recovery which was approx. 70 % throughout.
* Chemical estimation.
t "Midbrain" = tegmentum and periaqueductal grey.
side of the infusion; the dilated pupil responded to light; this response has been inter¬
preted by Mantegazzini and Ferrara (1960) as a central inhibition of oculomotor
tone due to the awakening effect of the drug. The mydriasis was followed in cats 1, 3
and 4 by electroencephalographic arousal which was either much more pronounced on,
or restricted to, the side of the infusion. The chemical findings showed that the dopa¬
mine content of the right caudate nucleus was more than twice that of the left, but that
the noradrenaline in the hypothalamus had not risen on the side of the infusion.
Judging by the physiological and chemical changes, it appears that, in these experi¬
ments, the effects of the infusion of DOPA were more completely restricted to the side
of the infusion than in the experiments of Table 1 in which the brain was not transected.










hemisphereL R % rise L R % rise
1 5 6 5-7 13-1 130 1-4 1-5 7 -f
2 15 19 7-5 15-7 109 11 11 0 —
3 20 22 6-9 16-4 138 1-1 11 0 +
4 20 30 6-2 14-8 138 1-3 1-3 0 + +
Catecholamine estimations (ttg/g fresh tissue) in different parts of the brain after an infusion of
dihydroxyphenylalanine (DOPA) into the right lingual artery. The figures have not been corrected for
recovery which was approx. 70% throughout.
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It is possible that the destruction of vessels inside the midbrain reduces the opportunity
for exchange of blood between the two sides.
In the caudate nucleus, dopamine is the dominant catecholamine; in this region of
the brain the oxidation of dopamine to noradrenaline apparently does not occur. In
the hypothalamus and midbrain, normal dopamine concentrations are very small
indeed (Bertler and Rosengren, 1959), and noradrenaline concentrations are high.
The dopamine in these regions may be no more than a precursor of noradrenaline. It
was of interest to know whether the infusion of DOPA only increased the dopamine at
the sites where it represents the final product of synthesis, or whether changes might
Table 3.—Dopamine estimations (ug/g fresh tissue) in different parts of the cat's
brain after an infusion of dihydroxyphenylalanine (DOPA) into
one lingual artery
Dopamine in
Caudate nucleus Hypothalamus and "reticular formation"*
Cat DOPA infused control side of control side of
No. mg min side infusion % rise side infusion % recovery % change
1 15 30 00 10-4 28 0-21 0-15 30 -29
2 15 28 11-1 17-5 58 0-14 0-35 30 150
3 15 31 9-2 10-7 16 0-38 0-49 36 29
4 — — — — 0-20 35
5 18 38 10-9 12-6 16 0-15 0-20 ? 33
6 14 28 10-7 16-4 53 0-58 0-82 69 41
7 12 26 10-2 17-5 73 0-55 1-67 82 204
Experiments 1-3 under pentobarbitone anaesthesia, experiments 5-7 on the cerveau isoli prepara¬
tion. Experiment 4, control figures for untreated cat. None of the figures are corrected for recovery,
Recoveries from the caudate nuclei about 70%. Changes below 0-1 ,ug/g are not significant.
* Consisting of tegmentum, periaqueductual grey and region of upper bulbar reticular formation
in experiments 1-4; of tegmentum and periaqueductual grey only, in the remaining experiments.
also occur in the parts where it may be only a precursor. Increases of dopamine in al!
parts of the brain had been found by Bertler and Rosengren (1959) after the intra¬
venous administration of DOPA to rabbits, but intravenous injections are not strictlj
comparable with arterial infusions in which much of the DOPA is immediately trapped
by the tissue.
A third series of experiments was therefore carried out, in which the dopamine was
not only estimated in the caudate nuclei but also in the noradrenaline-rich parts of the
brain, such as hypothalamus and midbrain. As before, differences in dopamine contenl
between left and right caudate nucleus were more pronounced in experiments carried
out on the cerveau isole (experiments 5-7, Table 3) than in those done on the intact brain
under pentobarbitone anaesthesia. Concentrations of dopamine in the hypothalamus
and midbrain reticular formation are so low that the accuracy of the estimation is less
than that for the caudate nucleus. Table 3 shows that the recoveries of dopamine,
added in amounts similar to those present in the mesencephalon, were at first muct
lower than in the tissues containing larger quantities. However, as explained under
"methods," the recoveries were greatly improved in expts. 6 and 7 and were similar
for all quantities of dopamine.
In all experiments, more dopamine was found in hypothalamus and midbrain oi
the side of the infusion than on the control side. The increase was largest when tit
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difference between the two caudate nuclei was most pronounced, but the highest abso¬
lute amount observed (1-6 /<g/g) was still only a small fraction of the content of the
normal caudate nucleus.
DISCUSSION
The most striking chemical difference between the two sides of the brain after
unilateral infusion of DOPA was a large increase, usually to more than double, of the
dopamine content of the caudate nucleus. In three of the four experiments in which
records were made of the EEG, there was arousal restricted to the side of the infusion.
The noradrenaline in the hypothalamus and in the midbrain was unchanged, and thus
it is tempting to attribute the arousal to the accumulation of dopamine in the caudate
nucleus. That the caudate nuclei can exert an effect on the arousal mechanism follows
from the work of Heuser, Buchwald and Wyers (1961). These authors showed that
electrical stimulation of the caudate nucleus at low frequencies produced spindles,
whereas high frequencies caused desynchronization of the EEG. The slow onset of the
response suggests that the DOPA itself is not responsible but a transformation product.
This view is supported by the well-known fact that arousal by DOPA can be greatly
facilitated by the administration of monoamine oxidase inhibitors, which favour the
accumulation of amines. Yet, the question remains, whether the most obvious chemi¬
cal change produced is also the one responsible for the arousal. It seemed particularly
important to make sure what happened in the reticular formation itself. Only very
small quantities of dopamine are normally found in those parts of the midbrain which
contain the reticular formation. This amount did not increase to high concentrations
after arterial infusion of DOPA, but the percentage increase was of the same order as
that found in the caudate nucleus. If we consider the dopamine in the reticular forma¬
tion entirely as a precursor to noradrenaline without any function of its own, this
increase should not have any physiological effects since the noradrenaline content of
the midbrain did not rise. If, however, dopamine is an active substance in its own
right also in regions in which its concentration is low and noradrenaline is the dominant
catecholamine, the possibility cannot be ruled out that a small increase at such a site
has physiological effects and could possibly cause arousal.
SUMMARY
Dihydroxyphenylalanine (5-20 mg) was infused into one cartoid artery of cats
through a catheter tied into one lingual artery. When dilatation of the pupil (anaesthe¬
tized cats) or encephalography arousal (cerveau isole preparation) had developed on
the side of the infusion, the brain was removed and catecholamine estimations were
carried out in different regions of the two cerebral hemispheres.
The dopamine content of the caudate nucleus was increased on the side of the
infusion, often by more than 100%.
The dopamine content of hypothalamus and midbrain-reticular formation of the
treated side was increased by a similar proportion.
The noradrenaline content of the hypothalamus and of the midbrain was not raised
by the infusion.
The possible relationship of chemical and physiological changes elicited by the
infusion is discussed.
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The distribution of dopamine (3,4-dihydroxyphenylethylamine) between the sub¬
cellular fractions from homogenates of dog caudate nucleus was compared with the
distributions of acetylcholine, 5-hydroxytryptamine and lactate dehydrogenase activity.
The distributions of noradrenaline and 5-hydroxytryptamine between the subcellular
fractions from homogenates of dog hypothalamus were also determined. Most of the
dopamine, in contrast to acetylcholine, occurred in the soluble supernatant fraction ;
the remainder was associated with the fractions rich in pinched-off nerve ending
particles, but localization in any one fraction was not as sharp as that of acetylcholine.
Evidence is presented that suggests that the dopamine occurs in a free or easily
released form throughout cell cytoplasm.
In a study of the subcellular distribution of dopamine (3,4-dihydroxyphenylethyl¬
amine) in the brain stem of the rabbit, Weil-Malherbe & Bone (1957b, 1959) found
that after high speed centrifugation the amine was equally distributed between the
particulate material and the supernatant fractions and that approximately 40%
of the total dopamine in the brain stem was associated with that fraction of the
particulate material which contained the mitochondria. More recently, Bertler,
Hillarp & Rosengren (1960), using caudate nuclei from cats and rabbits, and Weil-
Malherbe, Posner & Bowles (1961), using rabbit brain, have found that after sub¬
cellular fractionation only 25% of the dopamine was recovered in the particulate
material so that the majority of the dopamine seemed to occur in the " cytoplasmic
sap." A cytoplasmic localization for dopamine was also found in bovine splenic
nerves by Schumann (1958).
Originally, it was thought that the amines acetylcholine and 5-hydroxytryptamine
found in the central nervous system were associated with subcellular structures
similar to or identical with mitochondria (Bodian, 1942 ; Brodkin & Elliott, 1953 ;
Walaszek & Abood, 1957). More recent work using techniques of differential and
density gradient centrifugation have demonstrated that acetylcholine (Hebb &
Whittaker, 1958; Whittaker, 1959), 5-hydroxytryptamine (Whittaker, 1959;
Michaelson & Whittaker, 1963) and noradrenaline (Chrusciel, 1960 ; Michaelson,
unpublished) are associated with a distinct subfraction of brain homogenates which
* Present address: Laboratory of Chemical Pharmacology, National Heart Institute, N.I.H.,
Bethesda 14, Maryland, U.S.A.
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has been shown by electron microscopy to consist mainly of pinched-off nerve
ending particles (Gray & Whittaker, 1962) ; for these particles the name " synapto-
some " has recently been adopted (Whittaker, Michaelson & Kirkland, 1963b).
The present investigation was undertaken to examine the subcellular localization
of dopamine in the dog caudate nucleus and to obtain information as to the nature
of the subcellular structure with which dopamine is associated. This region was
selected because of its known high content of dopamine. A comparison was made
with the subcellular distributions of acetylcholine and 5-hydroxytryptamine, also
present in this tissue in relatively high concentrations. Lactate dehydrogenase was
used as a cytoplasmic marker and comparisons were made with the distribution of
noradrenaline in the hypothalamus of the dog.
METHODS
Preparation of fractions
Mongrel dogs anaesthetized with ether, chloroform or chloralose were bled from a carotid
artery. The brain was removed and the caudate nuclei (and hypothalamus) were rapidly
excised and weighed ; the tissues were then homogenized in 0.32 m-sucrose solution using a
glass and Perspex homogenizer (Aldridge, Emery & Street, 1960) to give a homogenate
containing 10% (w/v) of tissue. A sample of homogenate was kept for analysis.
In initial experiments, this homogenate was separated into total particulate material (P)
and high-speed supernatant fluid (S), by centrifugation at 100,000 g for 1 hr in the AH 40 head
of a Spinco Model L preparative ultracentrifuge. In other experiments the homogenate was
separated initially into three primary particulate fractions essentially as described by Whittaker
(1959). The first particulate fraction (Pi) was obtained by centrifuging for 11 min at 1,000 g
in a Servall bench centrifuge. This Pi fraction was washed twice with 5 ml. of 0.32 m-sucrose
solution and the washings were added to the supernatant fluid from the Pi preparation. The
next particulate fraction (P2) was separated from the supernatant fluid of the Pi preparation
by centrifuging at 17,300 g for 1 hr in a Servall RC-2 refrigerated automatic centrifuge. A
further small particulate fraction (P3) was separated from the supernatant fluid of the P2
preparation by centrifugation at 100,000 g for 1 hr in a Spinco Model L preparative ultra-
centrifuge, leaving a final high-speed supernatant fraction {S3) containing the soluble
constituents of the cell cytoplasm diluted with sucrose solution.
Subfractionation of the P2 fraction by equilibrium density gradient centrifugation was
carried out as described by Whittaker (1959). The Pi pellet was resuspended in 0.32 m-sucrose
solution so that 1 ml. of suspension corresponded to 500 mg of original tissue. The suspen¬
sion (1 ml./tube) was layered on top of a discontinuous density gradient, prepared 1 hr
before use, consisting of 2 ml. of 0.8 m-sucrose solution layered over an equal volume of 1.2
m-sucrose solution, and centrifuged at 100,000 g for 1 hr in the SW 39 swing-out bucket head
of the Spinco Model L preparative ultracentrifuge. Three distinct subtractions were obtained ;
the first (A) consisted of particles less dense than 0.8 m-sucrose solution, the second (B) of
particles of density intermediate between 0.8 m- and 1.2 m-sucrose solution, and the third (C)
of particles denser than 1.2 m-sucrose solution. All operations were carried out at 0° to 4° C.
Analysis of fractions
Each primary particulate fraction was resuspended in 1 ml. of 0.32 m-sucrose solution. After
removal of small samples for electron microscopy, acetylcholine assay and estimation of lactate
dehydrogenase activity, each fraction was diluted to 2 ml. with 0.01 n-hydrochloric acid and
the protein precipitated with 2.0 ml. of 0.8 n-perchloric acid. The S3 fraction was adjusted
to 0.4 ,n with respect to perchloric acid with 12 n-perchloric acid. The samples were then
centrifuged and the acid supernatant fractions separated from their packed solids. The
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perchloric acid was removed by neutralizing each of the acid supernatant fractions with 3 N-
potassium carbonate solution to pH 4.0 and centrifuging in the cold.
Separation of the catechol amines by ion exchange column chromatography was carried out
as described by Bertler, Carlsson & Rosengren (1958): the neutralized perchloric acid
extracts were passed through a column of Dowex 50 X-8 (200-400 mesh, 3x25 mm) equi¬
librated with 1.0 N-sodium acetate buffer (pH 6). For extracts of caudate nuclei the column
was washed with 6 ml. of 0.4 N-hydrochloric acid to remove any dihydroxyphenylalanine or
noradrenaline, and the dopamine eluted with 8 ml. of 2 N-hydrochloric acid. For hypo¬
thalamic extracts the column was washed with 4 ml. of water and the noradrenaline eluted
with 8 ml. of 0.4 N-hydrochloric acid.
Estimation of the dopamine was carried out fluorimetrically after condensation with
ethylene diamine, as described by Weil-Malherbe & Bone (1952, 1957a). The fluorescence
derived from the dopamine in the final eluate was compared in each case with the fluorescence
produced by a standard amount of dopamine added to a fraction of the same eluate to ensure
the correct development of the fluorescence. In control experiments the recovery of dopamine
added to tissue samples was usually greater than 70%.
Because of the small amounts of tissue available, acetylcholine was assayed on the leech
muscle micro-preparation described by Szerb (1961) using physostigmine (1 mg/100 ml.) as the
anticholinesterase in the bathing fluid. The samples to be assayed were heated to 100° C at
pH 4 to release bound acetylcholine and diluted with leech Locke solution before assay. In
experiments in which the homogenization was carried out in the presence of physostigmine it
was found that physostigmine was carried through the extraction procedure for dopamine and
formed a highly fluorescent compound with ethylene diamine. Thus it was not possible to
estimate the dopamine in these experiments.
The 5-OR indolyl compounds were measured as described by Ashcroft & Sharman (1962).
Whenever possible, the compounds were separated into basic (presumably 5-hydroxytrypt-
amine) and acidic (presumably 5-hydroxyindolylacetic acid) fractions. In the case of the
primary particulate fractions (Pi,Pi,Pi), which were also assayed for dopamine, only a small
quantity of the protein-free extract was available ; this was analysed for total 5-OR indolyl
compounds.
Estimation of noradrenaline was carried out fluorimetrically as described by Sharman, Vanov
& Vogt (1963). Lactate dehydrogenase activity was measured spectrophotometrically as
described by Johnson (1960) and is expressed as the change in extinction of the reaction mixture ■■
at 340 mp (AE340) with time.
The concentration of amines (or enzyme) in the tissue fractions was expressed as mpmoles
(or AE3io/min)/volume of fraction derived from 1 g of fresh tissue. The distribution of
constituents between fractions was expressed as the percentage of the total recovered
constituent found in each fraction. The results of similar experiments are expressed as the
mean value and, with more than four observations, the standard deviation from the mean was
calculated.
Electron microscopy
This was carried out by the negative staining method as described by Horne & Whittaker
(1962). Preparations were fixed at 0° C by the addition of equal volumes of 10% (w/v)
formaldehyde in 0.32 M-sucrose solution previously neutralized to pH 7.2 with 0.33 N-sodium
hydroxide solution. The mixture was diluted with six times its volume of ice-cold 1% (w/v)
aqueous phosphotungstic acid which had been brought to pH 7.2 with 2 N-sodium hydroxide
and was then transferred to grids with a micropipette. Most of the droplet was removed
from the grid with filter paper. A thin film of suspension remained which dried rapidly
leaving particles embedded in solid sodium phosphotungstate. In this method particles are
seen as a whole and not in section.
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RESULTS
Distribution between particulate-bound and soluble material
A number of experiments were carried out in which an homogenate of dog caudate
nuclei was separated into total particulate material (P) and a high-speed supernatant
fluid (S) which were then analysed. The results for dopamine, 5-OR indolyl
compounds, acetylcholine and lactate dehydrogenase activity are summarized in
Table 1. It will be seen that dopamine resembles lactate dehydrogenase and
Table 1
DISTRIBUTION OF CONSTITUENTS OF DOG CAUDATE NUCLEUS HOMOGENATES
BETWEEN THE TOTAL PARTICULATE MATERIAL CP) AND THE HIGH SPEED SUPER¬
NATANT (5) FRACTION
The homogenate content is expressed in m/xmoles/g of original tissue ; lactate dehydrogenase
activity is expressed as AE310/min/g of original tissue. *These fractionation experiments were
carried out using sucrose solution containing physostigmine sulphate (32-2 mg/1.) to preserve any
free acetylcholine
Mean
No. of homogenate Distribution
experiments content (% of recovered activity)
P S
Dopamine 3 40 37 63
Lactate dehydrogenase activity 3 85 34 66
Acetylcholine* 2 17 81 19
Basic 5-OR indolyl compounds
(5-hydroxytryptamine) 3 1-6 70 30
Acidic 5-OR indolyl compounds
(5-hydroxyindolylacetic acid) 4 1-7 26 74
5-hydroxyindolylacetic acid in being recovered predominantly in fraction S
representing the soluble constituents of the cell sap diluted with suspension medium.
This is in contrast to the localization of acetylcholine and 5-hydroxytryptamine,
which are recovered mainly in the total particulate fraction. It was also found
that homovanillic acid, the major acid metabolite of dopamine in the dog caudate
nucleus (Sharman, 1963), occurred predominantly in the high-speed supernatant
fraction.
Distribution between particulate fractions
The results of analyses of the primary particulate fractions separated from dog
caudate nucleus and dog hypothalamus are shown in Table 2. Since most of the
acidic 5-OR compounds present is found in the high speed supernatant fluid
(Table 1), the analyses of the total 5-OR compounds given in this section will
represent predominantly the basic 5-OR compounds, that is 5-hydroxytryptamine.
It will be seen from Table 2A that the distribution of acetylcholine among the
primary particulate fractions from dog caudate nucleus differed appreciably from
that of dopamine, the acetylcholine being much more sharply localized in the P2
fraction.
In the experiments analysing the subcellular distribution of noradrenaline and
5-OR indolyl compounds in dog hypothalamus it was found that both amines were
principally associated with the P2 fraction (Table 2B). It is of interest to note that
the ratio of the total particulate-bound material to soluble material for dopamine
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Table 2
PERCENTAGE DISTRIBUTION OF DOPAMINE, ACETYLCHOLINE, 5-OR INDOLYL
COMPOUNDS, NORADRENALINE AND LACTATE DEHYDROGENASE ACTIVITY
BETWEEN THE PRIMARY FRACTIONS FROM DOG CAUDATE NUCLEUS AND HYPO¬
THALAMUS HOMOGENATES
The hormgenite content is expressed in mxmoles/g of original tissue ; lactate dehydrogenase







super¬ Percentage of total particulate ate
Homa- natant bound material recovered in content in
No. of genate (P1+P2+ combined
experiments content P3 : S3) Pi A P3 fractions
A. Dog caudate nucleus
Dopamine 8 44± 7 41 : 59 33±11 54±11 13± 6 80±17
Total 5-OR indolyl
compounds 7 — — 27± 5 53±11 20±10 —
Acetylcholine 5 19± 3 95 : 5 9± 2 86± 6 5± 3 88± 9
Lactate dehydro¬
genase activity 2 100 51 : 49 27 67 6 89
Acidic 5-OR indolyl
compounds 1 — — 23 70 7 —
B. Dog hypothalamus
Noradrenaline 3 7 68 : 32 10 64 26 90
Total 5-OR indolyl
compounds 3 — — 16 67 17 —
in caudate nuclei is the inverse of that for noradrenaline in the hypothalamus. In
the particulate fractions from both tissues the 5-hydroxytryptamine distribution
parallels the distribution of the corresponding catechol amine.
Subfractionation of the P2 fraction by density gradient centrifugation led to a
further distinction between dopamine and acetylcholine (Table 3). It was found
that the acetylcholine was again more sharply localized, in this case in the B
sub-fraction.
Electron microscopy
Electron microscopic examination of the various fractions from the caudate
nucleus showed that these were similar in composition to, but more heterogeneous
than, the whole guinea-pig brain preparations previously examined by Gray &
Whittaker (1962) and Home & Whittaker (1962). Besides nuclei, myelin and
fragments of incompletely homogenized tissue, the P1 fraction contained free mito¬
chondria, synaptosomes and many small membrane fragments. Some of the
synaptosomes were very large and so would have been expected to sediment in this
fraction. This has been observed with the large synaptosomes formed from mossy
fibre endings in homogenates of cerebellar cortex (Whittaker, 1962).
The P2 fraction contained, as with whole guinea-pig brain preparations, myelin
fragments, mitochondria, synaptosomes and many small membrane fragments
mostly oval or circular in outline, down to microsomal dimensions. The synapto¬
somes varied greatly in size. Subfraction A of P2 consisted mainly of myelin and
small membrane fragments; however, synaptosomes were also present in
considerable numbers. Subfraction B was a relatively homogeneous fraction
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Table 3
PERCENTAGE DISTRIBUTION OF DOPAMINE, ACETYLCHOLINE AND LACTATE
DEHYDROGENASE ACTIVITY AMONG SUBFRACTIONS OF THE P2 PRIMARY
FRACTION
Values are means with standard deviations.
No. of experiments
% in fraction A
% in fraction B
% in fraction C
of
Lactate Particles identified in
Dopamine Acetylcholine dehydrogenase the electron microscope
5 4 2
45± 7 19 33 Myelin, small membrane
fragments, many small
synaptosomes
47 ±14 79 56 Mainly synaptosomes, some
shrunken







% recovery of P% content
in combined fractions
consisting mainly of synaptosomes, many large (2 p or more in diameter), often with
considerable lengths of axons attached, others shrunken and bizarre in shape and
densely packed with vesicles. This shrinking was caused by exposure to hypertonic
sucrose solution. Noteworthy was the almost complete absence of free mitochondria
in A and B, though small mitochondria were frequently present inside synaptosomes.
By contrast, the C subtraction consisted almost entirely of mitochondria, often
morphologically abnormal as previously observed in positively stained thin sections
of the corresponding whole guinea-pig brain fraction. Occasional particles in this
fraction poorly penetrated by phosphotungstate and often possessing long axon-like
" tails " were tentatively identified as synaptosomes whose cytoplasm had fused to
a dense mass as a result of dehydration in hypertonic sucrose solutions (the " black
bodies" in the positively stained preparations of Gray & Whittaker, 1962).
Fraction P3 consisted mainly of vesicular membrane fragments (microsomes)
of varying size from about 0.02 to 0.07 p; there were also a few small synaptosomes
and mitochondria. Two fractions obtained by subfractionating P3 on a density
gradient did not differ except that the smaller particles were more plentiful in the
light fraction and the synaptosomes and the mitochondria were recovered with the
larger membrane fragments in the denser fraction.
DISCUSSION
Dopamine
The topographical distribution of dopamine among the various parts of the brain
(Bertler & Rosengren, 1959) does not correspond to that of noradrenaline (Vogt,
1954). It is possible that dopamine ocurs in the brain other than as a precursor
of noradrenaline. Information about the subcellular distribution of dopamine in
brain tissue might help in elucidating its function.
In the present study the subcellular distribution of dopamine in the caudate
nucleus of the dog between total particulate and high-speed supernatant fractions
was somewhat similar to that observed by Weil-Malherbe & Bone (1959) using
rabbit brain stem, but it differed from the distributions of acetylcholine and
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5-hydroxytryptamine in the caudate nuclei fractions, and also from that of nor¬
adrenaline in dog hypothalamus homogenates. The distribution of these latter
amines in dog tissue corresponds well, however, with the distributions of acetyl¬
choline (Whittaker, 1959), 5-hydroxytryptamine (Michaelson & Whittaker, 1963)
and noradrenaline (Michaelson, unpublished observations) in guinea-pig whole brain
tissue. The dopamine distribution between total particulate and supernatant
fractions was closely paralleled by the distribution of lactate dehydrogenase activity,
and was also matched by the distribution of 5-hydroxyindolylacetic acid. This
difference in distribution between dopamine and the other amines must reflect a
difference in the subcellular localization or metabolism of dopamine when compared
with the other amines.
The percentage distribution of dopamine in the three primary particulate fractions
from caudate nuclei is similar to that found for 5-hydroxytryptamine in this tissue,
both being less sharply localized than acetylcholine. Dopamine from caudate
nucleus homogenates, unlike 5-hydroxytryptamine in whole guinea-pig brain
(Michaelson & Whittaker, 1963), is not readily lost from the particulate material
during the prolonged manipulation in sucrose media involved in the fractionation
procedure, as shown by the similarity in the ratios P/S (Table 1) and (P1 + P2 + P3)
/S3 (Table 2).
Upon subfractionation of the " crude mitochondrial" (P2) fraction by density
gradient centrifugation dopamine was not as closely associated with any one sub-
fraction as was observed for acetylcholine. In the present study dopamine was
equally distributed between subtractions A and B whereas acetylcholine was
preferentially localized in B. It would appear then that the structures containing
dopamine in the dog caudate nucleus have a larger range of densities than those
associated with acetylcholine. Electron microscopic examination of the subfractions
from the dog caudate nucleus revealed that the density gradient separation failed
to resolve the P2 fraction into such relatively homogeneous subfractions as was
observed for guinea-pig brain (Gray & Whittaker, 1962). Both the A and B sub-
fractions of P, contained many pinched-off nerve endings. It would appear that the
synaptosomes in the dog caudate nucleus have a larger range of sizes than the
synaptosomes derived from guinea-pig brain tissue.
Lactate dehydrogenase activity and dopamine had similar relative distributions.
Lactate dehydrogenase is thought to be associated with the cell cytoplasm (Johnson,
1960; Johnson & Whittaker, 1963). This association suggests that dopamine is
also distributed through the cell cytoplasm and that the dopamine associated with
the particulate material is trapped in the cytoplasm of the pinched-off nerve ending
particles. Additional evidence for a cytoplasmic localization of dopamine came
from two preliminary experiments in which the particulate fractions containing
dopamine were subjected to water-treatment and density gradient separation
(Whittaker et al, 1963a, b). After water-treatment 80% of the particulate-bound
dopamine was recovered in the supernatant fraction. It appears that the dopamine
is contained in a loosely bound or free form in a subcellular particle that can be
disrupted by water-treatment. In contrast, acetylcholine was still associated with
particulate material after water-treatment.
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Acetylcholine
The homogenates of caudate nuclei contained a relatively high concentration of
acetylcholine. Even in the presence of physostigmine, which preserves any free
acetylcholine initially present, there was very little acetylcholine in the high-speed
supernatant fluid. Thus nearly all of the acetylcholine was associated with
particulate material. On fractionation, this particle-bound acetylcholine was
localized in the P, fraction and the B fraction derived from it, in spite of the presence
of considerable numbers of synaptosomes in the P1 and A fractions. It is not known
for certain whether the free acetylcholine in brain tissue homogenates represents
acetylcholine released from cholinergic nerve endings which have been disrupted
during homogenization or acetylcholine originally present in other parts of the
cholinergic neurone. The latter appears probable, since Hebb & Whittaker
(unpublished) found that the acetylcholine in homogenates of ventral spinal columns,
a region in which cholinergic neurones are represented mainly by the cell bodies
of motor neurones and in which the only known cholinergic endings are those of
the recurrent collateral fibres to Renshaw cells, was mainly in the free form. If
this interpretation is correct, the results with caudate nuclei strongly imply that
cholinergic neurones are here represented almost exclusively by endings which
break off on homogenization to form a rather uniform population of synaptosomes
containing acetylcholine. This assumption is supported by the recent work of
Shute & Lewis (1963) who demonstrated histochemically in the rat that there is
a dense cholinergic neuropil in the caudate nucleus and putamen contributed by
the striatal radiation from the ventral midbrain tegmentum. Comparisons between
the morphology of the synaptosomes of fraction B and the cholinergic neuropil are
clearly needed.
It may be concluded from these experiments that the subcellular particle with
which part of the dopamine is associated is similar to but distinguishable from
that with which acetylcholine is associated. It was not possible to separate particles
containing dopamine and 5-hydroxytryptamine. However, the distribution ratios
of the latter two amines between the particulate and high-speed supernatant fractions
are quite different. A possible explanation is that both these amines are in the
same cell but that 5-hydroxytryptamine is confined to the synaptosomes and that
dopamine is distributed throughout the cell. It cannot be excluded, however, that
dopamine and 5-hydroxytryptamine are in different cells.
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Localization of acetylcholine, 5-hydroxytryptamine and noradrenaline within subcellular
particles derived from guinea pig subcortical brain tissue
{Received 21 September 1963; accepted 1 October 1963)
When brain tissue is homogenized in 0-32 M sucrose, nerve endings escape disruption and are snapped
off to form nerve-ending particles (NEPs) which can be isolated in a discrete fraction by differentia]
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and density gradient centrifugation.1-3 On suspension in water, the outer membranes of the NEP
are disrupted, and soluble cytoplasmic constituents together with some synaptic vesicles are released
A simple density gradient procedure4'5 permits the separation of fractions: fraction O containiu]
soluble cytoplasm; D, synaptic vesicles; E, microsomes; F and G, membrane fragments and NEI
ghosts; G and H, partially ruptured NEPs and /, mitochondria. Bound acetylcholine was found to Is
bimodally distributed with peaks in the synaptic vesicle (D) and damaged NEP (77) fractions.
Other work6-8 has shown that 5-hydroxytryptamine (HT) and noradrenaline (NA) are also local,
ized in the NEP fraction (although not so sharply as acetylcholine). The object of the present work*
to find out whether these two amines behaved similarly to acetylcholine on hypotonic disruption and
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Fig. 1. Comparison of the distribution within a density gradient of (A) 5-hydroxytryptamine (HI
and acetylcholine (ACh), and, (B) noradrenaline (NA) and acetylcholine (ACh) derived fnt
hypotonically-treated subcellular particles from guinea pig subcortical brain tissue. Solid lines repi
sent bound amine, dotted line represents free amine. Ordinate: percentage in each fraction of the toll
amine in the gradient. Amine recovered, as m/rmole/g tissue processed (no. of experiments average
and percentage recovery in brackets): HT, 1-27 (3, 137); ACh, 0-82 (2, 66); NA, 1-1 (2, 123); AO
5-8 (3, 132).
Some technical difficulties were encountered. The estimation of HT as total 5-OR indolylcompon:
without solvent extraction as used earlier4 gave falsely high values with fractions from the lots
part of the density gradient owing to the presence of interfering substances in the sucrose. This k
overcome by solvent extraction into butanol.8 The levels of the amines, particularly of HT, in who
brain preparations were low. The amines liberated as the free form on hypotonic rupture are a
destroyed, as with acetylcholine, so that means had to be devised for separately estimating frees:
bound amines in each fraction. Accordingly our earlier procedure was modified and two kindsi
preparation were used.
In the experiments with HT, the level of the amines was raised by injecting iproniazid (100 mgtl
subcutaneously 14-20 hr before killing the animals. This procedure does not alter the amine distriii
tion in the primary fractions.6 The midbrain, diencephalon and caudate nuclei, the regions richest
HT, were homogenized. After removal of the nuclear (7\) fraction at 1000 g for 11 min, a en:
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mitochondrial (?«) fraction was prepared by centrifuging the homogenate at 17000 g for 60 min. The
P., fraction was suspended in water and separated into fractions O-I as previously described.4 Each
fraction was diluted with water and centrifuged at 100,000 g for 60 min to give supernatants and
pellets. The amine present in the supernatants is regarded as "free" and that in the pellets as "bound"-
All the acetylcholine, as estimated by the leech muscle micromethod10 after release by heating at 100°
for 10 min at pH 4,11 was recovered in the pellets, i.e. was "bound", since in the absence of an anti¬
cholinesterase any free acetylcholine would be destroyed.
In the NA experiments, there was no premedication; only the midbrain and diencephalon were
used, since the caudate nucleus is known to contain very little of this amine. The NA was estimated
fiuorimetrically.12 Distribution studies with the primary fractions from these tissues showed that
about 30 per cent of the NA was recovered in the microsomal (P3) fraction; accordingly, after separa¬
tion of the Pi fraction, a combined P2 and P3 fraction was prepared by centrifuging at 100,000 g
instead of 17,000 g for 1 hr. Disruption in water was carried out more vigorously than in the HT
series, with mechanical homogenization for about 30 sec. Morphological examination showed that
fractions D-F were less homogeneous than the corresponding fractions from whole brain; they all
contained synaptic vesicles heavily contaminated with microsomes.
The results of the two series of experiments are shown in Fig. 1. In the HT series (Fig. 1 A) bound
acetylcholine was bimodally distributed with peaks in D and H. The D fraction was less opaque and
the yield of vesicular acetylcholine was lower than in previous whole brain studies.4 (Dog caudate
nucleus preparations have also been found to be more resistant to hypotonic rupture than guinea-pig
whole brain.) In contrast to acetylcholine, bound HT peaked in F, but was not clearly localized in any
fraction and showed no evidence of bimodal distribution. About 70 per cent of the total HT recovered
was present in the free form; fraction O, corresponding to soluble cytoplasm, contained the most,
with decreasing amounts in the lower parts of the gradient. The free amine in the lower fractions could
have occurred as the result of diffusion from O.
In the NA series (Fig. IB), acetylcholine was again bimodally distributed, and perhaps because of
the more vigorous disruption, the opacity of the D fraction and the yield of acetylcholine in this
fraction was greater. A greater proportion of NA was present in the bound form than was found
with HT, but the distribution of bound NA was similar to that of bound HT. The distribution of free
NA was also similar to that of HT, the highest concentration being in O with decreasing amounts in
lower fractions.
To summarize: when particulate fractions containing NEPs are disrupted by exposure to hypotonic
conditions, a considerable proportion of free amine is liberated and is recovered in tne soluble cyto¬
plasmic (O) fraction, with decreasing amounts in lower fractions. In the case of NA, over half the
amine remains bound, a proportion similar to that found with acetylcholine11 and of this significant
amounts are associated with particulate material free from NEPs. With HT, the proportion remaining
bound is lower and the absolute amounts present are too low to permit firm conclusions as to the
nature of the particulate binding sites.
It is obvious from these experiments that the storage sites for NA and HT within the subcellular
particles differ from that for acetylcholine and require further characterization. However, it is not yet
possible to distinguish between the localization of NA and HT.
In comparing the behaviour of NA and HT, the differences in the preparations used, the vigour
with which they were disrupted and a possible selective effect of iproniazid in the localization of HT
within the intact storage particle must be borne in mind. Further work is in progress to define more
accurately the nature of the amine storage sites.
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A FLUORIMETRIC METHOD FOR THE ESTIMATION OF
4-HYDROXY-3-METHOXYPHENYLACETIC ACID (HOMOVANILLIC
ACID) AND ITS IDENTIFICATION IN BRAIN TISSUE
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A fluorimetric method for the estimation of 4-hydroxy-3-methoxyphenylacetic acid
(homovanillic acid) has been developed and applied to normal brain tissue. The
presence of homovanillic acid in the caudate nucleus of normal animals of several
species has been demonstrated.
Methods for the estimation of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic
acid) have been based on the formation of coloured compounds by coupling the acid
with diazotized p-nitroaniline (Armstrong, Shaw & Wall, 1956) or diazotized
sulphanilic acid (Shaw, McMillan & Armstrong, 1957 ; DeEds, Booth & Jones, 1957).
The presence of atmospheric contaminants can interfere with these methods of
estimation (Shaw & Trevarthen, 1958). Sweeley & Williams (1961) have used gas
chromatography to separate and estimate homovanillic acid. Recently, Ruthven &
Sandler (1962) have reported a method based on the conversion of homovanillic acid
to 3,4-dihydroxyphenylacetic acid, which is then estimated colorimetrically.
Fluorimetric methods of estimation are, in general, more sensitive than colorimetric
methods. Duggan, Bowman, Brodie & Udenfriend (1957) suggested that the
fluorescence exhibited by homovanillic acid at pH 7 might form the basis of a
chemical assay. Many other aromatic acids fluoresce in the same spectral region
as homovanillic acid, and such a method might be criticized for its lack of specificity.
This report is concerned with the development of a more specific fluorimetric
method of determining homovanillic acid and with the identification of this
compound as a normal constituent of brain tissue.
METHODS
The phenol and indole derivatives used were:
Homovanillic acid (4-hydroxy-3-methoxyphenylacetic acid), 4-hydroxy-3-methoxyphenethyl-
amine, normetanephrine [2-amino-l-(4-hydroxy-3-methoxyphenyl)ethanol] and metanephrine
[l-(4-hydroxy-3-methoxyphenyl)-2-methylaminoethanol], each from the California Corporation
for Biochemical Research; 5-hydroxyindol-3-ylacetic acid, 4-hydroxyphenylacetic acid,
3-methoxyphenylacetic acid, 4-methoxyphenylacetic acid, 3,4-dihydroxyphenylacetic acid,
4-hydroxy-3-methoxycinnamic acid and 4-hydroxycinnamic acid, each from L. Light & Co.;
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4-hydroxy-3-methoxymandelic acid, 4-hydroxy-3-methoxyphenylalanine, bis(4-hydroxy-3-
methoxyphenylglycol) piperazine salt and iV-acetyl-4-hydroxy-3-methoxyphenethylamine, pre¬
pared by the method described by Goldstein & Musacchio (1962).
The reagents required were:
Ferric chloride as a 1% w/v solution in 0.1 n-HCI. Solutions of ferric chloride in water
are also suitable, but the fluorescence developed from homovanillic acid was more consistent
when aqueous solutions of ferric chloride had been left to stand for a few days. This was
thought to be due to the presence of hydrochloric acid produced by hydrolysis.
Sodium hydroxide as a 20% w/v solution in freshly distilled water.
Both de-ionized and distilled water have been used, but a high blank fluorescence was
observed with some samples of water, particularly samples which had been stored in poly¬
ethylene vessels. The most suitable water was freshly distilled water.
Extraction of tissues. Dogs, cats or rabbits were bled to death after anaesthetization with
ether, chloroform or chloralose. The caudate nuclei were dissected out as rapidly as possible.
The caudate nuclei of the cow and sheep were obtained immediately after slaughter with a
captive bolt. Only undamaged tissues were used. The caudate nuclei were weighed and
then homogenized in 2.0 ml. of 0.1 n-HCI per g of tissue. When immediate homogenization
was not possible the tissues were frozen and kept at —17° C. The acid homogenate was diluted
with water to a volume of 10.0 ml./g of tissue and deproteinized by the addition of 2.0 ml. of
a 10% w/v aqueous solution of zinc sulphate and 0.2 ml. of the 20% w/v solution of sodium
hydroxide for each 10.0 ml. of the diluted homogenate. The homogenate was carefully mixed
after each addition. The mixture was centrifuged at 900 g for 5 min and the supernatant
filtered through Whatman no. 54 filter paper. The solution was adjusted to pH 1-2 (indicator
paper) with concentrated hydrochloric acid, the solution saturated with sodium chloride and
extracted by shaking with an equal volume of ethyl acetate for 5 min. A second extraction
with an equal volume of ethyl acetate was carried out and the two extracts were combined
and dried over anhydrous sodium sulphate for 2 to 24 hr at 4° C. The extract was then
evaporated at 35° C to approximately 0.2 ml. under a stream of nitrogen. This concentrated
extract was applied to paper for chromatographic development.
Paper chromatography. Two-dimensional chromatograms were developed on Whatman
no. 1 paper which had been washed with 0.01 n-HCI. One-dimensional chromatograms were
developed on Whatman no. 50 or Whatman no. 1 paper.
In those experiments in which portions of chromatograms were eluted and the eluates
tested for the development of a fluorescence with the ferric chloride and sodium hydroxide
solutions, the paper was treated to reduce the fluorescence derived from the paper itself.
Whatman no. 50 paper was soaked in 2 n-NaOH for 24 to 48 hr. It was then washed by
repeated changes of distilled or de-ionized water until no alkali was detected in the washings.
The paper was stored under distilled water, which had been tested for a low fluorescence
on adding the sodium hydroxide solution. Before use the paper was air-dried at 25° C.
The one-dimensional chromatograms were developed on a modified form of the wick-and-strip
chromatogram described by Mathias (1954). A typical shape is shown in Fig. 5. This method
produces narrow bands across the chromatogram and the area of a " spot" is kept to a
minimum.
The following solvent systems were used to develop the chromatograms.
System A: Isopropanol, ammonia solution and water (80:2:18).
System B: Benzene, propionic acid and water. For this system one can use either the
organic phase of a 100:25:25 mixture or the single phase obtained by mixing the components
in the proportions 100:70:4.
System C: 0.01 n-HCI saturated with sodium chloride.
System D: Butanol, water, glacial acetic acid and dichloroethane. The organic phase from
a 1:1:1:3 mixture was used.
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Two-dimensional chromatograms were developed for 15 hr with system A, dried in air
and then developed for 7 hr with system B in a direction at a right-angle to that of the first
development. The ascending technique was used in every instance.
Phenolic compounds were located on the chromatogram by spraying with a 1% w/v solution
of Brentamine Fast Red GG Salt (I.C.I. Ltd.) in 0.1 n-HCI. This is a stabilized preparation
of diazotized y-nitroaniline. The chromatogram was air-dried and then sprayed with a 5%
w/v solution of sodium carbonate. The elution of portions of chromatograms was carried
out with 0.01 n-HCI or with distilled water.
Concentrations of reagents expressed as percentages refer to w/v solutions.
RESULTS
The characterization of the fluorescence developed from homovanillic acid. The
method of estimation is based on the observation that a blue fluorescence develops
when a solution of homovanillic acid is treated with ferric chloride and then made
alkaline with sodium hydroxide. A known amount of homovanillic acid was placed
in a 1.0 ml. glass-stoppered, volumetric flask of test-tube shape, and diluted to 1.0 ml.
with water. The ferric chloride and sodium hydroxide solutions were added in the
quantities given below. The flask was then centrifuged for 30 sec to remove the
ferric hydroxide which had formed. The clear supernatant was transferred to a
quartz cuvette and the fluorescence was examined in an Aminco-Bowman spectro-
photofluorimeter. The wavelength of maximum activation was 305 my., and there
was a smaller peak at 250 my. Maximum fluorescence was at a wavelength of
430 my. These are values uncorrected for instrumental error.
The effect of light on the reaction. Exposure of the reaction mixture to different
intensities of light resulted in the development of different intensities of fluorescence.
In order to obtain reproducible conditions, all reactions have been carried out in
shade. The volumetric flasks were placed up to their rims in holes, drilled in small
blocks of wood, before adding the reagents.
The time of reaction with ferric chloride. Samples containing 1.0 yg of homo¬
vanillic acid were mixed with 0.1 ml. of the ferric chloride solution and the reaction
was allowed to proceed for different times ; 0.1 ml. of the sodium hydroxide solution
was then added and the fluorescence (activation wavelength 305 my ; fluorescence
wavelength 430 my) measured after removal of the ferric hydroxide. The effect
of increasing the time of reaction is shown in Fig. 1. Maximal fluorescence was
obtained when the reaction was allowed to proceed for 45 sec.
The effect of the concentration of ferric chloride in the reaction mixture. The
reaction was carried out with 0.5 yg samples of homovanillic acid, using increasing
amounts of ferric chloride. The results are shown in Fig. 2. The maximum
fluorescence was developed with 1.0 mg of ferric chloride.
The effect of the concentration of sodium hydroxide in the reaction mixture. The
effect of increasing the amount of sodium hydroxide on the fluorescence developed
was investigated using 1.0 yg samples of homovanillic acid; 0.1 ml. of the ferric
chloride solution was allowed to act for 45 sec before adding the sodium hydroxide
solution. Maximum fluorescence was obtained with 10 to 30 mg of sodium
hydroxide (Fig. 3).





Time of reaction (sec)
160 200
Fig. 1. The effect of the time of reaction (abscissa) with ferric chloride on the development of the
fluorescence (ordinate) from homovanillic acid.
01 . . . .
0 0-5 1-0 1-5 20 2-5
Ferric chloride (mg)
Fig. 2. The effect of the concentration of ferric chloride (abscissa, expressed as mg added) on the
development of the fluorescence (ordinate) from homovanillic acid. The ferric chloride was
allowed to react for 45 sec.
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Sodium hydroxide (mg)
Fig. 3. The effect of the concentration of sodium hydroxide (abscissa, expressed as mg added) on the
development of the fluorescence (ordinate) from homovanillic acid.
The stability of the fluorescence. The fluorescence faded on exposure to ultra¬
violet light for more than a few seconds. Placing the fluorescent solution in the
dark for 1 to 2 min after a short exposure to ultraviolet light restored the fluorescence
almost to its original intensity. When the solution was stored in the dark at 4° C
the fluorescence was stable for a week.
The final procedure for the estimation of homovanillic acid. When all the
conditions for the development of maximal fluorescence were present, there was
variation in the fluorescence developed from replicate samples. An indication of
this variation can be seen in the results given in Fig. 3. However, consistent results
were obtained at the expense of the fluorescence developed, by increasing the time
of reaction with ferric chloride to 2 min. Thus, the final procedure used in estimating
the concentration of homovanillic acid was as follows. The solution was placed in
a 1.0 ml. glass-stoppered volumetric flask and, if necessary, diluted to 1.0 ml. with
distilled water ; 0.1 ml. of the 1% solution of ferric chloride in 0.1 n-HCI was mixed
with the solution and allowed to react, shaded from light, for 2 min. At the end
of this time 0.1 ml. of the 20% solution of sodium hydroxide was mixed with the
solution. The flask was then centrifuged at 900 g for 2 min to remove the insoluble
ferric hydroxide. The clear supernatant was decanted into a quartz cuvette. The
fluorescence (activation wavelength 305 m« ; fluorescence wavelength 430 m/<) was
measured at intervals of 30 sec for 2 min and the mean of the four readings taken.
The solution was not exposed to the activating light for longer than 5 sec at a time.
This method was applied to different amounts of homovanillic acid. The results
obtained on two occasions are shown in Fig. 4. The spectrophotofluorimeter was
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Expt. I Expt. 2
Homovanillic acid (fig)
Fig. 4. The relationship between the amount of homovanillic acid (abscissa) and the fluorescence
developed (ordinate), for two experiments.
standardized each time against the fluorescence of a block of Araldite CY212 epoxy
resin, which enabled the same sensitivity to be obtained in the two experiments.
Fig. 4 shows that there is a linear relationship between the amount of homovanillic
acid in the sample and the fluorescence developed. The results are reproducible
when the same reagents are used, but changes in the slope of the standard curve have
been observed with different solutions of ferric chloride.
The specificity of the method. The reaction was applied to other organic acids
and to some compounds structurally related to homovanillic acid. Of the com¬
pounds tested, 4-hydroxy-3-methoxymandelic acid, 4-hydroxy-3-methoxyphenethyl-
amine, (V-acetyl-4-hydroxy-3-methoxyphenethylamine, normetanephrine, meta-
nephrine, 4-hydroxy-3-methoxyphenylalanine and 4-hydroxy-3-methoxyphenylglycol
yielded a fluorescence with the same maximum as, and of somewhat less intensity
than, that developed with homovanillic acid. 4-Hydroxy-3-methoxybenzoic acid
(vanillic acid) and 4-hydroxy-3-methoxycinnamic acid gave rise to a very weak
fluorescence, approximately 3% of that derived from homovanillic acid. No
significant fluorescence was developed with 3-methoxyphenylacetic acid, 4-methoxy-
phenylacetic acid, 4-hydroxyphenylacetic acid, 3,4-dihydroxyphenylacetic acid and
5-hydroxy-indol-3 -ylacetic acid.
Serious interference might be caused by 4-hydroxycinnamic acid, which exhibits a
blue fluorescence (maximum activation wavelength 350 m/x, maximum fluorescence
wavelength 450 m/x) in alkaline solution. This fluorescence may, however, be
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distinguished by its activation and fluorescence maxima and also because homo-
vanillic acid does not fluoresce in alkaline solution alone.
The possibility of using this fluorescence reaction for the estimation of the
3-methoxy derivatives of adrenaline, noradrenaline and dopamine was considered.
However, the development of the fluorescence was completely inhibited when
adrenaline or noradrenaline was mixed in equal amounts with 4-hydroxy-3-methoxy-
phenethylamine. Inhibition of the development of the fluorescence was also observed
when a mixture of homovanillic acid and 5-hydroxyindol-3-ylacetic acid was used.
The fluorescence derived from homovanillic acid was completely destroyed when
ascorbic acid was added to the solution. These inhibitory effects are probably due
to the reducing properties of these compounds.
During these experiments, the yellow-green fluorescence which develops when
adrenaline is treated with ferric chloride and alkali (Barker, Eastland & Evers, 1932)
was investigated ; as this fluorescence faded, it was replaced by a blue fluorescence
(activation maximum 315 m/.i, fluorescence maximum 450 m/r). This phenomenon
was not observed with noradrenaline. This blue fluorescence derived from adrenaline
might be confused with that derived from the methoxy compounds. These observa¬
tions stress the importance of obtaining a good separation of the substance under
investigation from the other substances present in extracts before attempting an
estimation by fluorimetry.
The use of the reaction as a localizing test on paper chromatograms. Paper
chromatograms of authentic homovanillic acid and 4-hydroxy-3-methoxymandelic
acid were sprayed with a 1% solution of ferric chloride in 0.1 n-HCI. When dried,
the chromatograms were sprayed with a 20% solution of sodium hydroxide.
Examination in ultraviolet light (Chromatolite ; Chance OX7 filter) revealed blue
fluorescent spots at Rf values corresponding with those of the two acids. The
limit of detection was about 5 jug.
The identification of homovanillic acid in brain tissue. Dog caudate nucleus
(13.2 g) and cow caudate nucleus (7.7 g) were extracted and the extracts subjected
to two-dimensional chromatography. Table 1 gives the R F values and the colour
reaction with Brentamine Fast Red GG of the main phenolic substance detected
on the chromatograms ; a substance with an R p value in two solvent systems and a
Table 1
Rf VALUES OF THE PHENOLIC SUBSTANCE ISOLATED FROM THE BRAIN
OF DIFFERENT ANIMALS COMPARED WITH HOMOVANILLIC ACID
CHROMATOGRAPHED UNDER THE SAME CONDITIONS
Rf value in solvent system Colour with
diazotized
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Fig. 5. The localization of apparent homovanillic acid on a chromatogram of an extract of the
caudate nucleus of the dog.
Activation spectra
Fluorescence at 430 m/r
Fluorescence spectra
Activation at 305 m/j-
200 300 400 400
Wavelength (mja)
500 600
Fig. 6. Activation (left) and fluorescence (right) spectra of the fluorescence developed from the
phenolic substance extracted from the caudate nucleus of the dog. A: substance extracted from
the caudate nucleus. B: 2 pg of homovanillic acid. C: extract blank. D: reagent blank.
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colour reaction identical with that given by homovanillic acid is present in the
caudate nucleus. Although' JV-acetyl-4-hydroxy-3-methoxyphenethylamine would
be extracted by this method there was no evidence for the presence of this compound
on the chromatograms, its Rp value being greater than that of homovanillic acid in
system A. Other experiments have shown that the substance extracted from dog
brain tissue has an Rp value similar to that of homovanillic acid in two other solvent
mixtures (Table 1). The substance can also be extracted from the ethyl acetate
extracts of brain tissue into 10% sodium bicarbonate solution or n-NH4OH solution,
which indicates that the substance is acidic. Further evidence of its identity with
homovanillic acid was obtained in the following experiment.
An extract of the caudate nucleus of the dog was subjected to one-dimensional
chromatography ; the chromatogram was cut into consecutive strips and each strip
eluted separately with water. The fluorescence reaction was applied to each eluate.
Fig. 5 shows that a fluorescence was developed with material eluted from the region
corresponding to the Rp of homovanillic acid. The activation and fluorescence
spectra of the fluorescent product are shown in Fig. 6 and are identical with those
derived from homovanillic acid. It is therefore concluded that homovanillic acid is
normally present in the caudate nucleus of the dog.
The concentrations of homovanillic acid in the caudate nucleus were measured
li
with several species. Extracts were chromatographed in system B and the appro¬
priate region of the chromatogram was eluted and the fluorescence reaction applied
to the eluate. The estimated concentrations of homovanillic acid in these tissues are
given in Table 2.
Table 2
THE CONCENTRATION OF HOMOVANILLIC ACID IN THE CAUDATE NUCLEUS
Values marked with an asterisk refer to pooled tissues
Homovanillic acid










The recovery of homovanillic acid added to homogenates was generally 60 to
75%, and the figures in Table 2 are corrected on the basis of these recovery values.
discussion
The described fluorescence reaction for the estimation of homovanillic acid
appears to be a general reaction for a number of compounds related to 4-hydroxy-
3-methoxyphenylethane. The lack of absolute specificity requires that a method
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of separating such substances be applied to tissue extracts before an estimation
of the concentration of any of them can be made.
The nature of the fluorescent substance has not yet been determined, but light-
sensitive reactions between organic acids and ferric chloride have been described
(Ghosh & Purakayastha, 1929).
The application of the fluorimetric method to the estimation of homovanillic acid
in brain tissue extracts has shown that there is normally a high concentration of this
acid in the caudate nucleus of animals of several species.
Rosengren (1960) has reported that 3,4-dihydroxyphenylacetic acid is present in
the corpus striatum of normal rabbit, pig and man in a concentration of 0.5 jug/g
or less. The presence of a higher concentration of homovanillic acid in the caudate
nucleus indicates the importance of catechol-Omethyl transferase as well as that
of monoamine oxidase in the metabolism of the endogenous dopamine in the brain.
I wish to thank Roche Products for the 4-hydroxy-3-methoxymandelic acid, Hoffman La
Roche, Basle (through the courtesy of Dr A. Pletscher), for the 4-hydroxy-3-methoxyphenyl-
alanine, and Dr J. Axelrod for the 4-hydroxy-3-methoxyphenylglycol. I also wish to thank
Dr M. Vogt, F.R.S., for her advice and encouragement during this work.
REFERENCES
Armstrong, M., Shaw, K. N. F. & Wall, P. E. (1956). The phenolic acids of human urine. Paper
chromatography of phenolic acids. J. biol. Chem., 218, 293-303.
Barker, J. M., Eastland, C. J. & Evers, N. (1932). The colorimetric determination of adrenaline
in suprarenal gland extracts. Biochem. J., 26, 2129-2143.
DeEds, F., Booth, A. N. & Jones, F. T. (1957). Methylation and dehydroxylation of phenolic
compounds by rats and rabbits. /. biol. Chem., 225, 615-621.
DuggaN, D. E., Bowman, R. L., Brodie, B. B. & Udenfriend, S. (1957). A spectrophotofluoro-
metric study of compounds of biological interest. Arch. Biochem., 68, 1-14.
Ghosh, J. C. & Purakayastha, R. M. (1929). Photochemical reduction of ferric salts by mandelic,
lactic and tartaric acids. J. Indian Chem. Soc., 6, 827-838.
Goldstein, M. & Musacchio, J. M. (1962). The formation in vivo of TV-acetyldopamine and N-
acetyl-3-methoxydopamine. Biochim. biophys. Acta (Amst.), 58, 607-608.
Mathias, W. (1954). Serienuntersuchungen mit Hilfe einer neuen Form der Streifen-Papierchroma-
tographie. Naturwissenschaften, 41, 17-18.
Rosengren, E. (1960). On the role of monoamine oxidase for the inactivation of dopamine in the
brain. Acta physiol. scand., 49, 370-375.
Ruthven, C. R. J. & Sandler, M. (1962). Estimation of homovanillic acid in urine. Biochem. J.,
83, 3OP.
Shaw, K. N. F., McMillan, A. & Armstrong, M. D. (1957). Metabolism of 3,4-dihydroxyphenyl-
alanine. J. biol. Chem., 226, 255-266.
Shaw, K. N. F. & Trevarthen, J. (1958). The effect of atmospheric contaminants on paper chroma¬
tography of urinary indole and phenol acids. Nature (Lond.), 182,664.
Sweeley, C. C. & Williams, C. M. (1961). Microanalytical determination of urinary aromatic
acids by gas chromatography. Analyt. Biochem., 2, 83-88.
 
!E ESTIMATION OF SMALL QUANTITIES OF
DIHYDROXYPHENYLETHYLAMINE IN TISSUES
BY
R. LAVERTY and D. F. SHARMAN
Reprinted from British Journal of Pharmacology and Chemotherapy,
April, 1965, vol. 24, No. 2, p. 538.
COPYRIGHT © 1965
British Journal of Pharmacology and Chemotherapy
all rights of reproduction of this reprint are reserved




Brit. J. Pharmacol. (1963), 24, 538-548.
THE ESTIMATION OF SMALL QUANTITIES OF
3,4-DIHYDROXYPHENYLETHYLAMINE IN TISSUES
BY
R. LAVERTY* AND D. F. SHARMAN
From the Agricultural Research Council Institute of Animal Physiology, Babraham, Cambridge
{Received September 18, 1964)
Several methods have been used to estimate small amounts of 3,4-dihydroxyphenvl-
ethylamine (dopamine) which occur in many plant and animal tissues. The biological
assay of dopamine is, by comparison with that of other catechol amines, relatively in¬
sensitive. The pressor effect of dopamine on the blood pressure of the rat and the depressor
effect observed on the blood pressure of the guinea-pig have been used to assay dopamine
extracted from the splenic nerve and stellate ganglion of the ox (Schumann, 1956). These
methods are suitable for microgram quantities of dopamine.
Of the chemical methods which are applicable to the estimation of dopamine only those
involving the formation of a fluorescent derivative are likely to be sensitive enough to
estimate the small amounts of dopamine occurring in some tissues. The main fluorimetric
methods are based on two chemical reactions. The first of these was described by Natelson,
Lugovoy & Pincus (1949) who showed that catechol amines could condense with ethylene-
diamine to yield intensely fluorescent compounds. This reaction, which depends on the
presence of the catechol group, was developed by Weil-Malherbe & Bone (1957) and used
to estimate catechol amines including dopamine. The reaction was also used by Euler &
Lishajko (1957) to identify and estimate the dopamine in beef splenic nerve. The major
criticism of this method lies in its lack of specificity. The second reaction which has been
used involves the conversion of dopamine into an indole derivative by oxidation and treat¬
ment with alkali, which then shows a fluorescence in acid solution (Carlsson & Waldeck,
1958). This method has been used with slight modifications by several authors (Drujan,
Sourkes, Layne & Murphy, 1959; McGeer & McGeer, 1962) and has the advantage of a
greater specificity. In this laboratory the latter method was found to be unworkable,
apparently because of the presence of material in the water supply which is not easily
removed by distillation. We have therefore been compelled to use the condensation with
ethylenediamine as the basis for the estimation of dopamine. This paper describes ways in
which the specificity and sensitivity of this method can be improved so that very small
quantities of dopamine may be extracted from tissues, identified with reasonable certainty
and estimated.
METHODS
Materials. These were ascorbic acid (Roche Products), adrenaline base (Burroughs Wellcome), nor¬
adrenaline bitartrate (L. Light), dopamine hydrochloride (California Foundation for Biochemical Research),
* Beit Memorial Research Fellow. Present address: Wellcome Research Institute, University of
Otago Medical School, Dunedin, New Zealand.
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isoprenaline sulphate (Boots), 6-hydroxydopamine hydrobromide (Merck Sharpe & Dohme), catechol
(B.D.H.), a-methyldopamine hydrochloride, and ethylenediamine (May & Baker) distilled at least three
times until reagent blank fluorescence was low and constant, dichloromethane (G.P.R.; Hopkin & Williams)
distilled once, isobutanol (A.R.) distilled three times, acetic anhydride (A.R.; B.D.H.), sodium chloride
(R grade; May & Baker) check reagent blank fluorescence with each new batch distilled three times, and
hydrochloric acid (M.A.R.; Hopkin & Williams).
Methanol was purified by distilling from sodium hydroxide and then redistilled. Chromatography
solvents were of analytical reagent grade and distilled once before use. All other chemicals were of
Analytical Reagent grade.
Other materials were Dowex 50WX-8 cation exchange resin (Dow Chemical Co.), Whatman No. 50 paper
for chromatography (extracted with 2 N-sodium hydroxide solution and washed as described by Sharman,
1963), and deionized and distilled water.
The acetylation and extraction of dopamine were based on the methods described by Hagopian, Dorfman
& Gut (1961) for the extraction of dopamine and its metabolites frcm biological media and applied to the
estimation of catechol amines in urine by Goldstein, Friedhoff & Simmons (1959).
The preparation of tissue extractsfor acetylation. Peripheral nervous tissues and spinal cords were frozen
in liquid nitrogen and crushed in a stainless steel instrument similar to a tablet die. The powdered tissue
was then homogenized in 0.1 N-hydrochloric acid or in 0.1 N-sulphuric acid in a glass homogenizer. Other
central nervous tissues were homogenized directly in the acid. In each instance a few mg of ascorbic acid
were added to the acid before homogenizing the tissues. If a direct extraction from a deproteinized solution
was to be made, sulphuric acid was used and this also served as the protein precipitant. The homogenates
prepared in sulphuric acid were left for 15 min at 4° C, centrifuged at 6,000 g for 5 min at 0° C and the
supernatant fluid was acetylated. In those experiments in which the catechol amines were adsorbed on to
a column of Dowex 50WX-8 cation exchange resin, the tissue was homogenized in hydrochloric acid. The
proteins were then precipitated by adding perchloric acid to make the solution 0.4 N. Adsorption of the
catechol amines onto the resin was carried out essentially as described by Bertler, Carlsson & Rosengren
(1958). The total catechol amines were eluted from the column with 8 to 10 ml. of 2 N- or 3 N-hydrochloric
acid. Disodium edetate (20 mg) was added to the eluate which was then partially neutralized by the
addition of approximately 1.2 g of sodium bicarbonate. The eluates were then ready for acetylation. A
reasonable separation of adrenaline and noradrenaline from dopamine could be obtained by eluting the
former two amines from the column with 10 ml. of 0.4 N-hydrochloric acid and the latter amine with 8 ml.
of 2 N-hydrochloric acid. Two compounds closely related to dopamine, 6-hydro- ydopamine and a-methyl¬
dopamine, were found to be eluted mainly in the second fraction.
Acetylation of solutions containing catechol amines. Acetic anhydride was added to the solution in the
proportion of 0.3 ml. of the anhydride for each 4 ml. of solution. A slight excess of powdered sodium
bicarbonate was then added in small portions and the solution was shaken as soon as the effervescence
subsided. The mixture was ready for extraction when all the acetic anhydride had disappeared. The
procedure took about 15 min. Details of the products formed with some catechol amines, usually
3-0,4-0,iV-triacetyl derivatives, are described by Welsh (1955).
Extraction ofthe acetylated catechol amines. After acetylation the solution was extracted twice with two
times its volume of dichloromethane. The dichloromethane extracts were filtered through anhydrous
sodium sulphate, and evaporated to approximately 0.2 ml. under a stream of air in a water bath at 40 to
50° C.
Paper chromatography. All chromatograms were developed on alkali-washed Whatman No. 50 paper.
This paper shows a minimum of background fluorescence. The sheets of paper were cut into lanes so
that each sample was run on a 2-cm-wide strip. Two solvent systems have been used: a slight modification
of Bush System C (Bush, 1952) consisting of toluene, ethyl acetate, methanol and water in the proportions
10 : 1 : 5 : 5 by volume. The chromatogram was equilibrated with the aqueous phase for 16 hr and then
developed for 4 to 5 hr with the organic phase.
When a separation of 6-hydroxydopamine (a possible metabolite of dopamine; Senoh, Creveling,
Udenfriend & Witkop, 1959) from dopamine was required a solvent system based on one of the /er/.-butanol
systems described by Eberlein & Bongiovanni (1955) was found to be suitable. This was a mixture of
petroleum spirit (boiling point 80 to 100° Cj, tert.-butanol and water in the proportions 8 : 3 : 8 by volume.
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The chromatogram was equilibrated with the aqueous phase for 16 hr arid then developed for approximately
18 hr with the organic phase.
The acetylated derivatives of the catechol amines were eluted frcm small portions of the chrcmatograms
by shaking the piece of paper with 4 ml. of water for 1 hr. The paper was removed before the condensation
with ethylenediamine was carried out.
Acetyl derivatives prepared from authentic catechol amines were run on marker strips in parallel with
each set of estimations. The marker strips were sprayed with a fivefold dilution of the ethylenediamine-
hydrochloric acid mixture described in the following section, placed between two sheets of glass and heated
at 80° C for 20 min. The position of the acetyl derivatives of the catechol amines on the chrcmatogram
could be easily seen by the coloured, fluorescing spots which developed. Usually the position of the
dopamine derivative was determined and that portion of each chromatogram strip lying between the origin
and a point 2 cm in front of the dopamine position was divided into eight or ten equal portions. Each of
these was eluted and condensed with ethylenediamine. Measurement of fluorescence yielded a profile of
the catechol derivatives present on the chrcmatogram. In a few experiments the whole length of the
chromatogram was divided up to see if other substances giving rise to a fluorescent derivative could be
detected.
Condensation with ethylenediamine. A mixture of ethylenediamine and 2 N-hydrochloric acid, 3 : 2 by
volume, was freshly prepared. Of this solution 0.5 ml. was added to the 4.0 ml. of eluate frcm the chrcma¬
togram and mixed carefully. The mixture was then heated at 60 to 65° C for 20 min in the dark. The
samples were removed from the water bath, cooled, saturated with sodium chloride and then shaken with
3.0 ml. of isobutanol for 4 min. After centrifugation, the isobutanol layer was examined fluorimetrically.
Standards were prepared by acetylating known amounts of catechol amines in a volume of 4 ml. and
condensing them with ethylenediamine. This latter technique of acetylation and condensation without
extracting the acetylated derivative can also be applied to the dopamine eluate from resin columns.
Fluorescence. Activation and fluorescence spectra were determined in an Aminco-Bowman spectro-
photofluorimeter. Wavelengths given in this paper are uncorrected instrumental values. Calibration
against a mercury line spectrum indicated an accuracy of ± 5 m/x in the range of the wavelengths ofmaximum
activation and fluorescence. Routine estimations were made on a Locarte filter fluorimeter modified to
take square quartz cuvettes (1.Ox 1.0x4.4 cm; internal measurements), and fitted with a device to enable
the rapid changing of filters in the fluorescent light path. In a few experiments the volumes used were one-
fifth of those described above and the fluorescence was measured in a round cuvette (0.4 cm diameter x
3.8 cm length; internal measurements). This resulted in a further fourfold increase in the sensitivity of the
method.
The primary (activation) filter was a combination of a Corning 3389 filter and a Corning 5113 (half
standard thickness) filter with the former filter nearest to the mercury lamp. This set transmits mainly
the line of the mercury spectrum at 436 m,ft. Two secondary (fluorescence) filters were used so that dif¬
ferential fluorimetry, based on differences in fluorescence spectra, could be carried out. These were Ilford
Bright-Spectrum No. 623 (maximum transmission 490 m/x) and Ilford Bright-Spectrum No. 625 (maximum
transmission 540 m/f).
The differential fluorimetric estimation of mixtures of dopamine and another catechol amine (called C)
was carried out using the following equations. C represents a catechol amine which gives a
fluorescence spectrum different from that given by dopamine.
Hg of dopamine = (BCi—AC2)/(C1D2—CsDi)
/xgofC = [A—(/ig dopamine x DJJ/Q
fluorescence reading with filter 1
fluorescence reading with filter 2
fluorescence for 1.0 fig of dopamine on filter 1
fluorescence for 1.0 fig of dopamine on filter 2
fluorescence for 1.0 fig of other catechol amine with filter 1
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RESULTS
The effect of acetylation on the fluorescence obtained by condensing catechol amines with
ethylenediamine. If catechol amines are acetylated before condensing them with ethylene-
diamine the intensity of the fluorescence developed is increased. Furthermore, the
wavelength of maximal fluorescence may be changed. Condensates derived from adrenaline
and from 6-hydroxydopamine fluoresce at a shorter wavelength. These changes are shown
in Table 1, which also shows that after acetylation dopamine and a-methyldopamine can
now be distinguished from those catechol derivatives which before acetylation gave rise to
almost the same fluorescence spectrum.
The separation of the acetyl derivatives of catechol amines on paper chromatograms. The
Rf values of some acetylated catechol amines in the modified Bush system C are given in
Table 2. The RF values obtained for the first three compounds are in agreement with the
results of Goldstein, Friedhoff, Simmons & Prochoroff (1959). Table 2 also shows that the
derivatives of dopamine and a-methyldopamine are separated in the modified Bush solvent
system C. Fig. 1 illustrates the separation of acetylated 6-hydroxydopamine from the
dopamine derivative in the tert.-butanol solvent system.
Recovery of catechol amines. Small quantities of catechol amines were added to tissue
homogenates and estimated after acetylation using the direct extraction method described
above. Table 3 shows the recovery of noradrenaline and dopamine from tissue homogenates.
Dopamine appears to be well recovered from tissue homogenates, but noradrenaline shows
a variable and somewhat lower recovery. This difference might be explained by the
proximity of the noradrenaline acetate position to the origin of the chromatogram so that
other substances might be included in the eluate which cause a reduction in the fluorescence
developed from the noradrenaline.
When the resin column stage, which involves a loss of approximately 35%, is included in
the extraction procedure the expected overall recovery would be about 40%. In two
experiments in which dopamine was recovered from tissue homogenates by this procedure
the recovery was 44 and 32%. The estimation of adrenaline has not yet been examined
in detail.
Application to nervous tissue. In a preliminary survey the methods have been used to
make a few or single observations on a wide range of nervous tissues from different species
so that the range and applicability of the methods could be examined.
A combination of the resin column extraction, acetylation and paper chromatographic
separation of acetylated catechol amines was applied to a selection of nervous tissues
obtained from dogs and cats and the dopamine and noradrenaline contents were estimated.
The results obtained are given in Table 4. They agree with previous observations on the
distribution of dopamine in nervous tissues (Bertler & Rosengren, 1959) and also show the
presence of dopamine in sympathetic ganglia other than the stellate ganglion (Schumann,
1956).
Figs. 1 and 2 show the fluorescence profiles of that part of chromatograms of extracts
of dog hypothalamus and superior cervical ganglion where the acetylated naturally
occurring catechol amines are found. They were developed with the tert.-butanol solvent
system and show well-defined dopamine peaks. There was, however, a very small amount
of fluorescence detected about 18 cm in front of the dopamine region. This has not been
-1^
Table1
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Table 2
Rf VALUES OF ACETYLATED CATECHOL DERIVATIVES IN BUSH SOLVENT SYSTEM C









RECOVERY OF CATECHOL AMINES ADDED TO TISSUE HOMOGENATES
Amount recovered























Fig. 1. Fluorescence profile of part of a chromatogram of an extract of dog hypothalamus. Developing
solvent—petroleum spirit: fer/.-butanol: water. Arrows show position of acetyl derivatives of
authentic catechol amines.
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Table 4
THE CONCENTRATION OF NORADRENALINE AND DOPAMINE IN NERVOUS TISSUES
The extraction method included a cation exchange resin column and the results were corrected for a recovery
of 40%. Tissues were pooled samples from four cats and three dogs. * These estimations were made on
the thoracic and lumbar cord from each of two cats and on a pooled sample of portions of the thoracic

















Weight Concentration Weight Concentration
of of
tissue Noradrenaline Dopamine tissue Noradrenaline Dopamin
(g) Og/g) Og/g) (g) Og/g) Og/g)
1-71 0-10 9-9 1-64 0-09 9-9
0-73 2-85 0-20 0-95 1-35 0-25
1-19 0-67 0-05 2-10 0-17 0-05
2-22 0-58 0-15 2-54 0-43 0-33
1-25 0-12 0-07 1-70 0-16 0-01
1-21 0-12 <0.003 1-61 0-05 0-003
1-91 0-16 0-007 1-00 0-10 0-008
2-89 0-08 0-010
— — 0-26 12-2 0-45
— —• 0-07 7-8 0-78
— — 0-65 2-2 0-17
— — 0-35 26-5 2-00
— — 0-20 5-5 0-80
























Fig. 2. Fluorescence profile of part of a chroma-
togram of an extract of dog superior cervical
ganglion. Developing solvent—petroleum
spirit: to-t.-butanol: water. Arrows show the











Fig. 3. Fluorescence profile of part of a chroma-
togram of an extract of the median eminence
and pituitary stalk of the cat. Developing
solvent—toluene : ethyl acetate : methanol :
water. Arrows show position of acetyl
derivatives of authentic catechol amines.
identified. The results obtained from experiments in which the acetylated catechol amines
were extracted directly from deproteinized solutions are given in Table 5. They demonstrate
the presence of dopamine in the superior cervical ganglion of several species and also show
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hat dopamine is a major catechol amine in the pituitary stalk and median eminence, a
result which has been suggested by the histological and pharmacological examination of
this tissue by Fuxe (1964).
The estimation of the dopamine in a single pituitary stalk and median eminence of the
cat is at the lower limit of the sensitivity of the method. By using the tissue from two cats
and employing the microcell it is possible to find not only dopamine, but also adrenaline
and noradrenaline in the pituitary stalk and median eminence of the cat. A profile of the
fluorescence from such a chromatogram is given in Fig. 3 and shows the presence of the
three catechol amines in this tissue.
Table 5
THE CONCENTRATION OF NORADRENALINE AND DOPAMINE IN NERVOOS TISSUES
Results were obtained by extracting the acetylated amines directly from deproteinized tissue homogenates.
Number of animals from which pooled tissue sample was obtained are given in parentheses. Concentra¬
tions are in /^g/g of fresh tissue corrected for a mean recovery of 71% for dopamine and 56% for









(mg) Tissue Noradrenaline Dopamine
132 Caudate nucleus (3) 0-27 6-39
116 Hypothalamus (3) 1-29 0-14
199 Midbrain (3) 0-55 0-13
165 Cerebral cortex (3) 0-18 <0.01
87 Hypothalamus (1) 1-52 0-20
610 Midbrain (2) 0-59 0-18
88 Massa intermedia of thalamus (1) 0-36 0-10
10 Stellate ganglion (1) 13-0 4-64
25 Superior cervical ganglion (1) 3-5 0-85
69 Hypothalamus (1) 2-43 0-20
78 Superior hypothalamus (2) 1-23 0-35
108 Medial hypothalamus (2) 2-59 0-25
52 Inferior hypothalamus (2) 2-89 0-81
102 Globus pallidus and putamen (1) 0-05 8-22
34 Superior cervical ganglion (1) 5-25 0-82
44 Stellate ganglion (1) 2-82 1-32
7 Pituitary stalk and median eminence (1) 1-1 1-3
20 Pituitary stalk and median eminence (2) 2-9 8-7
81 Caudate nucleus (1) * 11-78
178 Superior hypothalamus (1) 3-01 0-27
218 Inferior hypothalamus (1) 1-44 0-21
256 Massa intermedia of thalamus (1) 0-70 0-34
36 Pituitary stalk and median eminence (1) 0-32 5-05
400 Stellate ganglion (1) 4-07 1-48
156 Caudate nucleus (1) * 10-9
253 Superior hypothalamus (1) 1-48 0-15
222 Medial hypothalamus (1) 1-81 0-10
85 Inferior hypothalamus (1) 2-16 0-11
244 Massa intermedia of thalamus, medial (1) 0-34 0-31
283 Massa intermedia of thalamus, lateral (1) 0-12 0-46
445 Anterior midbrain (1) 0-29 0-41
342 Medial anterior midbrain (1) 0-45 0-27
302 Medial posterior midbrain (1) 0-55 0-14
425 Posterior midbrain (1) 0-34 0-04
39 Pituitary stalk and median eminence (1) 0-16 2-0
165 Stellate ganglion (1) 1-95 0-85
546 R. LAVERTY and D. F. SHARMAN
DISCUSSION
The method described here for the detection, identification and estimation of small
quantities of dopamine has overcome some of the difficulties of the earlier methods in
which ethylenediamine was used to estimate catechol amines. It is possible to identify as
little as 10 to 20 ng of dopamine in tissue. The specificity of the fluorescence developed
with dopamine has been improved by acetylating the catechol amines before condensing
them with ethylenediamine and by determining the position of the acetates on a paper
chromatogram. Of the catechol amines normally present in tissues only dopamine will give
rise to a product having a maximum fluorescence at 520 m/x. a-Methyldopamine was the
only other catechol compound of those investigated which gave rise to a similar fluorescence.
The acetyl derivative of this substance was separated from the dopamine triacetate by paper
chromatography and thus, if present, would not interfere with the dopamine estimations.
3,4-Dihydroxyphenylalanine (dopa) and 3,4-dihydroxyphenylacetic acid were not extracted
by the procedures used for the catechol amines. A small amount of fluorescence was
obtained when 3,4-dihydroxymandelic acid was acetylated, extracted with dichloromethane
and then condensed with ethylenediamine. This might be due to the presence of 3,4-di-
hydroxybenzaldehyde, formed by oxidation, in the sample of acid used. 3,4-Dihydroxy-
benzaldehyde, 3,4-dihydroxyphenylethanol and 3,4-dihydroxyphenylgIycol, possible cate¬
chol intermediates in the metabolism of catechol amines, have not yet been examined, but
they would not be included in the eluates from a cation exchange resin column. Under
normal conditions these latter substances might be expected to be present in tissues in very
small quantities only, but must be considered when processes altering the metabolism of
catechol amines are being investigated.
One disadvantage of the present method when the resin column stage is omitted, is its
inability to distinguish between dopamine and A-acetyldopamine, a substance which can
be formed in vivo (Goldstein & Musacchio, 1962) and also between other catechol amines
and their A-acetyl derivatives. However, the results of Goldstein (1964) appear to indicate
that A-acetyl derivatives of dopamine and its metabolites do not occur in the brain tissue
of the rat after administration of dopa. Thus it can be concluded that the method can
be used to identify and estimate small quantities of dopamine with reasonable certainty
and accuracy. The estimation of noradrenaline by the method as it stands is not as good
as that of dopamine. This is probably explained by the proximity of the noradrenaline
acetate region to the origin of the chromatogram and resultant interference with the
development of the fluorescence by material left at the origin. This could probably be
overcome by developing the chromatogram for a longer time. A further difficulty lies
in the estimation of noradrenaline in the presence of a large amount of dopamine. The
acetylation of dopamine resulted in the formation of about 99.5% of the 3,0,4-C,A-triacetyl
derivative and there was about 0.5% of an incompletely acetylated derivative present on
the chromatogram which runs to the same place as the noradrenaline triacetate. The
two substances can be estimated by differential fluorimetry but a small amount of nor¬
adrenaline in the presence of a large amount of dopamine can be easily overlooked. This
fact also limits the use of the method for radioactive estimations.
The methods described here are applicable to the estimation of small quantities of
dopamine in tissues. When larger amounts of tissues (0.5 to 5.0 g) are involved it is advisable
to use the resin column stage in the extraction, although the recovery of dopamine is rather
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low. For quantities of tissues below 0.5 g this stage can be omitted with a concomitant
increase in the recovery of dopamine, but the observations made above with regard to
other catechol derivatives must be taken into account.
The amount of dopamine estimated in various parts of the nervous system is, in general,
in agreement with that found by other workers (Bertler & Rosengren, 1959). However,
only very small quantities of dopamine have been detected in spinal cord, a result which
differs from the observations of McGeer & McGeer (1962) who reported a concentration of
0.45 /xg/g in the spinal cord of the cat. Observations made in this laboratory have shown
that the concentration of dopamine in tissues can be extremely variable and it is certainly
advisable to examine the spinal cord more fully. According to Hamberger, Norberg &
Sjoqvist (1964), Holmstedt and his colleagues have been unable to detect dopamine in
significant amounts in the superior cervical ganglion of the cat. The present experiments
clearly demonstrate the presence of this amine in all the sympathetic ganglia which were
examined and indicate the degree of sensitivity of the method. This is further illustrated by
the demonstration that the major catechol amine in the median eminence and pituitary
stalk of the cat, sheep and goat is dopamine.
SUMMARY
1. Because of difficulties encountered in the estimation of small amounts of dopamine, a
method has been developed that enables the identification and estimation of as little as
10 to 20 ng of this substance.
2. Dopamine and a-methyldopamine can be distinguished from a number of other
catechol derivatives by first acetylating these substances with acetic anhydride in the
presence of sodium bicarbonate and then condensing the acetyl derivatives with ethylene-
diamine. The condensates formed from dopamine and a-methyldopamine fluoresce at a
longer wavelength than the condensates derived from the other compounds. The intensity
of the fluorescence developed is also increased by acetylating the catechol amines before
condensing them with ethylenediamine.
3. Acetylated catechol amines are easily extracted from aqueous solutions into dichloro-
methane.
4. The acetyl derivatives of catechol amines can be separated by paper chromatography.
Two solvent systems used were toluene, ethyl acetate, methanol and water (10: 1 : 5 : 5),
and petroleum spirit, (erf.-butanol and water (8:3: 8). The former system separated
acetylated dopamine from acetylated a-methyldopamine. The latter system was required
to separate acetylated dopamine from acetylated 6-hydroxydopamine.
5. The catechol amines in extracts prepared from nervous tissues were acetylated,
extracted and then separated by paper chromatography. They were then estimated by
differential fluorimetry after condensing the acetyl derivatives with ethylenediamine.
Dopamine was present in the superior cervical ganglia of the dog, the cat and the rabbit.
The major catechol amine in the pituitary stalk and median eminence of the cat, the goat
and the sheep was dopamine.
We would like to thank Dr M. Vogt, F.R.S., for her advice and encouragement. We are grateful to
Dr C. S. Miller (Merck Sharp & Dohme Research Laboratory, Rahway, N.J., U.S.A.) for a gift of
6-hydroxydopamine and to Dr S. E. Smith (St. Thomas's Hospital, London) for a sample of a-methyl¬
dopamine.
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There have been a number of studies of the effects of drugs on the content of various
amines found in brain tissue. In particular, the concentrations in the brain of noradrenaline
(Vogt, 1954) and 5-hydroxytryptamine (Paasonen & Vogt, 1956; Brodie, Shore &
Pletscher, 1956) have been determined before and after treatment with drugs, and many
attempts have been made to correlate the change in brain amine concentration with an
observable change in animal behaviour. Later, brain dopamine (3,4-dihydroxyphenyl-
ethylamine) has been included in such studies (Bertler, 1961).
In the present experiments, the content of dopamine, noradrenaline and 5-hydroxytrypt-
amine in different parts of cat and dog brain was measured, and so was the content of
homovanillic acid (4-hydroxy-3-methoxyphenylacetic acid) and 5-hydroxyindol-3-ylacetic
acid, the major acid metabolites of dopamine and 5-hydroxytryptamine. The corresponding
acid metabolite of noradrenaline, vanillylmandelic acid (4-hydroxy-3-methoxymandelic
acid), has not been detected in brain tissue (Anden, Roos & Werdinius, 1964; Sharman,
unpublished) and so could not be determined. The simultaneous determination of an
amine and its metabolite permitted a study of the effect of the drug not only on the content
of the amine but also on a possible indicator of the rate of metabolism of the amine.
The concentrations of both dopamine and homovanillic acid are highest in the brain in
the caudate nucleus and putamen; since the caudate nucleus is easy to dissect out repro-
ducibly it was used for the estimation of these two compounds. The caudate nucleus is
thought to form part, with other basal ganglia which also contain dopamine, of the " extra¬
pyramidal motor system", though recent evidence suggests that it has a more generalized
function, acting as an integrative centre for the whole of the cortex (Laursen, 1963;
Carman, Cowan & Powell, 1963). In the brains from patients with Parkinson's syndrome,
Bernheimer, Birkmayer & Hornykiewicz (1963) found a much-reduced concentration of
dopamine in the caudate nucleus, as well as smaller reductions in the concentrations in
the brain of noradrenaline and 5-hydroxytryptamine. This suggests a relationship between
brain dopamine metabolism and Parkinson's syndrome, as do the results of Barbeau &
* Beit Memorial Research Fellow. Present address: Wellcome Research Institute, University of
Otago Medical School, Dunedin, New Zealand.
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Sourkes (1961) who found a reduced urinary excretion of dopamine in patients with
Parkinsonism. For this reason we have studied a number of drugs which are reported to
influence or induce a Parkinson-like syndrome in animals or man. In addition, some drugs
were studied which cause or mimic central sympathetic excitation. Preliminary reports of
some of the results have been published (Laverty, 1963; Sharman, 1963b).
METHODS
Adult cats, dogs and rabbits were used. Whenever possible litter mates were used as controls for the
treated animals. If litter mates were not available, the experimental and control groups were usually
matched for sex and size. The brains from control animals were analysed simultaneously with those from
treated animals; in most experiments, control and treated animals were housed under identical conditions
before and during treatment.
Drugs were administered subcutaneously, except for some cats where intraperitoneal or oral administra¬
tion was used and a few rabbits to which the drugs were given either intraperitoneally or intravenously
into a marginal ear vein.
The animals were killed by bleeding during chloroform anaesthesia. The brain was removed and the
caudate nuclei and the hypothalamus were removed and deep-frozen; in cats the thalamus (excluding the
medial geniculate bodies) was also removed and frozen. All tissues were weighed frozen. Within 2 hr
of removal of the tissue from the animal, the hypothalamus and caudate nuclei were each homogenized
with at least twice their weight of 0.1 n-hydrochloric acid, with the addition of a few mg of ascorbic acid.
The protein in the hypothalamic homogenate and in a portion of the caudate nucleus homogenate was
precipitated with an equal volume of 0.8 n-perchloric acid and centrifuged off at 0° C. ThepH of the super¬
natant fluid was adjusted to pH 4 with 3 n-potassium carbonate; the precipitated potassium perchlorate
was removed by further centrifugation at 0° C. The supernatant fluid was then applied to a Dowex
50 X-8 ion-exchange resin column (25x4 mm) prepared as described by Bertler, Carlsson & Rosengren
(1958). The column was fitted with a capillary tube which maintained a flow rate of 8 to 10 ml./hr without
applied pressure. When the supernatant fluid had run through, the column was washed with 4 ml. of water;
then the noradrenaline was eluted with 8 ml. of 0.4 n-hydrochloric acid. A further fraction which contained
dopamine could be obtained by eluting with 8 ml. of 2 n-hydrochloric acid. The columns used for caudate
nucleus extracts were washed with 6 ml. of 0.4 n-hydrochloric acid instead of water to remove any nor¬
adrenaline or dihydroxyphenylalanine, and the dopamine was eluted with 8 ml. of 2 n-hydrochloric acid.
Edetic acid disodium salt (20 pg) was added to the dopamine eluates which were then brought to pH 4
with solid sodium bicarbonate.
Noradrenaline in the eluates was determined fluorimetrically by a ferricyanide oxidation method
(Sharman, Vanov & Vogt, 1962). The fluorescence was measured using a Locarte filter fluorimeter with
a Chance 0X1 primary filter, and an Ilford 625 secondary filter. This filter combination gave equivalent
fluorescence with equal amounts of noradrenaline and adrenaline; the results given for noradrenaline include
any adrenaline present. In many experiments the adrenaline content of the noradrenaline eluate was also
measured by a differential method using a second filter set; the primary was a combination of Corning
3389 and Corning 5113 and the secondary, Chance OY4. With this set, adrenaline gave approximately
three times the fluorescence given by an equal amount of noradrenaline.
Dopamine was measured fluorimetrically by a modification of the method of Weil-Malherbe & Bone
(1952). To 4 ml. of neutralized column eluate was added 0.3 ml. of ethylenediamine and 0.2 ml. of 2 n-
hydrochloric acid (instead of 0.2 ml. of 2 n-ethylenediamine dihydrochloride) and the mixture was heated
in the dark for 20 min at 65° C. The reaction mixture was saturated with sodium chloride and extracted
with 3 ml. of isobutanol. The fluorescence of the isobutanol extract was read in an Aminco-Bowman
spectrophotofluorimeter at 415/520 mp (uncorrected instrumental wavelengths). In some later experiments
the dopamine in the eluate was acetylated before condensation (Laverty & Sharman, 1965); this increased
the sensitivity of the method.
5-Hydroxytryptamine and 5-hydroxyindol-3-ylacetic acid were measured fluorimetrically as described
by Ashcroft & Sharman (1962); in dogs a portion of the caudate nucleus homogenate and in cats the
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thalamus was used. Homovanillic acid was measured in portions of the homogenates from cat and dog
caudate nuclei by the method described by Sharman (1963a). In rabbits only catechol amines were
estimated.
In experiments with tritiated dopamine, the radioactivity was measured using a Packard Tri-Carb liquid
scintillation counter. Samples of aqueous solution, usually 1 ml., were added to 15 ml. of scintillator solu¬
tion in dioxane (Bray, 1960) and counted directly with an efficiency of 10 to 13% against an internal standard
of tritiated dopamine. The l-[3H]-dopamine was obtained from New England Nuclear Corp. (150 jtC/mg).
The following dtugs were used: atropine sulphate (B.D.H.), atropine methylbromide, caramiphen
hydrochloride (Geigy), chlorpromazine hydrochloride (May & Baker), dexamphetamine sulphate, 3,4-
dihydroxyphenylalanine (dopa, L. Light), diethazine hydrochloride (May & Baker), ephedrine hydro¬
chloride, guanethidine (Ciba), morphine hydrochloride (B.D.H.), oxotremorine (May & Baker), pento¬
barbitone sodium (Abbott), reserpine (Ciba), j3-tetrahydronaphthylamine hydrochloride (Theo. Schuchardt,
Munich), trifluoperazine dihydrochloride (Smith, Kline & French), thioproperazine dimethanesulphonate
(May & Baker) ar.d thioridazine hydrochloride (Sandoz). Doses are given in terms of the salts.
Standard solutions of amines and metabolites were prepared, in terms of free base or acid, from adrenaline
base (Burroughs Wellcome), dopamine hydrochloride (California Corp. for Biochemical Research),
homovanillic acid (California Corp. for Biochemical Research), 5-hydroxytryptamine hydrogen oxalate
(Regis), 5-hydroxyindo!-3-ylacetic acid (L. Light) and noradrenaline bitartrate (L. Light).
RESULTS
Recovery experiments. A number of experiments were carried out on the recovery of
dopamine and noradrenaline added to various tissue samples. The recovery from 0.2 jug
of noradrenaline added to cat, dog and rabbit brain tissue samples was 78 ±2.6% (mean
and standard error) in twenty-eight determinations and was reasonably consistent and
reproducible. Dopamine recoveries tended to be more variable; the mean recovery from
0.5 /eg of dopamine added to cat, dog and rabbit tissue in fifty-five estimations was 64^3.3%.
The recovery figures were calculated from the difference measured between two samples
of tissue homogenate, one of which contained added amine; each was run through the
entire column extraction procedure. In an attempt to reduce the variability arising from
the use of two separate columns, radioactive dopamine was added to a tissue homogenate
and the recovered radioactivity measured. This should enable the estimation of the
Table 1
COMPARISON OF THE RECOVERIES OF ADDED DOPAMINE (0-5 MG) ESTIMATED BY
FLL'ORIMETRIC AND RADIOACTIVE TRACER TECHNIQUES























unknown dopamine content and of the recovery in the same sample. A number of control
experiments (Table 1) were done in which the recovery estimated by fluorimetric means
was compared with the recovery estimated by radioactivity. It will be seen that the two
recoveries were similar but that the recovery estimated by fluorimetric means was much
more variable. This may reflect losses in some experiments of the dopamine in the final
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eluate without a corresponding loss of radioactivity, or may reflect a larger experimental
error involved in fluorimetric estimations.
Radioactive dopamine was used to detect where the losses occurred in the extraction
procedure. When radioactive dopamine was added to a homogenate of mouse lung and
the dopamine losses followed at various stages it was found, in four experiments, that
approximately 5% was trapped in the precipitated protein and 2% in the potassium per-
chlorate precipitate; a further 3% was not adsorbed on the resin and the main loss (12%)
occurred when the resin was washed with 0.4 N-hydrochloric acid. The remaining radio¬
activity (78%) was recovered in the 2 N-hydrochloric acid eluate.
Radioactive tracer methods also gave information about the efficiency of the ethylene-
diamine reaction and isobutanol extraction. It was found that 39% of the radioactivity in
the eluate was recovered in the isobutanol extract used to measure the fluorescence
developed. The exact reaction products are unknown (Harley-Mason & Laird, 1959)
but it is apparent that the reaction between dopamine and ethylenediamine to form an
isobutanol-soluble fluorescent product was being operated at less than maximum yield.
Recoveries of 5-hydroxytryptamine (0.2 /xg) and 5-hydroxyindol-3-ylacetic acid (0.2 /xg)
added to tissue samples averaged 69 ±1.4% (eleven experiments) and 51 ±2.0% (eleven
experiments) respectively. The mean recovery of homovanillic acid (2 to 5 /xg) added to
dog tissue was 72+6.2% (eleven experiments).
The results presented in this paper are uncorrected for losses.
The amounts of adrenaline and dopamine in the hypothalamus of the animals used in
this study were measured, but the results have not been given in detail, as the amounts
present were too close to the lower limits of sensitivity of the methods for great reliance to
be placed upon them. Single doses of morphine, /8-tetrahydronaphthylamine, dexamphet-
amine, ephedrine, pentobarbitone or atropine, and chronic treatment with phenothiazines
did not change the ratio of adrenaline to noradrenaline in the cat hypothalamus. The
adrenaline found in the hypothalamus as a percentage of the total adrenaline plus nor¬
adrenaline was 4% in cats and 11% in dogs. This agreed with previous results (Vogt, 1954).
The determination by the ethylenediamine reaction of small amounts of dopamine found
in the hypothalamus yielded values of about 0.5 /xg/g but cannot be relied upon as tissue
blank figures were high relative to the amount of dopamine present. By using a more
sensitive method involving acetylation, separation of the acetylated amine and measure¬
ment at two different fluorescence wavelengths (Laverty & Sharman, 1965) it is possible to
show that the dopamine content of cat and dog hypothalamus is approximately 0.2 /xg/g.
A striking feature of the present experiments is the extreme variability of the dopamine
content of the caudate nucleus (range 2.1 to 12.3 /xg/g in the cat). This is not due to excessive
variability in the extraction methods, since in fifteen experiments in which duplicate
estimations were made on each sample there was agreement between the duplicate samples
and the variation between animals was still present. The variability of the dopamine
content appeared to be as great or greater between different groups of animals as within
groups, particularly with the cats, and was probably due to poor control over their previous
environment. In dogs and rabbits the use of litter mates reduced but did not eliminate the
variability. A wide range (0.12 to 0.49 /xg/g) was also observed for the concentration of
5-hydroxytryptamine in the thalamus of the cat.
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Excitant drugs
Biochemical effects. The effect on the concentration of amines and metabolites in the
brain of a group of drugs which cause forms of excitation involving sympathetic mechanisms
in cats was studied in the cat, dog and rabbit. The results of these experiments are
summarized in Table 2.
Cats. In confirmation of previous work (Vogt, 1954), it was found that the noradrenaline
content of the cat hypothalamus was low 4 hr after injection of morphine and /3-tetrahydro-
naphthylamine, but normal after ephedrine. In the caudate nucleus, the homovanillic acid
content was raised 4 hr after the first two, but not after the third drug. Dexamphetamine
only slightly lowered the hypothalamic noradrenaline and slightly raised the homovanillic
acid level. Yet dexamphetamine was the only drug of these four to lower significantly the
dopamine content of the caudate nucleus. In whole rat brain dexamphetamine was seen
to lower the noradrenaline content without affecting that of dopamine (Baird & Lewis,
1963).
The peculiar " rage-like " effect seen in cats after the injection of tremorine or its
metabolite, oxotremorine (Toman, 1963), prompted a study of the effects of oxotremorine.
The drug was given in two doses (0.25 and 0.125 mg/kg, intravenously) spaced at an interval
of 2 hr in cats protected from the peripheral effects of the drug by an injection of atropine
methylbromide (1.5 mg/kg, subcutaneously) 15 min before the first injection. The only
biochemical change found after treatment with oxotremorine was a rise in the homovanillic
acid content of the caudate nucleus. Small rises in the 5-hydroxytryptamine concentration
were obtained with morphine and /3-tetrahydronaphthylamine and a small fall with
dexamphetamine; in addition, morphine produced a small increase in the concentration
of 5-hydroxyindol-3-ylacetic acid.
Dogs. Only /3-tetrahydronaphthylamine and dexamphetamine were tested. Both lowered
hypothalamic noradrenaline content but, in contrast to the observation on cats, the homo¬
vanillic acid level did not rise, nor did that of dopamine fall after amphetamine, indicating
a greater susceptibility of the dopamine metabolism in cats than in dogs.
Rabbits. Morphine, /J-tetrahydronaphthylamine and dexamphetamine had no effect on
the dopamine content of the caudate nucleus of rabbits. Though, with the exception of
morphine, these drugs had pronounced excitatory effects, only a slight fall in hypothalamic
noradrenaline level was observed after amphetamine.
Behavioural effects. Morphine in cats caused an obvious central excitation which ranged
from "hallucinations " to an increase in motor activity, hissing and occasional convulsions.
There was also increased salivation, mydriasis and panting. Rabbits were, if anything,
sedated by morphine and respiration was depressed.
,8-Tetrahydronaphthylamine caused in cats, dogs and rabbits pupillary dilatation,
salivation and intense excitement characterized by increased alertness, apprehension and
bouts of violent activity. From time to time, some cats and rabbits showed muscular
rigidity and tremor. There was usually panting and an increase in body temperature.
Dexamphetamine caused alertness in all species, but differed from /l-tetrahydronaphthyl-
amine in causing specific patterns of motor activity. Cats showed rhythmic head movements
and paced about the cage, dogs continually circled the pen and rabbits chewed the bars of















































































































































































766 R. LAVERTY and D. F. SHARMAN
occasionally also by aggressiveness. There was salivation, mydriasis and panting, and an
increased body temperature. Ephedrine was used in two cats as a control for amphetamine;
they became alert and irritable but did not show the specific patterns of motor activity seen
after amphetamine.
Oxotremorine caused an immediate response consisting of extreme " rage " and aggres¬
sion, which was, however, quite different from that produced by other drugs. The animal's
actions were much more co-ordinated, closely resembling the actions of a normal cat playing
with its captured prey; there was purposeful response to external stimuli such as an
immediate attack upon another cat placed in the same cage. The effect lasted approximately
1.5 hr; a subsequent dose (0.125 mg/kg, intravenously) given 2 hr after the first caused a
lesser and briefer response of a similar pattern.
Tranquillizing phenothiazines
Biochemical effects. Four phenothiazine derivatives used as tranquillizers in patients
were examined in cats for their effect on the content of amines and their metabolites in
brain tissue. Table 3 summarizes the results. Chlorpromazine and thioridazine were com¬
pared 4 hr after a single administration. Chlorpromazine (10 mg/kg) lowered the dopamine
content and increased the homovanillic acid content of the caudate nucleus but did not
lower the hypothalamic noradrenaline level. In contrast, single doses of thioridazine (10 and
50 mg/kg) decreased the concentration of noradrenaline but did not lower the dopamine
level. Like chlorpromazine, they increased the homovanillic acid content of the caudate
nucleus. The 5-hydroxytryptamine content was lowered by the larger dose. After chronic
administration of chlorpromazine, trifluoperazine and thioproperazine the only change
observed was an increase in the content of homovanillic acid in the caudate nucleus,
whereas thioridazine was without effect on any of the compounds measured.
Behavioural effects. After a single administration of chlorpromazine the cats became
quiet, withdrawn and ataxic. The nictitating membranes were relaxed; the animals were
not hypothermic when killed. A single injection of thioridazine (10 mg/kg) had little
apparent effect initially, but 4 hr after injection the animals were quiet, walked clumsily
and had relaxed nictitating membranes. The high dose of thioridazine (50 mg/kg) caused
relaxation of the nictitating membranes and anal sphincter and diarrhoea; the cats were
not hypothermic when killed. Cats treated with thioridazine were less quiet than after
chlorpromazine, showing periods of calling and walking about the cage, and one cat
treated with the large dose had pronounced rigidity of all limbs and tremor.
Treatment with phenothiazine drugs was prolonged in an attempt to produce conditions
similar to those of patients showing Parkinsonism-like side-effects on chronic pheno¬
thiazine treatment. Trifluoperazine was given subcutaneously; this caused ulceration at
the site of injection in some animals. For this reason, the other drugs were given orally, in
capsules. All drugs were given in doses sufficient to cause an observable degree of tran-
quillization, without causing loss of weight or other noticeable deterioration in condition.
No signs of tremor, rigidity, plasticity or anything that could be described as a Parkinsonian
syndrome were observed. The animals moved little of their own volition, but were quite
capable of normal movement. Any aggression or fear in response to handling or administra¬
tion of drugs remained unchanged throughout treatment. Thioridazine produced side-
effects, the animals suffering from diarrhoea, which prevented a higher dose from being
used; some of the treated animals had relaxed nictitating membranes.
Table3
THEEFFECTOFSOMEP ENOTHIAZINETRANQUILLIZERSHMEANCO TE TSFSOMEAMI SDH IRAC DMETABOLITESINBRAINTISSUE SeeTable2fordetail dcaption.Allxperimentswereocat Meantissuecontent(pg/gfreshtis ue)f DrugAcuteexperim nts Chlorpromazine Control Thioridazine Thioridazine Control Totalcontrols Chronicexperiments Chlorpromazine Control Trifluoperazine Control Thioproperazine Control Thioridazine Control TotalcontrolsDose(mg/kg) and durationof treatment 10s.c.,4hr 10s.c.,4hr 50i.p.,4hr 20oral,14days 8s.c.,12days 100oral,4days 15oral,4daysNoradrenaline 2-0+0-25 1-6+0-19 2-0+0-15 1-3+0-13 2-7±0-08 2-1±0-21(5, (4)** (4)1** (4)(9) 1-4+0-08( )1-8±0-10(4)1-8±0-12(4)1-8±0-14(4)1-6,7 1-4+0-09(3)1-6+0-04(4)1-4+0-05(3) 1-6+0-07(14)Dopamine 4-6±0-4 6-7±0-5 6-2+0-3 7-0+0-8 7-4+0-9s.,6-9±0-4(12) 5-3±0-3 6-6+0-9 5-5±0-9 6-8±0-1 5-7±0-4 3-5+0-9 8-3±0-3 8-7+1 2Homovanillic acid
5-Hydroxy- tryptamine
5-Hydroxyindol-3-yl- aceticacid
3-6+0-4 2-0+0-4 3-7+0-3 6-0+1-2 2-1±0-1 2-1±0-2
(5)t* ^4)1** (4)1* (9)





































8 (3)t* (4)(9) (4)(4)(4) (4)(3)(3)(4)(3)(14)
0-18+0-01 0-28±0-07 0-28±0-09 0-33±0-08 0-19±0-03 0-24+0-04
(5) (5) (4)(3) (4)(9)
0-15+0- 0-26+0- 0-30+0- 0-34+0- 0-16+0- 0-25+0- 0-17+0- 0-15+0 0-24+0-
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Other drugs
A number of other drugs were examined before and during the course of the above
experiments. The first four were used to test the methods; the remaining three in order to
investigate drugs used clinically to alleviate Parkinsonism. The results are given in Table 4.
Dopa, the amino acid precursor of dopamine, was used to increase dopamine metabolism.
It was given intraperitoneally to cats; in dogs anaesthetized with pentobarbitone it was
infused slowly into one carotid artery, the other having been tied off. In both species, the
dopamine content of the caudate nucleus increased, and so did the homovanillic acid
content in dogs. In cats the homovanillic acid content did not rise, due probably to the
short duration of the experiment.
Reserpine (2 mg/kg) reduced the content of all amines in the cat brain and caused a
corresponding increase in the two acid metabolites. Guanethidine given to cats had no
appreciable effect on catechol amine or homovanillic acid contents. Pentobarbitone
anaesthesia had no effect on the brain amines or the acids.
Atropine given in a large dose (25 mg/kg, intraperitoneally) to cats had no effect on
amines or their metabolites. It produced pronounced peripheral and mild behavioural
effects, the animals remaining quiet when undisturbed but later becoming excitable when
handled.
Diethazine (50 mg/kg) and caramiphen (1 mg/kg) had no effect on brain amines and
metabolites when given to dogs as a single dose. No behavioural effects were observed.
DISCUSSION
The aim of the present study was to investigate the effect of drugs on the concentrations
in the brain of certain amines and their major metabolites in an attempt to see whether there
was any correlation between the behavioural effect of the drug and changes in the content or
rate of turnover of an amine in the brain. An increase in the rate of turnover of dopamine
was suspected to have taken place whenever an increase in the content of homovanillic acid
was observed, particularly when this occurred without a corresponding increase in the
metabolite derived from 5-hydroxytryptamine. However, the possibility that a restriction
on the outflow of acidic substances from the brain can be produced by a drug cannot be
discounted especially when more than one acidic metabolite is increased.
The effects of the drugs which cause central sympathetic excitation on the concentra¬
tion of the amines in the brain confirm and extend earlier observations and once again
illustrate the different responses that are observed with different species. The changes
observed with these drugs in the 5-hydroxytryptamine concentration were increases after
morphine and /3-tetrahydronaphthylamine and a fall after dexamphetamine. None of
these effects were very pronounced. Previous authors (Brodie et al., 1956, and Paasonen &
Giarman, 1958, using other species, and Maynert, Klingman & Kaji, 1962, using the dog)
found morphine ineffective and dexamphetamine was a depleting agent only in very high
doses (Paasonen & Vogt, 1956). Whereas the concentration of dopamine was only excep¬
tionally affected in the cat by drugs which cause central sympathetic excitation, that of
homovanillic acid was raised by four of the five drugs tested. The metabolism of dopamine
in the caudate nucleus of the cat, like that of the noradrenaline in the hypothalamus of this
species, is peculiarly sensitive to drug action. This is illustrated by the fact that the two
Table4
EFFECTOFSOMETH RDRUGSONHEANCONTE TSFSOMEAMIN SDH IRAC DME ABOLITESBRAIN xTISSUEdetails.I.c.a.,Intrac rotidarterial.05-Hydr xytryptaminend5-hydroxyindoI-3-ylaceticcidw rm asuredthm ssai terme iaofthethalamus species Cat DogDrug Dopa Reserpine Control Guanethidine Control Pentobarbitone Control Atropine Control Totalcontrols Dopa Control Diethazine Caramiphen Control TotalcontrolsDose(mg/kg) and durationof treatment 300i.p.,min 2i.p.,hr 50i.p.,4hr 50i.p.,0-5-1hr 25i.p.,3hr 15i.c.a.,1-1-5hr 50s.c.,4-5hr 1s.c.,4-5hrNoradrenaline 1-4,8 3-3 2-1,3 1-4 1-4,9 1-9,2-0 1-5,2-2 2-0 2-1±0-3(5) 1-4,6 1-4,5 M,1-8Meantissuecont nt(/xg/gfreshtis ue)f Dopamine 8-1,11-7* <1-0(5)t** 4-9±0-7(4)7-8,6 3 7-0 9-5,11-7 9-4,11-1 7-6,9 9 8-9 6-9±l-0(8) 6-6±0-7(3)** 2-7±0-3(4) 5-8,6-3 8-0,10-0 6-0,7 2 4-0±0-9(6)Homovanillic acid 1-1,4 5-1±0-5(5){** 2-0±0-5(4)2-1,4-3
4-0
1-5,3 2 2-7,3-3 2-1,2-3 2-7
2-6±0-4(8) 17-l±l-5(3)t* 10-0±l-2(4)12-8,3 13-2,5 11-6,4 8 11-4±-(6)
5-Hydroxy- tryptamine 0-33,0-380 0-980 0-18,0-29 0-33,0-44 0-23,0-25 0-25 0-28,0-30 0-27,0-28 0-30,0-35
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drugs (/5-tetrahydronaphthylamine and dexamphetamine) which were tested in cats and
dogs increased the homovanillic acid in the cat only. If one wished to correlate the
behavioural effect of the two related drugs, dexamphetamine and ephedrine, with their
different actions on the metabolism of dopamine in the cat, the only clear sign produced by
dexamphetamine and not by ephedrine was the stereotyped forced motor activity.
Oxotremorine is the active metabolite formed in the liver from tremorine (1,^pyr¬
rolidine^,3-butyne; Cho, Haslett & Jenden, 1961; Welch & Kocsis, 1961), a substance
reported to cause tremor in mice, rats and dogs similar to Parkinsonian tremor (Everett,
1961). In cats, an intense, co-ordinated excitation was produced with little or no tremor,
and this was accompanied by an increase in the homovanillic acid in the caudate nucleus.
The increase in homovanillic acid in the caudate nucleus frequently occurs together with
a loss of noradrenaline from the hypothalamus. This points to the possibility that under
these conditions both dopamine and noradrenaline are being utilized to a greater extent
than normal. Since the synthesis of dopamine is faster than that of noradrenaline (Holzer
& Hornykiewicz, 1959; Udenfriend & Zaltzman-Nirenberg, 1963), it is not surprising that
the dopamine content of the tissue is unchanged whereas that of noradrenaline is reduced.
One might expect that under these conditions not only the acid metabolite of dopamine,
homovanillic acid, but also the corresponding metabolite of noradrenaline, vanillylmandelic
acid, would be raised in those tissues in which the metabolism of noradrenaline is increased.
The investigation of this question has not yet been possible because the methods for
determining vanillylmandelic acid are not yet sufficiently sensitive.
The phenothiazine derivatives selected for examination were chlorpromazine, trifluo¬
perazine, which causes a high incidence of Parkinsonian side-effects in man (Ayd, 1961),
thioridazine, for which a low incidence of these side-effects has been reported (Cole &
Clyde, 1961), and thioproperazine, which has a potent catatonic action in rats (Leslie &
Maxwell, 1964). Chlorpromazine has been reported to increase the acid metabolites of
dopamine in the brain of the rabbit (Anden et al., 1964). Though evidence was obtained in
the present work that all four drugs are able to affect the metabolism of dopamine, the
effect of thioridazine in the doses used differed from that of the other drugs. After a single
dose of thioridazine the caudate nucleus was not depleted of dopamine as was observed
with chlorpromazine. After repeated administration any changes in the content of homo¬
vanillic acid which were produced initially had disappeared, whereas they persisted with
the other three phenothiazine derivatives. In addition, the acute administration of
thioridazine caused a depletion of the hypothalamic noradrenaline, an effect which was not
seen with chlorpromazine. After thioridazine, the incidence of Parkinsonism is reported
to be much lower than after the other phenothiazine drugs used in this work. The observa¬
tion that it affects amine metabolism in the brain differently from its congeners may have
some bearing on this property.
The experiments also show that drugs may have similar behavioural effects but different
biochemical actions on amines in the brains of different species; furthermore, that drugs as
closely related chemically as the phenothiazine tranquillizers may each have characteristic
behavioural and biochemical effects. It is only possible to conclude that there are no
simple rules by which the behavioural effect of a drug can be correlated with changes in
the metabolism of amines in the brain.
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SUMMARY
1. The effects of sixteen drugs on the content of certain amines and their metabolites in
brain tissue were studied in an attempt to see whether drugs with central effects caused any
change in amine metabolism.
2. The contents of noradrenaline in the hypothalamus and dopamine in the caudate
nucleus of cats, dogs and rabbits, of homovanillic acid in the caudate nucleus of cats and
dogs, and of 5-hydroxytryptamine and 5-hydroxyindol-3-ylacetic acid in the thalamus of
cats and the caudate nucleus of dogs, were measured fluorimetrically following chromato¬
graphic separation or solvent extraction.
3. Of those drugs which cause central sympathetic stimulation or " excitement " in cats,
morphine (30 to 50 mg/kg), /3-tetrahydronaphthylamine (30 mg/kg) and dexamphetamine
(10 mg/kg) lowered the noradrenaline content, but only dexamphetamine lowered the
dopamine content. All three drugs and also oxotremorine (0.38 mg/kg) increased the
homovanillic acid concentration. Morphine and /3-tetrahydronaphthylamine slightly
increased the 5-hydroxytryptamine content whereas dexamphetamine slightly reduced it;
morphine caused a small rise in the 5-hydroxyindol-3-ylacetic acid content. Ephedrine
(50 mg/kg) had no effect on any amine or metabolite content.
4. In dogs, /3-tetrahydronaphthylamine (30 mg/kg) and dexamphetamine (10 mg/kg)
lowered hypothalamic noradrenaline and dexamphetamine lowered the 5-hydroxytrypt-
amine content. No effect on dopamine metabolism was seen. In rabbits, morphine (15 to
80 mg/kg), /3-tetrahydronaphthylamine (15 mg/kg) and dexamphetamine (15 mg/kg)
produced no change in dopamine level, but dexamphetamine reduced the hypothalamic
noradrenaline.
5. Of the phenothiazine derivatives tested in cats, chlorpromazine (10 mg/kg) and
thioridazine (10 to 50 mg/kg) given as single injections increased the homovanillic acid
but only chlorpromazine lowered the dopamine content. Thioridazine, however, lowered
the hypothalamic noradrenaline and, in a large dose, the thalamic 5-hydroxytryptamine
content. After treatment for 12 to 14 days with chlorpromazine (20 mg/kg, orally), tri¬
fluoperazine (8 mg/kg, subcutaneously) and thioproperazine (100 mg/kg, orally), the
homovanillic acid content of the caudate nucleus was increased but the other compounds
were not changed; after 14 days' treatment with thioridazine (15 mg/kg, orally) no measur¬
able biochemical change had occurred. Thus thioridazine, which, unlike the other
phenothiazine derivatives tested, rarely causes Parkinsonism in man, differs from these
compounds in its effects on the metabolism of brain catechol amines.
6. Atropine (25 mg/kg), diethazine (50 mg/kg) and caramiphen (1 mg/kg), drugs asso¬
ciated with the treatment of Parkinsonism, were without effect on brain amine metabolism.
7. No simple correlation between the biochemical and the behavioural effects of the
drugs could be found.
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The presence of homovanillic acid (4-hydroxy-3-methoxyphenylacetic acid), an acid
metabolite of dopamine (3,4-dihydroxyphenylethylamine), in the mammalian brain,
particularly in the corpus striatum, has been demonstrated in a number of species (Anden,
Roos & Werdinius, 1963a ; Sharman, 1963a; Bernheimer, 1964; Pletscher, Bartholini,
Bruderer, Burkard & Gey, 1964). Juorio & Vogt (1965) reported that the striatal region
of the rat brain contained very little homovanillic acid and that the level of this acid
did not change after the administration of reserpine. In contrast, treatment with reserpine
increases the homovanillic acid content of the brain of the rabbit (Anden, Roos &
Werdinius, 1964) and of the cat (Sharman, 1963b). It was of interest to examine the
response to reserpine in the brains of other small mammals and to reinvestigate the
metabolism of the endogenous dopamine in the rat brain.
METHODS
Materials
These were: L-cysteine hydrochloride (Roche); Dowex 1x2 anion exchange resin 100-200 and
200-400 mesh (Dow Chemical Co.); homovanillic acid (California Corporation for Biochemical
Research); hydrochloric acid, (Microanalytical Reagent quality); and potassium ferricyanide
(Analytical Reagent quality, recrystallized from water). Other reagents were of Analytical Reagent
quality. Glass distilled water was used throughout.
The following drugs were used: reserpine (Serpasil, Ciba), either manufacturer's ampoules or a
solution prepared from Serpasil powder dissolved in 10% ascorbic acid in water ; tetrabenazine,
dissolved in a little glacial acetic acid and the solution diluted with 0.9% saline ; chlorpromazine
hydrochloride, dissolved in 0.9% saline ; and DL-3,4-dihydroxyphenylalanine (DL-dopa, L. Light), a
suspension prepared in 0.9% saline.
The animals used were guinea-pigs, coypu, albino rats from three colonies and Meriones (the
gerbil). Rats and Meriones were stunned and decapitated ; guinea-pigs and coypu were anaesthetized
with chloroform and bled. The brain was rapidly removed and the required part dissected out and
chilled on ice. When the extraction was not carried out immediately the tissues were stored at
— 17° C. They did not usually remain at this temperature for longer than 1 hr. The tissue
excised was selected for reproducibility of the dissection and varied in the different species as
follows: guinea-pig, caudate nucleus and a small amount of the underlying striatal tissue; coypu,
caudate nucleus ; rat, a block of tissue including the striatum and most of the orbital cortex ;
and Meriones, as for the rat, but with some parietal cortex.
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Extraction of homovanillic acid
The tissue was homogenized in 2 ml. of 1 N-acetic acid for each g of tissue, using a glass
homogenizer. The homogenate was diluted with water to a volume of 5 to 10 ml. 1 N-sodium
hydroxide (1 ml./g tissue) was added and the homogenate was mixed thoroughly. After centrifugation
the clear supernatant fluid was ready for extraction on a column of anion exchange resin. A
small column of Dowex 1x2 anion exchange resin was set up as shown in Fig. 1. The resin "was
washed with 10 ml. of 2 N-hydrochloric acid, followed by 10 ml. of water. It was then converted
to the acetate form by means of 10 ml. of 1 N-acetic acid. After washing with a further 15 ml.
of water, the column was ready for the passage of the tissue extract. Frequently a small air bubble
was trapped just above the resin, preventing the flow of liquid. This was easily removed with
a thin glass rod. The tissue extract was filtered into the reservoir above the resin column and the
filter paper was washed with water to bring the final volume of liquid in the reservoir to 10 to
20 ml. When all of the extract had passed through the column, the reservoir and column were
carefully washed with 10 to 15 ml. of water. Homovanillic acid was eluted with 4 to 4.5 ml.
of 0.1 N-hydrochloric acid.
A slight modification of the method described by Anden et al. (1963a) for the estimation of
homovanillic acid was used. A portion of the eluate from the resin column was diluted to 1 ml.
with water. 1 ml. of a freshly prepared 5 N-ammonium hydroxide solution, containing 20 /*g/ml.
of potassium ferricyanide, was then added with mixing. After 4 min the reaction was stopped
by the addition of 0.2 ml. of a freshly prepared 0.1% solution of cysteine hydrochloride. A blank
determination was made for each eluate by reversing the order of the addition of the last two
solutions. The fluorescence developed from authentic homovanillic acid in the presence of the
eluate was also determined.
The fluorescence was measured either with an Aminco-Bowman Spectrophotofluorometer or with
a Locarte filter fluorimeter. In the former instrument the wavelength of the activating light was
310 m/i (uncorrected instrumental value). In some experiments a wavelength of 320 m/i was used
for convenience in standardizing the instrument. The fluorescence was measured at a wavelength
of 430 m/t (uncorrected instrumental value) with a Corning 5113 filter in the fluorescence light
path. The activating light of the Locarte fluorimeter was passed through two Chance OX7 filters,
and the fluorescence light was filtered through a combination of a Corning 5113 (half standard
thickness) filter and a Corning 3389 filter. It was found that the results obtained with the filter
fluorimeter were somewhat higher than those obtained using the spectrophotofluorimeter unless
the method involved the paper chromatographic separation described below. This was due to the
11 cm 2-2.5 cm 10 cm
Fig. 1. Diagram of the apparatus used to extract homovanillic acid,
Fluorimetry
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presence of some fluorescing material, not visible in the non-oxidized blank, but also seen in
extracts of brain tissue which did not contain homovanillic acid. The results calculated from
measurements made with the filter fluorimeter were corrected for this tissue fluorescence. The
recovery of authentic homovanillic acid added to tissue homogenates was determined in five series
of experiments by three different workers. The mean recoveries ranged from 57 to 71% with an
overall mean recovery of 64% (n = 67). The standard error of a single observation was ±15.6%.
Limitations of the method
The method was developed so that drugs could be quickly screened for their effect on the
homovanillic acid content of the brain, and in common with many other simple methods, there
are certain limitations to its use. Many acidic substances are adsorbed on to the anion exchange
resin under the conditions used. The adsorption of homovanillic acid depends on the nature of
other anions present in the extract. For example, the adsorption of homovanillic acid proceeds
adequately in the presence of 0.2 m-acetate at pH 5.2. A concentration of chloride up to 0.02 m
in a solution of 0.14 m-acetate (pH 5.2) did not prevent the retention of homovanillic acid, but
concentrations of chloride above 0.02 m reduced the recovery, 0.1 m-chloride resulting in a loss of
70%. Homovanillic acid is completely eluted by 8 ml. of 1.0 n-acetic acid or 4 ml. of 0.1
n-hydrochloric acid. These observations indicate that the hydrogen ion contributes to the elution
of homovanillic acid from the column. Experiments showed that some derivatives of phenylacetic
acid could be separated from the corresponding mandelic acid derivatives, the former being eluted
with a more dilute solution of acetic acid. It was found, however, that the development of the
fluorescence from homovanillic acid was irregular in the presence of acetic acid. With hydrochloric
acid the results are reproducible, but there is a small decrease in the intensity of the fluorescence
derived from homovanillic acid. A number of acidic substances, in addition to homovanillic acid,
are eluted from the column with 0.1 n-hydrochloric acid. 5-Hydroxyindolylacetic acid was not
eluted from the column by 0.1 n-hydrochloric acid, but the eluate would contain any
3,4-dihydroxyphenylacetic acid, 3,4-dihydroxymandelic acid and 4-hydroxy-3-methoxymandelic acid.
3,4-Dihydroxyphenylacetic acid is known to occur in striatal tissue (Anden et al., 1963b). When
3,4-dihydroxyphenylacetic acid was present in solutions in a concentration equal to that of
homovanillic acid a reduction of 10 to 20% in the fluorescence was observed. Because the eluting
acid and possibly other substances present in the eluate are likely to bring about some reduction
in the fluorescence, all estimations were calculated against the fluorescence developed from a known
amount of homovanillic acid added to a portion of the eluate. In practice, any quenching other than
that by the 0.1 n-hydrochloric acid has rarely been seen. The development of a fluorescent
compound from homovanillic acid by oxidation with potassium ferricyanide in ammonium hydroxide
solution, under the conditions described here, is reasonably specific for this acid. Some other
derivatives of 4-hydroxy-3-methoxyphenylethane give rise to a small fluorescence. Of these, only
4-hydroxy-3-methoxymandelic acid is likely to be extracted by this method. This acid has not
been detected in brain tissue (Anden et al., 1964 ; Sharman, unpublished).
Identification of homovanillic acid in the tissues
Tissue extracts, deproteinized with zinc sulphate and sodium hydroxide, or eluates from resin
columns were extracted with ethyl acetate. The acids in these extracts were separated by paper
chromatography on alkali-washed, hardened filter paper, using a benzene: propionic acid: water
mixture as the developing solvent (for details see Sharman, 1963a). Consecutive strips were cut
from the whole chromatogram and eluted with water. The fluorescence reaction described above
and that described by Sharman (1963a) have been applied to these eluates. The positions of
materials on the chromatograms giving rise to a fluorescence were compared with the position of
authentic homovanillic acid used as a marker. This was visualized by means of the reaction with
diazotized p-nitroaniline to give a blue-grey colour. The procedures applied to identify homovanillic
acid were also used in some experiments to confirm the estimates made with the quicker but less
specific method using the anion exchange resin. For identification, it was frequently necessary to
pool the tissues from two to twenty animals.
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Estimation of dopamine
The dopamine content of rat striatal tissue was estimated fluorimetrically after acetylation of
the amine in an eluate from a column of cation exchange resin (Dowex 50 x 8) and condensation
with ethylenediamine to form a fluorescent derivative (Laverty & Sharman, 1965a).
RESULTS
Rat
Groups of rats, obtained from three different sources, were given reserpine, 2 mg/kg.
One of these colonies (A) was the same source as the rats used by Juorio & Vogt (1965).
The results are given in Table 1. Observations made 4 hr after injection of the drug,
Table 1
THE EFFECT OF DRUGS ON THE CONCENTRATION OF HOMOVANILLIC ACID IN THE
CORPUS STRIATUM OF THE RAT
Drugs were given subcutaneously in a single dose : reserpine, 2 mg/kg ; chlorpromazine, 10 mg/kg ; and
tetrabenazine, 50 mg/kg. The results are expressed as the means and standard errors of the concentration
of homovanillic acid in pg/g fresh tissue and are corrected for recovery. The number of experiments is
given in parentheses. Homovanillic acid was estimated after extraction on an ion exchange column. Signi¬
ficance of difference from control value : *P<0-01 ; fP<0-05



























the time interval used by Juorio & Vogt (1965), show that, in contrast to animals from
colony A, rats from colonies B and C responded with an increase in homovanillic acid
in the striatum. The increase seen with rats from colony B was only significant at the
5% level but, in a further series of similar experiments in which the homovanillic acid
was estimated after paper chromatography, the effect of reserpine on rats of the same
colony was highly significant (Table 2). The results given in Table 2 also confirm that
Table 2
THE EFFECT OF DRUGS ON THE CONCENTRATION OF DOPAMINE AND HOMOVANILLIC
ACID IN THE CORPUS STRIATUM OF THE RAT
Results are expressed as means and standard errors of the concentration in pglg fresh tissue and are corrected
for recovery. Homovanillic acid estimations were made after paper chromatographic separation of extracts
of pooled tissues. Dopamine estimations were usually made on a portion of the homogenate used for the
estimation of homovanillic acid. The number of experiments is given in parentheses. I.p.=intraperitoneal;





Colony Drug (mg/kg) (hr)
A Control
A Reserpine 2 s.c. 4
A Reserpine 5 i.p. 4
A Dopa 200 i.p. 4
B Control
B Reserpine 2 s.c. 4
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rats from colony A did not. show an increase in homovanillic acid 4 hr after the
administration of reserpine, even when a larger dose (5 mg/kg) was used. However, rats
from colony A did show an increase in homovanillic acid after 6 and after 8 hr. There
was no difference between rats from colonies A and C in the response to chlorpromazine
(10 mg/kg); a clear increase in homovanillic acid was seen 3 hr after the injection
(Table 1). The effect of tetrabenazine was only tested on rats of colony C. The
homovanillic acid content of the striatum was increased after 90 min (Table 1).
Homovanillic acid was identified by scanning the whole chromatograms, developed
from extracts of the brains of untreated rats (colonies A and C), of rats treated with
reserpine (colony A) and of rats given chlorpromazine (colony C). Fig. 2 shows the
distribution of material giving rise to fluorescence on chromatograms of extracts from
the brains of normal and reserpine-treated rats of colony A. In addition to confirming
the presence of homovanillic acid in these tissues, Fig. 2 shows that there is, in normal
animals, another fluorescing acidic substance. This fluorescence was seen in alkaline
solution, even without the oxidation with ferric chloride, which was used in these
experiments to develop the fluorescence from homovanillic acid. The amount of this


















Homovanillic acid Solvent frontOrigin
Fig. 2. The distribution of material giving rise to fluorescence on paper chromatograms of acids
extracted from the brain of the rat. Fluorescence was developed as described by Sharman
(1963a).
Guinea-pig, coypu and Meriones
The effects of reserpine, chlorpromazine and tetrabenazine on the content of
homovanillic acid in the striatal tissues of the guinea-pig and the coypu are illustrated
in Table 3, which also shows the effects of the first two drugs in Meriones. In all instances
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the drug treatment resulted in an increase in the content of homovanillic acid. The
identity of the homovanillic acid in the brains of normal animals was established in
all three species.
Table 3
THE EFFECT OF DRUGS ON THE CONCENTRATION OF HOMOVANILLIC ACID IN THE
CORPUS STRIATUM OF THREE RODENTS
Results (means and standard errors) are expressed as jug/g fresh tissue and are corrected for recovery.
§Homovanillic acid estimations made after paper chromatographic separation. S.c. = subcutaneous ;
i.p. = intraperitoneal. Significance of difference from control values : *P<0-01 ; 1\P<0-05
Duration of Homovanillic acid
Dose treatment No. of content
Species Drug (mg/kg) (hr) observations Ms)
Guinea-pig — — 48 2-68 ±0-20
— — 5 2-65±0-60§
Reserpine, s.c. 2 2 11 5-36±0-82*
4 9 6-33±l-02*
8 11 4-43 ±0-73*
16 5 3-41 ±0-45f
Chlorpromazine, s.c. 10 2 4 4-78±0-65*
4 5 4-62±0-35*
8 5 3-21 ±0-55
16 5 l-78±0-21




Coypu — 6 4-02±0-35
Reserpine, i.p. 4 4 6 7-27±0-87*
Chlorpromazine, i.p. 10 4 2 11-78 ; 8-58
8 2 7-45 ; 7-60
Tetrabenazine, i.p. 20 4 2 10-10 ; 5-42
Meriones — 18 0-54±0-09
Reserpine, s.c. 2 4 12 1-22 ±0-26*
8 5 0-49±0-26
Chlorpromazine, s.c. 10 4 9 1-71 ±0-24*
DISCUSSION
The results show that homovanillic acid is a normal metabolite of dopamine in the
brains of several rodents. The concentration of this acid is much lower in the striatum
of the rat than in other species which have been studied, and this difference is not a
result of a greater amount of non-striatal tissue in the piece of brain excised, of which
at least one-third was striatal tissue. Significant amounts of homovanillic acid were not
detected in cortical tissues. In spite of the large fall in the concentration of dopamine
which occurred after reserpine, the increase in homovanillic acid was absent or very
small, corresponding at most to about 10% of the fall in the dopamine concentration.
This contrasts with the rabbit (Anden et al„ 1964) and the cat (Laverty & Sharman,
1965b), in which, 2 hr after the injection of reserpine, the homovanillic acid corresponded
to approximately 55% and 33% of the missing dopamine. This suggested that the rat
either metabolized dopamine through an alternative pathway or that the homovanillic
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acid was more rapidly removed from the brain in this species. That the rat brain is
capable of building up high concentrations of homovanillic acid was illustrated by the
large increase produced by the administration of DL-dopa (Table 2) and confirms in the
rat the observations of Carlsson & Hillarp (1962) on the rabbit. Bertler, Falck &
Rosengren (1963) have reported that this treatment results in the formation of dopamine
in cells in the walls of the blood-vessels in the brain as well as in nervous tissue, and
it is not clear what contribution to the total homovanillic acid content estimated is made
by the metabolism of the dopamine in the walls of the cerebral blood-vessels. This
objection is, however, not valid for the large rise in homovanillic acid seen after
chlorpromazine, which presumably occurs exclusively in nervous tissue. Preliminary
experiments on pooled brains of reserpine-treated rats did not reveal any increases in
3-methoxytyramine, 4-hydroxy-3-methoxyphenylethanol or 3,4-dihydroxyphenylacetic
acid, known metabolites of dopamine. Their formation would be an alternative reason
why, in this species, reserpine causes such a small and delayed increase in the
homovanillic acid content of the striatum. When tetrabenazine, which depletes dopamine
more rapidly than reserpine, is injected into rats there is a large increase in homovanillic
acid. This might be due to the saturation of a mechanism which removes the
homovanillic acid from nervous tissue. If such a mechanism were more efficient in the
rat than in other species, this would explain the low concentration of homovanillic
acid in the striatum of normal and reserpine-treated rats.
In the guinea-pig the time courses of the increases of homovanillic acid after reserpine
or chlorpromazine were three times shorter than those observed by Anden et al. (1964)
in the rabbit. In general, the administration of reserpine or chlorpromazine to mammals
results in an increase of the content of homovanillic acid in the striatal tissue, but it is
apparent that even within a single species quantitive and temporal differences in this
response can occur.
SUMMARY
1. The effect of some tranquillizing drugs on the homovanillic acid content of the
striatum has been studied in rat, guinea-pig, coypu and Meriones. The administration
of reserpine or chlorpromazine produced an increase in the concentration of homovanillic
acid in all four species. Tetrabenazine was examined in the first three species ; it also
increased the homovanillic acid content of the brain.
2. In the rat the normal level of this acid is low and the increase afer reserpine
is small and may be delayed. It is suggested that, in this species, there is a more
efficient mechanism for removing homovanillic acid from the brain than in other species.
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Several drugs have been shown to increase the concentration of 4-hydroxy-3-methoxy-
phenylacetic acid (homovanillic acid; HVA), a major metabolite of 3,4-dihydroxyphenyl-
ethylamine (dopamine), in the striatal tissues of several mammalian species (Anden, Roos
& Werdinius, 1963, 1964 ; Sharman, 1963 ; Laverty & Sharman, 1965a ; Juorio, Sharman
& Trajkov, 1966). This report is concerned with the application of a screening test for
drugs which increase the concentration of homovanillic acid in the striatum using the




The drugs were administered intraperitoneally or, in a few cases, intravenously, dissolved in 0.9%
sodium chloride solution with the following exceptions.
Reserpine was injected as the manufacturers' solution.
Tetrabenazine, spiroperidol, haloperidol and triperidol were dissolved in the minimum amount of
glacial acetic acid. Dilutions were then made with 0.9% sodium chloride solution.
Probenecid was dissolved in the minimum volume of 1 N-sodium hydroxide and 0.9% sodium
chloride solution was then added. If necessary, the pH was adjusted to 7-8 with 0.1 N-hydrochloric
acid.
a-Methyl-p-tyrosine was dissolved in the minimum volume of 1 N-sodium hydroxide and the
solution diluted with 0.5 M-disodium hydrogen phosphate solution ; 0.4 N-hydrochloric acid was
then added carefully until a slight precipitate of the amino acid was formed. The final concentration
of a-methyl-p-tyrosine was usually 8 mg/ml.
Dissection of tissues
The mice were stunned and decapitated and the brains rapidly dissected out and placed on a glass
plate on ice. The part of the brain used for the estimations of homovanillic acid and of dopamine
consisted of the striatum together with some orbital cortex. This piece of tissue was selected for ease
of reproducibility in the dissection and was obtained by dividing the brain along the midline and
exposing the caudate nucleus through the lateral ventricle. The cortical tissue anterior and dorsal
to the caudate nucleus was removed and the striatum together with some orbital cortex obtained
with a single cut posterior to the caudate nucleus. For the estimation of 5-hydroxyindol-3-ylacetic
acid the whole brain anterior to the pons was used. Pooled tissues from two to three mice were
used for the estimation of homovanillic acid and from two mice for the estimation of
F
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5-hydroxyindol-3-ylacetic acid. The dopamine estimations were carried out with the tissue from
a single animal. Albino mice of both sexes were used.
The estimation of homovanillic acid
The method used to extract and estimate homovanillic acid has been described in detail by
Juorio et al. (1966). Briefly, the homovanillic acid was adsorbed from the deproteinized tissue extract
on to a small column of Dowex 1X2 anion exchange resin. The homovanillic acid was then eluted
with 0.1 N-hydrochloric acid and estimated fluorimetrically by a modification of the method of
Anden et al. (1963) using an Aminco-Bowman Spectrophotofluorometer.
Dopamine was extracted with a column of Dowex 50X8 cation exchange resin as described by
Bertler, Carlsson & Rosengren (1958). The dopamine in the eluate from the column was acetylated
and estimated fluorimetrically in a Locarte filter fluorimeter after condensation of the acetyl
derivative with ethylene diamine (Laverty & Sharman, 1965b). 5-Hydroxyindol-3-ylacetic acid was
estimated fluorimetrically as described by Ashcroft & Sharman (1962). All estimations are
uncorrected for recoveries.
RESULTS
Effect of drugs on the concentration of homovanillic acid in the striatum
The effect of a number of drugs on the concentration of homovanillic acid in the
striatum of the mouse is shown in Table 1. No difference was found between untreated
control animals and those treated with the vehicles in which the drugs were dissolved.
All of these values have been combined to give the control value in Table 1.
Table 1
THE EFFECT OF DRUGS ON THE CONCENTRATION OF HOMOVANILLIC ACID IN THE
STRIATUM OF THE MOUSE
Except where otherwise stated drugs were injected intraperitoneally
* Significantly different (PCO-Ol) from control value. A single observation showing an increase of
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Concn. of homovanillic acid
Duration of (pglg tissue±s.e.m.)
treatment No. of observations in
(hr) parentheses
45 mg/kg in two doses at 2-hr
interval





















Arecoline HBr 21.V. 2 0-31 ; 0-30
61.V. 2 0-28
10I.V. 2 0-30
Pilocarpine HC1 2I.V. 2 0-27
4I.V. 2 0-34 ; 0-34
Anti-depressant drugs
Pargyline HC1 400 0-5 0-20 ; 0-18
1 0-20 ; 0-26
4 0-08 ; 0-06
Imipramine 20 4 0-40±0-09(4)
Desmethylimipramine 20 4 0-23 ; 0-25
Other drugs
Probenecid 200 3-5 0-75 ; 0-78
270 3-5 1-31 ±0-10(4)*
Zoxazolamine 90 mg/kg divided into 3 doses 0-25 ±0-02 (3)
at 1-hr intervals
Total duration 2-5 hr
Tolazoline 35 mg/kg divided into 4 doses 0-28 ±0-02 (5)
at 30-min intervals
Total duration 2 hr
Bulbocapnine HC1 40 0-5 0-51 ±0-05 (4)*
Benzhexol HC1 501.V. 2 0-43 ; 0-40
The large increases caused by most of the tranquillizing drugs are in agreement with
the observations of Anden et al. (1964) and Roose (1965) on the rabbit, Laverty &
Sharman (1965a) on the cat and Juorio et al. (1966) on four rodents. The small increase
seen after chlordiazepoxide was seen only after doses of this drug which produce a loss
of the righting reflexes.
Of the two excitant drugs, only /3-tetrahydronaphthylamine produced an increase in
the level of homovanillic acid, an effect also seen in the cat (Laverty & Sharman, 1965a).
These authors also observed that morphine elevated the homovanillic acid in the cat.
When tested in the mouse morphine did not show this effect even after 45 mg/kg.
However, the very active morphine-like compound M.99 (6,14-endoetheno-7-(2-hydroxy-
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2-pentyl)-tetrahydro-oripavine hydrochloride) produced a clear increase after a dose of
only 0.1 mg/kg. M.285 (N-cyclopropylmethyl-6,4-endoetheno-7-(2-hydroxy-2-propyl)-
tetrahydro-nororipavine hydrochloride), which has strong nalorphine-like properties, did
not produce an increase in homovanillic acid when 0.5 mg/kg were given. With a larger
dose (1 mg/kg) a possible small increase in the homovanillic acid was seen (Table 2).
Table 2
THE EFFECT OF PRETREATMENT ON DRUG-INDUCED INCREASES IN THE
HOMOVANILLIC ACID CONCENTRATION IN THE STRIATUM OF THE MOUSE
Except where stated otherwise all drugs were injected intraperitonea lly
* Significant difference (PcOOl) from M.99 alone





Dose treatment Pretreatment 15-60 min before No. of observations
Drug (mg/kg) (hr) (dose in mg/kg) in parentheses
Chlorpromazine HC1 5 3
Diethazine
0-70±0'05 (10)
10 0-66 ; 0-77
Caramiphen 10 0-76 ; 0-61
Desmethylimipramine 20 0-78±0-06 (3)
Imipramine 20 0-93 ±0-01 (4)
Methylphenidate 20 0-80 ; 0-72
-• Methylphenidate 50 0-60 ; 0-65
Spiroperidol 0-1 2 0-70±0-03 (11)
M.285 1 0-63 ±0-04 (8)
Spiroperidol 01 3 0-66 ±0-04 (9)
Phencyclidine 5 0-59 ; 0-67
Benzhexol 10I.V. 0-51 ; 0-81
M.99 0-2 2 0-75 ±0-06 (7)
M.285 1 0-53 ±0-04 (8)*
M.285 1 2 0-45 ±0-04 (7)t
Control animals (Estimations made in parallel with above three 0-37±0-05 (6)
sets of results)
Inhibition of monoamine oxidase by pargyline resulted in a fall in the homovanillic
acid level, an effect seen in the rabbit after treatment with the monoamine oxidase
inhibiting drug nialamide (Anden et al., 1963). The two other anti-depressant drugs
tested, which are not inhibitory to monoamine oxidase, had no significant effect on the
concentration of homovanillic acid. The drugs causing central cholinergic stimulation
were also ineffective in this respect. Of the other drugs tested, probenecid is of interest
as an inhibitor of organic acid transport in the renal tubules ; it produced a large elevation
of the level of homovanillic acid in the striatum. An increase in the concentration of
5-hydroxyindol-3-ylacetic acid in the brain of the rat after treatment with probenecid has
been reported by Neff, Tozer & Brodie (1964). Zoxazolamine has uricosuric properties
which can be additive with those of probenecid, and is a centrally acting muscle relaxant,
but it did not affect the concentration of homovanillic acid in striatal tissues.
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Antagonism of drug induced increases in the concentration of homovanillic acid
Because the major tranquillizing drugs are known to produce side effects which
resemble Parkinson's disease, some drugs which are used to treat this disease were tested
to see if they would prevent the increase in homovanillic acid produced by chlorpromazine
and spiroperidol. The drugs were administered intraperitoneally 15-60 min before the
tranquillizing drug.
The results are shown in Table 2 and they indicate that diethazine and caramiphen do
not prevent the increase in homovanillic acid produced by chlorpromazine and that
benzhexol is ineffective against spiroperidol. Imipramine, desmethylimipramine and
methylphenidate were also inactive. Table 2 also shows that M.285, in a dose that blocks
the behavioural effects of M.99 administered 15 min later, can partially antagonize the
increase in homovanillic acid produced by the latter drug. The same dose of M.285 did
not change the homovanillic acid increase after spiroperidol (0.1 mg/kg).
Investigation of the mechanisms by which drugs can elevate the concentration of
homovanillic acid in the striatum
Five of the drugs found to increase the homovanillic acid concentration in the striatum
of the mouse were selected for further investigation into the mechanisms by which they
produce this effect. These were spiroperidol, M.99, /3-tetrahydronaphthylamine, pro¬
benecid and bulbocapnine.
(a) Behavioural effects
These five drugs produce very different behavioural effects in the mouse.
Spiroperidol in a dose of 0.1 mg/kg had little effect on the gross behaviour of the mice.
They remained fairly active but frequently showed ptosis. With a larger dose (0.5 mg/kg)
the animals became inactive but did not collapse.
The response to M.99 (0.2 mg/kg) was extremely variable. A pronounced Straub
effect on the tail was the first sign of the action of the drug. The animals then became
excited and moved erratically about the cage. A rigid catalepsy then developed and in
many but not all of the experiments the animals lost their righting reflexes. There was
a pronounced fall in temperature.
/3-Tetrahydronaphthylamine caused piloerection on the back of the neck and excitement.
Probenecid (200 mg/kg), had no obvious effect on the behaviour of the mice.
Bulbocapnine (40 mg/kg) caused a flaccid catalepsy which wore off after one hour.
None of these behavioural effects was prevented by the administration of a-methyl-p-
tyrosine.
(b) Effects on the rate of utilization of dopamine
The effects of these five drugs on the concentrations of dopamine and homovanillic
acid in the striatum of the mouse were studied after treatment with the drugs alone and
after pretreatment with a-methyl-p-tyrosine (80 mg/kg). This amino acid competitively
inhibits the enzyme tyrosine hydroxylase (Nagatsu, Levitt & Udenfriend, 1964;
Udenfriend, Zaltzman-Nirenberg & Nagatsu, 1965), which catalyses the rate-limiting step
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in the synthesis of dopamine in vivo. Spector, Sjoerdsma & Udenfriend (1965) have
shown that the administration of this amino acid results in a fall of the dopamine concen¬
tration in the caudate nucleus and suggested that the rate of the decrease in dopamine
concentration in a tissue, after treatment with a-methyl-p-tyrosine, would reflect the
turnover rate of the dopamine in that tissue.
The results obtained in this series of experiments are given in Tables 3 and 4. A
maximum inhibition of the tyrosine hydroxylase was effected in these experiments because
a larger dose of a-methyl-p-tyrosine (160 mg/kg) did not produce a larger fall in the
concentration of dopamine than that following a dose of 80 mg/kg. Table 3 shows that
of the five drugs only /3-tetrahydronaphthylamine changes the dopamine concentration
when given alone. In a dose of 30 mg/kg this drug caused a significant increase in the
concentration of dopamine in the striatum of the mouse. Table 3 also shows that after
a-methyl-p-tyrosine, the administration of spiroperidol in doses of 0.1 mg/kg and 0.5
Table 3
THE EFFECT OF DRUGS ON THE DECREASE IN THE CONCENTRATION OF THE DOPAMINE
IN THE STRIATUM OF THE MOUSE PRODUCED BY THE ADMINISTRATION OF a-METHYL-
p-TYROSINE
a-Methyl-p-tyrosine (80 mg/kg) administered 15 min before drug
* Significant difference (PC0-01) from corresponding control value
t Significant difference (P<0-01) from control animals not treated with a-methyl-p-tyrosine
Duration of
Dopamine concn. (/ag/g tissue±s.e.m.)


























1 -83 ±0-13 (9)
2-07 ±0-21 (9)
Table 4
THE EFFECT OF a-METHYL-p-TYROSINE ON THE DRUG-INDUCED INCREASE IN THE
LEVEL OF HOMOVANILLIC ACID IN THE STRIATUM OF THE MOUSE
a-Methyl-p-tyrosine (80 mg/kg) administered 15 min before drug
* Significant difference (PcO-Ol) from corresponding control value
t Significant difference (P<0-0l) from control animals not treated with a-methyl-p-tyrosine
Duration of
Concn. of homovanillic acid (/ag/g tissue±s.e.m.)
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mg/kg results in a significantly larger fall in the concentration of dopamine than occurs
after the amino acid alone. The other four drugs did not change the fall in dopamine
concentration caused by the a-methyl-p-tyrosine.
The specificity of the dopamine estimations. To confirm that the apparent increase in
the dopamine concentration seen after /3-tetrahydronaphthylamine was due to dopamine
and not to a metabolite of the drug, striatal tissues from treated mice were extracted as
for the estimation of dopamine. After the acetylation step in the procedure the solution
was extracted with dichloromethane and the material in this extract subjected to paper
chromatographic separation as described by Laverty & Sharman (1965b). Fluorescence
was only found on the chromatogram in the region of triacetyldopamine, and this was
present in an intensity which corresponded with the increased amount found by direct
estimation in the tissue. Furthermore, no increase in dopamine was detected in the hypo¬
thalamic region of the mouse brain after treatment with /3-tetrahydronaphythylamine,
where metabolites of /3-tetrahydronaphthylamine, if such were formed, should also be
detected.
Udenfriend et al. (1965) have shown that a small amount of a-methyl-3,4-
dihydroxyphenylalanine can be formed from a-methyl-p-tyrosine in vitro by the enzyme
tyrosine hydroxylase. If this transformation were to occur in vivo then it is possible
that the dopamine estimations given in Table 3 would include any a-methyl dopamine
formed by decarboxylation of the a-methyl-3,4-dihydroxyphenylalanine. However, no
a-methyl dopamine could be detected in extracts of striatal tissue from mice treated with
a-methyl-p-tyrosine when these were examined by the methods described above for the
identification of dopamine since these allow the separation of dopamine and its methy¬
lated derivative a-methyl dopamine. Using these methods it was possible to demonstrate
that a-methyl dopamine was formed in striatal tissue 2 hr after the administration of
a-methyl-3,4-dihydroxyphenylalanine (80 mg/kg).
(c) Effects on the concentration of homovanillic acid
Table 4, in agreement with Table 1, shows that all five drugs can produce a significant
increase in the homovanillic acid concentration in the striatum of the mouse. Inhibition
of tyrosine hydroxylase by a-methyl-p-tyrosine causes a reduction in the level of the
homovanillic acid in this tissue. Furthermore, a-methyl-p-tyrosine given 15 min before
the drug reduces the increase in homovanillic acid produced by probenecid and the higher
dose of spiroperidol and abolishes that caused by the lower dose of spiroperidol,
/3-tetrahydronaphthylamine, M.99 and bulbocapnine.
(d) Effects on 5-hydroxyindol-3-ylacetic acid
The five drugs were also examined for their effect on the concentration of 5-hydroxy-
indol-3-ylacetic acid in the brain. The results are given in Table 5. Probenecid was
found to cause an increase in the concentration of 5-hydroxyindol-3-ylacetic acid in the
brain whereas /3-tetrahydronaphthylamine produced a reduction in the concentration of
this acid. No effect on the 5-hydroxyindol-3-ylacetic acid level was observed after
spiroperidol, M.99 and bulbocapnine.
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Table 5
THE EFFECT OF DRUGS ON THE CONCENTRATION OF 5-HYDROXYINDOL-3-
YLACETIC ACID IN THE BRAIN OF THE MOUSE
















































The method for estimating homovanillic acid described by Juorio et al. (1966) has
proved to be sensitive enough to be used in a screening test for drugs which affect the
homovanillic acid in the striatum, using the albino mouse as the test animal. This enables
several observations to be made when only a limited amount of a drug is available.
The dopamine in the striatum is thought to have a physiological role of its own and
the major final metabolite of dopamine in this region of the brain appears to be homo¬
vanillic acid. An increased formation of homovanillic acid could follow an increased
synthesis of the amine. If the dopamine storage mechanism is not saturated under
normal conditions, this increased synthesis would be accompanied by an increase in
the amount of dopamine present in the tissue. An inhibitor of dopamine synthesis
would abolish drug-induced increases in the concentrations of both dopamine and
homovanillic acid. Secondly, an increased requirement for dopamine could result in a
compensatory increase in the synthesis of dopamine through a feedback mechanism
which maintains the level of the stored amine. Inhibition of the synthesis of dopamine
would reduce the increase in homovanillic acid, but the increased requirement for the
amine would be reflected in a depletion of the stored dopamine greater than that
produced by inhibition of the synthesis of dopamine under normal conditions. When the
formation of dopamine is inhibited a small increase in homovanillic acid might be
produced by a drug acting in this way but this will depend on the magnitude of the
increase in the rate of depletion of the stored amine.
Finally, a drug might also reduce the rate of outflow of homovanillic acid from the
brain. After inhibition of the synthesis of dopamine an increase in homovanillic acid
would still be seen. If such a drug is not acting specifically on the mechanism which
removes homovanillic acid from the brain then a concomitant increase in other acidic
substances such as 5-hydroxyindol-3-ylacetic acid should be seen.
These mechanisms are illustrated diagrammatically in Fig. 1.
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Fig. 1. The sites in the major metabolic pathway of dopamine in the striatum at which a drug
might act to produce an increase in the concentration of homovanillic acid.
In the mouse, /3-tetrahydronaphthylamine seems to be acting by the first mechanism
proposed, increasing the synthesis of dopamine, since both the concentration of the amine
and its acid metabolite are increased. Both of these effects are abolished when the
synthesis of dopamine is inhibited by a-methyl-p-tyrosine. Because /3-tetrahydronaph-
thylamine does not accelerate the fall in the dopamine concentration caused by a-methyl-
p-tyrosine, there is no increase in the requirement for dopamine. The enzyme tyrosine
hydroxylase catalyses the rate-limiting step in the synthesis of dopamine and it is tempt¬
ing to ascribe the action of /3-tetrahydronaphthylamine to an effect on this enzyme.
Spiroperidol might be acting on the second mechanism. It appears to act by increasing
the turnover of dopamine, since, after inhibition of the synthesis of dopamine there is a
faster rate of depletion of the amine in mice treated with this drug than in untreated
animals. Only the larger dose of spiroperidol increased the concentration of homovanillic
acid after treatment with a-methyl-p-tyrosine. It would further appear that part of the
action of this drug is dependent upon an intact synthetic pathway for dopamine.
Probenecid is a typical example of a drug which acts by generally preventing the
outflow of acidic substances from the brain. This drug has no effect on the concentration
of dopamine when given alone or after a-methyl-p-tyrosine. After the latter treatment,
probenecid still produces a large increase in homovanillic acid. This increase is not as
large as in the normal animal and reflects a lowering of the turnover rate of dopamine
as the " stored " amine is reduced. The general action of probenecid is illustrated by the
fact that it was the only drug of the five examined which elevated the concentration of
5-hydroxyindol-3-ylacetic acid in the brain of the mouse. Neff et al. (1964) have
demonstrated an active system for transporting 5-hydroxyindol-3-ylacetic acid out of the
brain of the rat, which can be inhibited by probenecid. The observations presented in this
paper confirm the presence of a similar system in the mouse.
On the evidence presented here, the actions of M.99 and bulbocapnine in elevating
homovanillic acid do not appear to fit any of the proposed schemes. These drugs did
not increase the concentration of dopamine like /3-tetrahydronaphthylamine and in the
presence of an inhibitor of dopamine synthesis there was no increase in the rate of
disappearance of dopamine, as had been seen with spiroperidol. Their action requires
an intact synthetic pathway for dopamine, and they do not act by preventing the outflow
of homovanillic acid from the brain. A possible explanation of the action of M.99 and
bulbocapnine is that they produce a diversion of the dopamine after the amine is formed
by the decarboxylation of 3,4-dihydroxyphenylalanine and that it is metabolized before
it comes under the influence of the "storage " mechanisms. Such a diversion would tend
to reduce the amount of dopamine in the " store " and this, in turn, might lead to an
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increased synthesis of dopamine to maintain the " store." This diversion of the
metabolism of dopamine could also play a part in the action of spiroperidol.
Although it is suggested that spiroperidol, /3-tetrahydronaphthylamine, M.99, pro¬
benecid and bulbocapnine produce an increase in homovanillic acid by different
mechanisms, the possible correlation between these different mechanisms and the
behavioural effects of these drugs cannot be attempted until more detailed behavioural
studies have been made.
SUMMARY
1. A rapid method is described for the detection of drugs which affect the concentra¬
tion of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid) in the striatum, using
the albino mouse as the test animal.
2. Among the drugs which were found to increase the concentration of homovanillic
acid in the striatum of the mouse, spiroperidol, /3-tetrahydronaphthylamine, M.99, bulbo¬
capnine and probenecid were selected for a fuller analysis. This included the effect of
these drugs on the fall in brain concentration of 3,4-dihydroxyphenylethylamine
(dopamine) elicited by a-methyl-p-tyrosine.
3. These observations, and the study of the effects of these drugs on the concentration
of 5-hydroxyindol-3-ylacetic acid in the brain, have suggested a number of mechanisms
by which drugs can produce an increased concentration of homovanillic acid in the
striatum.
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The administration to rats of probenecid, an inhibitor of the transport of organic acids
in the renal tubules, has been shown to cause an increased concentration in the brain
of 5-hydroxyindol-3-ylacetic acid, a metabolite of 5-hydroxytryptamine (Neff, Tozer &
Brodie, 1964). Sharman (1966) reported a similar response to probenecid in the mouse
and observed a concomitant elevation in the striatum of the concentration of 4-hydroxy-
3-methoxyphenylacetic acid (homovanillic acid), a metabolite of 3,4-dihydroxyphenyl-
ethylamine (dopamine). Werdinius (1966) showed that an increase in the concentration
of homovanillic acid also occurred in the brain of the rat after treatment with probenecid.
From these observations it has been concluded that there is an active transport
mechanism for the removal of these acid metabolites from the brain in these two species.
This report is concerned with a method which distinguishes between two types of drug
action by which an increase of the striatal concentration of homovanillic acid in the
mouse can occur, using the response to a standard dose of probenecid.
METHODS
Female albino mice of a single strain were used. Drugs were administered intraperitoneally,
dissolved in a 0.9% w/v solution of sodium chloride. Probenecid was dissolved in the minimum
volume of lN-sodium hydroxide and 0.9% w/v sodium chloride solution was then added. If
necessary, the pH of the solution was adjusted to 7-8 with 0.1 N-hydrochloric acid. Spiroperidol
was dissolved in the minimum volume of glacial acetic acid (10 mg spiroperidol will dissolve in
0.05 ml. glacial acetic acid), the solution was diluted with a little water and final dilutions were
made with 0.9% w/v sodium chloride solution. The dissection of the striatal tissues, the extraction
and fluorimetric estimation of homovanillic acid were carried out as described by Sharman (1966).
The striatal tissue from 2 mice was used for each estimation.
RESULTS
Effect of increasing doses of probenecid on the concentration of homovanillic acid in
the striatum of the mouse
The concentration of homovanillic acid in the striatum was estimated 1.5 hr after the
administration of increasing doses of probenecid. Control animals were injected with
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0.9% w/v sodium chloride solution. The dose-response curve obtained is given in Fig.
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Fig. 1. Dose-response curve for the effect of probenecid on the concentration of homovanillic
acid in the striatum of the mouse.
Increase in the concentration of homovanillic acid in the striatum of the mouse produced
by a standard dose of probenecid in combination with other drugs
Several types of drugs can cause an elevation of the concentration of homovanillic
acid in the striatum of the mouse (Sharman, 1966). The effects on the concentration
of striatal homovanillic acid of some of these drugs given alone and in combination with
a dose of probenecid (100 mg/kg) are shown in Table 1. The increase due to the
administration of probenecid is larger, when this drug is given in combination with
2-aminotetralin (/3-tetrahydronaphthylamine), 30 mg/kg; spiroperidol (8-[3-(4-fluoro-
benzoyl)-propyl]-4-oxo-l-phenyl-l,3,8-triaza-spiro [4,5] decane), 0.5 mg/kg ; chlorproma-
zine, 1 mg/kg and 5 mg/kg, and M99 (6,14-endoetheno-7-(2-hydroxy-2-pentyl)-tetrahydro-
oripavine hydrochloride), than when given on its own. Spiroperidol (0.1 mg/kg) did not
increase the effect of probenecid (100 mg/kg), although this dose of spiroperidol caused
a significant increase in the concentration of homovanillic acid when given alone.
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Table 1
THE EFFECT OF SOME DRUGS GIVEN ALONE AND IN COMBINATION WITH PROBENECID
ON THE CONCENTRATION OF HOMOVANILLIC ACID IN THE STRIATUM OF THE MOUSE
Concentration of homovanillic acid in the















































Number of observations for each estimation is given in parentheses.
Drugs in column 1 were given 10-15 min before the probenecid (100 mg/kg).
Estimations were made 1-5 hr after the administration of the probenecid, (100 mg/kg\
* 2 x 2 factorial analysis of variance shows that interaction between drugs is significant P<0-05.
t Significantly different EcO-Ol from control value.
DISCUSSION
The ways in which an increase in the concentration of homovanillic acid in the striatum
of the mouse might occur have been discussed by Sharman (1966), but it was not possible
to differentiate clearly whether the accumulation was due to an increased rate of forma¬
tion of the acid or to a reduced rate of its removal from the brain, for only when the
rates of removal of other acidic substances were also affected could one feel certain
that the mechanism for the removal of homovanillic acid was impaired. The present
experiments enable these two mechanisms to be examined.
A simple approach to the processes by which homovanillic acid is formed in and
removed from the brain of the mouse is to regard the formation and removal as two
consecutive enzyme reactions in an irreversible chain, as shown in Fig. 2, and to assume
Fig. 2.
Enzyme reaction 1
^ Intermediate compound Enzyme reaction 2^
that probenecid acts by competitive inhibition of the second enzyme. It can be shown
(Webb, 1963) that, in such a situation, the concentration of the intermediate compound,
in this case homovanillic acid, depends on the rate of its formation and on the ratio
of the maximum rates of the two enzyme reactions. Figure 3 shows some theoretically
calculated curves for the relationship between the concentration of such an intermediate
compound and the rate of the first enzyme reaction and also the effect of changes in the
ratio of the maximum rates of the two reactions. From such curves, in the absence of
detailed information about conditions prevailing in the mouse striatum, it can be taken
as a first approximation that, for low concentrations of the intermediate compound, a
two-fold increase in the rate of the first reaction is reflected by a doubling of the
concentration of the intermediate.
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Fig. 3. Typical curves showing the relationship of the concentration of the intermediate compound
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Vmax reaction 2
The increase in the concentration of the intermediate compound when the second





where [Bj] = Concentration of intermediate after competitive inhibition of enzyme 2.
[B] = Concentration of intermediate without inhibition of enzyme 2.
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[I] = Concentration of competitive inhibitor.
Kj = Dissociation constant for the enzyme-inhibitor complex.
In the present experiments the concentration of the inhibitor, probenecid was kept
constant. Under such conditions if the time taken to reach the new level of intermediate
[B.]
does not exceed 1.5 hr, then the ratio should have a constant value and should
be independent of the rate of formation of the intermediate compound. If all of the
homovanillic acid in the striatum of the mouse is involved in the system which is
sensitive to probenecid, then the ratio of the concentration of homovanillic acid in the
striatum of mice treated with probenecid to the concentration of this acid in mice not
[B-l [B]
so treated should be equal to . If the ratio - = ,■ has the value n then it can
[& J J
be calculated that, in the case where not all of the homovanilhc acid in the striatum
is involved in the probenecid sensitive transport system, the difference in the striatal
concentrations of homovanillic acid between mice treated with probenecid and in similar
mice not so treated is equal to n-1 times that portion of the total concentration of
homovanillic acid in the mice not treated with probenecid, which will be affected when
this inhibitory drug is administered.
i.e.:
From equation (1) when [I] is constant, — = K
Kj
then, [Bj] — [B] = [B] K (2)
let ™ = n
[BJ
then from equation (1) n = 1+ K
substituting for K in equation (2) [Bj] ~[B]=(n-l) [B]
let [x] be a part of the initial homovanillic acid concentration unaffected by probenecid,
then [B] + [x] increases to [Bj] + [x] after probenecid.
([BJ + [x]) - ([B] + [x])=[Bj] - [B]=(n-1) [B]
It is therefore possible to distinguish an increase in the concentration of homovanillic
acid due to competitive inhibition of the active transport mechanism, or due to the
formation of the acid at a site where this mechanism is not effective, from an increase
due to an increased formation of homovanillic acid at the site where it is normally
formed, or resulting from non-competitive inhibition of the second enzyme reaction. This
latter effect is equivalent to reducing the maximum rate of the second enzyme and the
result of such a change can be predicted from the curves given in Fig. 3.
Assuming that all of the homovanillic acid in the striatum of the normal mouse is
removed by the probenecid sensitive transport system then, in the present experiments, the
value of n calculated from the effect of probenecid in control animals is found to be
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2 for a dose of 100 mg/kg. Thus:
1. If a drug increases the concentration of homovanillic acid by competitive inhibition
of the active transport system, or by causing the formation of this acid at a site where
this system is not effective, then the administration of probenecid (100 mg/kg) in combina¬
tion with such a drug will produce an additional increase in the concentration of
homovanillic acid equal to or smaller than the increase seen after this dose of probenecid
given alone.
2. If a drug produces an increase in the concentration of homovanillic acid by an
increase in the rate of formation of this acid, or by non-competitive inhibition of the
active transport mechanism, then the administration of probenecid (100 mg/kg) in com¬
bination with such a drug will produce an additional increase in the concentration of
homovanillic acid equal to the concentration of this acid observed in animals treated
with the drug alone.
Furthermore, by subtracting the additional increase produced by probenecid (100
mg/kg) from the concentration of homovanillic acid observed in animals treated with
the drug alone, it is possible to separate these two types of increase when they occur
together.
The increases in the concentration of homovanillic acid seen after a multiple dose of
probenecid and after the lower dose of spiroperidol (0.1 mg/kg) correspond with those
proposed for the first type of mechanism, the additional increase due to probenecid (100
mg/kg) being approximately equal to the increase seen in the control animals after this
dose of probenecid. After the administration of 2-amino-tetralin (30 mg/kg), chlorpro-
mazine (1 mg/kg) and M99 (0.2 mg/kg), the increase has the magnitude required by the
second type of mechanism. The additional increase due to probenecid (100 mg/kg) is
approximately equal in each case to the concentration observed after treatment with each
drug alone. The response to the larger doses of spiroperidol (0.5 mg/kg) and chlorpro-
mazine appears to result from the action of the two types of mechanism. In these two
cases the additional increase due to probenecid (100 mg/kg) is smaller than the concentra¬
tion of homovanillic acid seen in animals treated with these drugs alone. This effect,
particularly in the case of chlorpromazine, could be a result of the high rate of formation
of homovanillic acid. The time taken to reach the new level of intermediate might be
longer than 1.5 hr and thus the increase produced by probenecid would be smaller than
expected from the equation.
Using the rate of depletion of dopamine from the mouse striatum after inhibiting the
synthesis of this amine in the brain, Dickinson (personal communication) and Sharman
(1966) have found evidence that chlorpromazine and spiroperidol cause an increased rate
of utilization of dopamine, the amine from which homovanillic acid is formed, but in
the case of spiroperidol, the increase in utilization was thought to be insufficient to
account for the increase in homovanillic acid produced by this tranquillizing drug. The
present results suggest that the action of low doses of spiroperidol in increasing the striatal
concentration of homovanillic acid does not involve an increase in the rate of utilization
of dopamine through its normal pathway.
An increase in the utilization of dopamine was not observed after treatment with M99
(Sharman, 1966). The possibility that this drug increases the homovanillic acid concen¬
tration by non-competitive inhibition of the active transport mechanism must therefore
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be considered. The present results yield some indirect evidence that this is not the
explanation for the effect of this drug on the concentration of homovanillic acid in the
striatum. The dose-response curve relating the striatal concentration of homovanillic
acid to the dose of probenecid shows that the concentration of homovanillic acid does not
rise above 0.8 /xg/g. This could represent the maximum concentration that it is possible
to reach in 1.5 hr after total inhibition of the removal of the acid from the brain when
the rate of formation of homovanillic acid is normal, and corresponds to a normal turn¬
over rate of the acid of 0.05 /xg/g/min.
Treatment with M99 together with probenecid elevated the homovanillic acid to 0.98
fig/g in 1.5 hr, so that it would appear that at least part of the action of M99 is due
to an increase in the rate of formation of homovanillic acid in the striatum.
SUMMARY
1. The administration of probenecid, a competitive inhibitor of renal acid transport,
to mice results in an increase in the concentration of 4-hydroxy-3-methoxyphenylacetic
acid (homovanillic acid) in the striatum. This indicates that there is an active acid
transport system in this tissue.
2. The effect on striatal homovanillic acid of giving a standard dose of probenecid
alone and in combination with other drugs which change the concentration of this acid
in the striatum was examined.
3. If the probenecid-sensitive acid transport system in the striatum is regarded as
a simple monolinear enzyme chain, then it is possible to distinguish those drugs which
increase the concentration of homovanillic acid by competitive inhibition of the acid
transport system from those drugs which increase the rate of formation of the acid.
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Lesions were placed in the left ventromedial tegmental area of the brains of nine
monkeys (Macaca mulatto,). After 1-4 months, the brains were removed, and the
striatum was dissected and prepared for chemical analysis. In seven animals in
which the lesion was strictly unilateral, the striatal dopamine was very much
reduced below the level found on the intact side of the brain. In the two monkeys
in which the lesion impinged on the right side of the brain, the concentration of
dopamine was reduced on both sides. Homovanillic acid and 3,4-dihydroxy-
phenylacetic acid, metabolic derivatives of dopamine, were measured in the left
and right striata of four and five monkeys respectively. Both compounds were
present at subnormal concentrations on the side of the lesion. The concentration
of homovanillic acid did not fall to as great an extent as did that of dopamine.
These results are discussed in relation to data reported by others in regard to
(a) animals treated with tranquilizing drugs, and (b) brains of patients who died
with Parkinson's disease.
Neuf singes (Macaca mulatto), porteurs de lesions int^ressant la rdgion teg-
mentaire ventromediane gauche du tronc cerebral, ont servi a cette etude.
Les cerveaux furent preleves aprfes une periode d'observation de 1 a 4 mois; les
striata furent disseques separement en vue de determinations chimiques. Chez
sept des animaux porteurs d'une lesion strictement unilaterale la dopamine du
striatum ipsilat6ral etait abaiss6e considerablement par comparaison avec le
striatum contralateral. Chex deux singes ou la lesion a debordd du c6te droit la
dopamine striatale etait abaissee des deux cdtes. Chez quatre singes l'acide
homovanillique et chez les cinq autres l'acide 3,4-dihydroxyphenylac6tique
furent m&ures au niveau des striata, droit et gauche. La concentration de ces
deux derives metaboliques de la dopamine etait au-dessous de la normale du c6te
de la lesion. Cependant la depletion d'acide homovanillique n'etait pas aussi
accentuee que celle de la dopamine. Les resultats rapportds ici sont confrontes
avec les donnees d'autres chercheurs obtenues chez (a) des animaux ayant regu des
tranquilisants; et (6) des cerveaux de patients ayant prdsentd un syndrome
parkinsonnien.
Since the discovery of dopa and dopamine in the brain (1-3) and the relatively
high concentration of the latter substance in the basal ganglia and certain
associated structures (4, 5), there has been much interest in the neural functions
of this amine. Much of our information about the metabolism of dopamine
and its metabolites in the brain comes from pharmacological studies, but the
most pertinent information at present comes from the direct determination
of this catecholamine in necropsy material from patients who died with
'Medical Research Council Visiting Scientist. Permanent address: Institute of Animal
Physiology, Agricultural Research Council, Babraham, Cambridge, England.
2Fellow of the Quebec Medical Research Council, 1965-1966, and graduate student, Depart¬
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Parkinson's disease (6, 7) and from monkeys in which the placing of a specific
unilateral lesion in the brain has resulted in chronic disturbances of posture,
including hypokinesia and tremor of the contralateral limbs (8-10). In both
cases, clinical and experimental, there is a distinct decline in the concentration
of dopamine in the striatum. There may be a loss of striatal serotonin as well,
and in the experimental condition changes in both amines have been corre¬
lated with specific postural deficits (9).
Many possibilities can be suggested to account for the decrease in dopamine
in Parkinson's disease, and some of these have been tested. Thus, Bernheimer
and Hornykiewicz (11) have already excluded from consideration a decrease in
dopa decarboxylase, but a reduction in tyrosine hydroxylase activity, an
earlier step in the biosynthesis of dopamine, might produce the same result.
Another possibility, based upon histological and neurochemical evidence, is
that the concentration of dopamine in the striatum is dependent upon the
presence in that tissue of fibers originating in the substantia nigra which contain
or release dopamine (8, 12). Lesions affecting the latter structure would then
result in a loss of nigro-striatal fibers and the dopamine that they form. On
this basis, the concentration of striatal dopamine would be proportional to the
number of intact innervating fibers originating in the substantia nigra.
Bernheimer and Hornykiewicz (13) have measured the concentration of an
important metabolite, homovanillic acid, in the brains of Parkinsonian patients.
This substance was found, like dopamine, to be reduced in concentration in the
caudate nucleus and putamen, but not as much as its precursor. It was therefore
of interest to determine whether monkeys with characteristic brain lesions
resulting in the loss of striatal dopamine would show changes in homovanillic
acid. The availability of a new method for the estimation of dopac (3,4-di-
hydroxyphenylacetic acid) has permitted us to measure this substance as well.
Experimental
Nine monkeys (Macaca mulatta) were used in this work. Electrolytic lesions
were made unilaterally as previously described (8), and the animals were
observed for 1-4 months before being killed. The brain was removed quickly
and the striatum dissected and weighed. The tissue was rapidly frozen, and held
in this state until ready to be extracted for determination of the metabolites.
The remainder of the brain was reserved for histological study. This revealed
that there was more or less severe cell loss in the substantia nigra on the left
side in all animals. In addition, there was a slight loss of cells on the right side
in monkey BP 25, and a large loss in BP 28. Details of the histological and
postural deficits in these monkeys will be presented elsewhere.
The determination of dopamine in four monkeys of series X was performed
by the method of Laverty and Sharman (14); for the five animals of series XI,
the procedure of Murphy and Sourkes (15) was employed. Homovanillic acid
was adsorbed from a deproteinized tissue extract on a column of Dowex-1
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X-2 anion exchange resin (16), eluted with 0.1 N hydrochloric acid, and
estimated fluorometrically by a modification of the method of Anden, Roos,
and Werdinius (17). Dopac was determined, after adsorption on and elution
from alumina, by an ethylenediamine reaction employed in the following way
(Murphy and Sharman, unpublished). Aliquots of the eluates were treated
with acetic anhydride (14), after which the reaction mixture was extracted
with dichloromethane to remove acetylated catecholamines and neutral
compounds. Acetylated dopac was extracted into another portion of the solvent
after the reaction mixtures were rendered strongly acidic. The solvent was
evaporated, and the residue condensed with ethylenediamine at 63° for 20-25
minutes. Dopac yields the typical yellow fluorophore of ethylenediamine con¬
jugates but, following acidification beyond pH 3 and subsequent neutralization
of the reaction mixture, a distinct blue fluorophore is obtained. Fluorescence
at 450 m/i is recorded, with activation at 390 mp (uncorrected instrumental
values).
Results
Analytical results for the monkeys are set out in Table I. In each animal the
concentration of striatal dopamine in the operated side was lower than in the
intact side of the brain. In some animals (BP 25, 26, and 27) the concentration
in the unoperated side was somewhat lower than usually seen, and in one mon¬
key (BP 28) in which the lesion impinged on the opposite (right) side and was
associated with bilateral involvement of the nigra, the concentration was
TABLE I





acid (HVA) HVA:Df Dopac Dopac: Df
Series X
18 Left 2.4 6.5 2.28
Right 7.2 11.2 1.31
22 Left 3.0 7.4 2.07
Right 6.5 12.1 1.56
23 Left 0.4 4.7 9.86
Right 4.7 9.6 1.72
30 Left 1.0 5.6 4.71
Right 10.1 17.0 1.42
Series XI
7 Left 1.6 <0.1 <0.01
Right 4.8 0.1 <0.01
25 Left 0.1 0.3 4.6
Right 2.4 0.3 0.1
26 Left 0.4 0.1 0.2
Right 2.9 0.4 0.1
27 Left 1.6 0.4 0.2
Right 3.3 0.7 0.2
28 Left <0.1 0.2 4.7
Right 0.3 0.3 1.2
♦Monkeys (our series BP) had a lesion administered to the ventromedial tegmental area of the left side. Con¬
centrations are all expressed as micrograms per gram wet weight of tissue.
fMolar ratio, calculated before rounding the concentrations to the first decimal place.
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very low. The interpretation of these changes will be dealt with elsewhere, in
conjunction with the histological findings.
Substantial amounts of homovanillic acid were found in the striatum, ranging
from 9.6 to 17.0 ng/g for the unoperated side. Less was present in the operated
side. On a molar basis there was more of this compound than of dopamine.
A comparison of the values for the two sides of the brain shows that the decrease
in striatal homovanillic acid is proportionately smaller than the fall in dopamine.
For example, in two monkeys (BP 23 and 30) the concentration of dopamine
in the operated side was less than 10% of that in the unoperated side, but the
homovanillic acid declined by only 51 and 67% respectively. If one considers
the homovanillic acid to reflect the formation and metabolism of neuronal
dopamine, then the molar ratios of these two substances, shown in Table I,
indicate that when the number of dopamine-producing fibers in the striatum is
reduced, the remaining ones are capable of increasing their production very
substantially.
In contrast to the amounts of homovanillic acid, little dopac was present.
In this series it never exceeded a concentration of 0.70 jig/g, indicating that
dopac is a minor metabolite in this tissue. In four of five animals in which it was
measured, there was less dopac in the striatum of the left (operated) side than
in the right.
Discussion
The concentration of homovanillic acid in the striatum of the monkeys in
this work ranged from 4.7 to 17.0 jug/g- The lowest values (4.7-7.4 Mg/g)
were found in the operated side of the brain, where the concentration of
dopamine was much reduced, as observed on previous occasions. Hence, these
low values for homovanillic acid can be understood as arising from the deficient
number of dopamine-forming, or "dopaminergic" fibers in the striatum (9, 10).
The concentration of homovanillic acid in the unoperated side of the brain
was 9.6-17.0 jig/g and was of the same order of magnitude as found in the
caudate nucleus of dog and rabbit (18), but somewhat higher than reported
for the caudate nucleus and putamen of man (13, 19) or the corpus striatum
of rabbit (17).
The concentration of dopac was much smaller than that of homovanillic
acid, and did not seem to bear any clear relation to the concentration of dop¬
amine in the striatum. The mean value was about 0.3 jtg/gi which is similar
to that found by Anden et al. recently (20) (but not earlier (21)) for the corpus
striatum of the rabbit, and very much smaller than the value given (1.34±0.46
Mg/g) by Matsuoka et al. (22) for the caudate nucleus of the rabbit.
The difference in patterns may lie in the fact that homovanillic acid is a
terminal product of the metabolism of dopamine, accumulating to a certain
level before being lost from the nervous tissue, whereas dopac can undergo
transformation to homovanillic acid; the concentration of dopac would then
depend upon an additional factor, i.e. the relative activity of catechol O-methyl
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transferase in its vicinity. Another possibility that would account for this
difference is that most of the striatal dopamine may be readily methylated at
the 3-hydroxy position, so determining homovanillic acid as the main terminal
product; if only small amounts of dopamine gained access to monoamine
oxidase, then only very small amounts of dopac could be formed.
In postmortem material from patients with Parkinson's disease, Bernheimer
and Hornykiewicz found ratios of homovanillic acid to dopamine of about
1.8 for the caudate nucleus and 3.6 for the putamen. Corresponding values
for the control brains were 1.2 and 1.1. In the present monkeys with brain
lesions, the ratio was 2.1-9.9 for the operated side, compared with 1.3-1.7
for the unoperated side. As the latter side had concentrations of dopamine
well within the normal range, it may be presumed that there was no metabolic
abnormality on this side, and that the homovanillic acid concentrations
observed represent "normal" values for the monkey striatum. Bernheimer and
Hornykiewicz have expressed some concern over the validity of the data for
homovanillic acid and dopamine obtained in postmortem tissues (13), especially
because they have found experimentally that a fall in brain dopamine occurring
after death may be accompanied by an increase in homovanillic acid. Their
tissues were obtained only at some variable, but relatively long, period after
the death of -the patients, whereas in the present work the striatum was dis¬
sected and frozen within 30 minutes of the death of the monkey. Although
chemical changes could have occurred in this time also, one would expect them
to be smaller and more consistent. In any case, the similarity of the patterns
for the experimentally controlled monkeys with brain lesions and the patients
with Parkinson's disease is striking. The results can be explained on the basis
of a reduced supply of dopaminergic fibers to the striatum from the substantia
nigra (9) as a result of a lesion in that tissue, and leading to a diminution in the
concentrations of dopamine, homovanillic acid, and dopac in the striatum. At
the same time, there would be an increased rate of formation or release of
dopamine (or both) by the remaining intact neurons, resulting in relatively
more homovanillic acid. This increase might be initiated by a feedback mech¬
anism working through some neural connection such as the striato-nigral path¬
ways linking the caudate nucleus and putamen to the nigra. Such a compensatory
mechanism has already been suggested by Roos (20, 23) in connection with the
action of some major tranquilizers. Drugs like chlorpromazine and haloperidol,
which can block the effects of dopamine, increase the concentration of homo¬
vanillic acid and dopac in the corpus striatum, without affecting the level of
dopamine, serotonin, or 5-hydroxyindoleacetic acid.
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SUMMARY
1. The release of dopamine and its metabolite homovanillic acid from
the 'superfused' caudate nucleus was studied in the cat. Fluorimetric
assay of the two compounds was carried out on 30 min samples of artificial
cerebrospinal fluid perfused through the anterior horn of one lateral
ventricle.
2. When tubocurarine 0-5 or 1 x 10-4 g/ml. was added to the perfusion
fluid, amounts of dopamine of the order of 0-1 ng/min, and very much
larger quantities of homovanillic acid (up to 8 ng/min) appeared in the
perfusing fluid.
3. No release of dopamine was obtained under conditions when tubo¬
curarine failed to produce any clinical signs or when gallamine was
substituted for tubocurarine.
INTRODUCTION
In experiments which are still in progress we are investigating whether
stimulation, by a variety of means, of the cat's caudate nucleus, releases
substances which might be transmitters or their metabolites. In devising
a method of demonstrating the release of such substances, we were
particularly anxious to avoid any lesion to the caudate nucleus itself, and
therefore chose the perfusion of the anterior horn of the lateral ventricle
(Carmichael, Feldberg & Fleischhauer, 1964) as a safe technique which
allows testing of the perfusate for substances given off from the surface
of the 'superfused' caudate nucleus. When the substantia nigra was
stimulated electrically in such perfusions, dopamine was found to be
frequently, but not consistently, released into the perfusion fluid; the
metabolite of dopamine, homovanillic acid, was released with more regu¬
larity. There were, however, occasions when dopamine appeared in the
perfusion fluid when no external stimuli were applied, and such events
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seemed to be correlated with shivering or slight trembling of the muscula¬
ture of limbs or trunk. It therefore seemed desirable to produce shivering
intentionally and to study its effect on the release of dopamine and
homovanillic acid. Shivering was induced by perfusing the cerebral
ventricles with a solution of tubocurarine (Carmichael, Feldberg & Fleisch-
hauer, 1962). Some of the results have been reported to the Physiologica
Society (Portig & Vogt, 1967).
METHODS
Collection of ventricular perfusates. Cats of either sex and weighing at least 2-5 kg were
anaesthetized with ether followed by chloralose (60-80 mg/kg intravenously) and the heads
fixed in a stereotaxic instrument for superfusion of the caudate nucleus. Following the
description by Carmichael et al. (1964), the aqueduct was cannulated, and a 'Collison
cannula', to be used as an outflow, was screwed into the left side of the skull at the Horsley
Clarke co-ordinates All and L 4-5. When contact with the ventricle had been established,
a steel needle connected to a slow-infusion pump and filled with artificial cerebrospinal fluid
was lowered into the anterior end of the left anterior horn to co-ordinates A18-19, L2 and H5.
The tubing in the aqueduct was then occluded in order to divert the perfusion fluid into
a collecting tube inserted into the Collison cannula. This tube ended about 9 cm below
the opening of the inflow needle. Rate of delivery from the pump was about 4-5 ml./hr.
Any slowing of the flow indicating obstruction and leading to an increased intracranial
pressure had to be corrected immediately by adjusting the position of the Collison cannula,
since it was found that a rise in intracranial pressure invariably led to a fall in the con¬
centration of various substances released into the perfusate. The perfusion fluid had the
composition (g/1.) NaCl 8-1, KC1 0-25, CaCl2 0-14, MgCl2 0-11, NaHC03 0-3, Na2HP04 0-07,
CO(NH2)2 0-13, glucose 0-6. Ascorbic acid 0-01 was added whenever dopamine was to
be estimated. (+ )-Tubo-eurarine chloride (Koch-Light) or gallamine triethiodide (Flaxedil,
May & Baker) were dissolved in the perfusion fluid to make up concentrations of either
1:10000 or 1:20000 and perfusion was switched over to these mixtures as soon as a sufficient
number of control samples had been obtained in the absence of the drug. The effluent wii
collected in graduated tubes standing in ice water; these tubes contained 2 mg ascorbit
acid for all dopamine estimations. All samples were frozen and kept at —17° C if not
analysed immediately. When dopamine was to be measured, the samples were acidified
with 0-1 n-HCI before freezing.
Blood pressure was recorded from a femoral artery by pressure transducer, an electrode
(bipolar, coaxial type, external diameter 0-45 mm) was lowered into the right caudate
nucleus to record spontaneous or evoked potentials on a cathode ray oscilloscope, and the
electroencephalogram was recorded with the aid of a steel pin from the right secondary
visual area on a Grass polygraph. A Starling pump was used for artificial respiration.
Chemical procedures. Dopamine was estimated by the method of Laverty & Sharmai
(1965) slightly modified as follows: approximately 2 ml. of acidified perfusate was madcap
to 5 ml. with 0-01 n-HCI and acetylated by adding 0-5 ml. acetic anhydride and, gradually,
with stirring, 1 g of solid NaHCOs. Acetylation was complete in about 15 min. The mixta!
was extracted with 10 ml. dichloromethane and spun if necessary; the bottom layer was re¬
duced to a small volume by a stream of air, applied to alkali-washed Whatman No. 50 paper
and ehromatographed in a mixture of toluene:ethylacetate:methanol:water 10:4:5:5for
about 3 hr at 26° C. Determination of the position of dopamine reference spots, elution,
condensation with ethylene diamine and fluorimetry in a filter fluorimeter were carried
out as described by Laverty & Sharman (1965). Recovery was checked each time and
ranged from 70 to 80 %. A few ng of dopamine can be detected by this method.
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Homovanillic acid extraction was simplified by modifying an earlier method (Sharman,
1963) and avoiding the chromatographic step. For the development of fluorescence ferri-
syanide and ammonia were used (Anden, Roos & Werdinius, 1963), and the fluorescence
was measured with an Aminco-Bowman spectro-photo-fluorimeter. An interference filter
(Grubb Parsons Filter Type G.P., peak wave-length 4262 A and 44 % transmission) was
placed into the path of the emitted light, and this, by reducing unspecific fluorescence,
increased the sensitivity several-fold.
The details were as follows: To each sample of perfusate 0-2 ml. conc. HC104 followed by
0-3 g KC1 were added, the mixture was spun and the deposit discarded. Concentrated HC1
(0*1 ml.) was added to the supernatant and followed by enough solid NaCl to saturate the
mixture, which was then extracted by shaking for 5 min with 10 ml. w-butyl acetate, the
solvent used by Giacalone & Valzelli (1966) to extract 5-hydroxyindolyl acetic acid. (The
butyl acetate was purified by distillation and saturated with water before use.) After
centrifuging, the butyl acetate was pipetted off into a stoppered tube which contained
2 ml. of 0-05 M solution of Tris (2-amino-2-(hydroxyrnethyl) propane- 1,3-diol). By shaking
for 5 min the homovanillic acid was back-extracted into the Tris. The mixture was spun,
the butyl acetate layer discarded and the watery layer divided into three portions, one of
which was used as the unknown, the second as an internal standard and the third as
a blank. The method allows estimation of total amounts down to 50 ng, and uses 100 ng
homovanillic acid as the 'internal standard'. Recovery averaged 75%. The addition of
HC104 before the extraction with butyl acetate can be omitted, but the omission may lead
to higher blanks.
Whenever drugs were added to the perfusion fluid, careful checks were made that neither
'blanks' nor 'internal standards' were modified by their presence. No difficulties were
encountered with either tubocurarine or gallamine.
RESULTS
When the anterior horn of one lateral ventricle was perfused with
tubocurarine 1:20000 for 2| hr or longer, dopamine appeared in the
perfusate in small, somewhat variable, but measurable, concentrations
(Fig. 1). Release persisted for periods up to 2-|- hr. Perfusions led, with
some delay, to twitches, salivation, shivering and large deflexions on the
e.e.g. registered from one secondary visual area. As soon as twitches
were detected, they were stopped by the intravenous injection of gallamine
(6-12 mg of the triethiodide per dose), to avoid possible mechanical
artifacts. Some experiments were also performed during continuous intra¬
venous infusion of gallamine so that movements were avoided altogether.
Carmichael et al. (1962) have shown that tremor is induced by an action
of (+ )-tubocurarine on the hypothalamus. In one experiment, therefore,
the ( +)-tubocurarine was delivered to the third and not to the lateral
ventricle by connecting a second infusion pump to the tubing inserted
into the aqueduct, and collecting from the Collison cannula the combined
perfusates of lateral and third ventricles. Dopamine appeared in the
perfusion fluid within the first half hour of tubocurarine infusion, but the
quantity was not clearly greater than when only the anterior horn of the
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lateral ventricle was perfused, though release was somewhat more prolonged
(Pig. lc).
The remaining experiments on the release of dopamine were carried
out with shorter periods of infusion of tubocurarine with the following
objects in mind: to see whether the effect was repeatable, whether it was
correlated with the pharmacological effects elicited by tubocurarine, and
whether it was specific for this drug. Since successful perfusions without










Fig. 1. Release of dopamine by prolonged cerebroventricular perfusions with
tubocurarine (dTc).
Dopamine (DA) determined in 30 min samples ofartificial cerebrospinal fluid; dTc
perfused through the anterior horn of a lateral ventricle (a and fa), or through the
3rd ventricle (c), of a cat. The columns represent concentrations in consecutive
samples, expressed as ng/30 min, and not corrected for recovery. Heavy bars:
perfusion of ventricle with tubocurarine 10~4 g/ml. (a), or 5 X 10-5 g/ml. (6 and c).
about 6 hr, tubocurarine was given for 1 hr at a time, thus allowing for
a suitable number of control periods before and after the two infusions.
With these shorter perfusions, the amount of dopamine released was
occasionally hardly above the threshold of the method. However, when
the amount was measurable, two periods of tubocurarine usually produced
two rises of similar size and time course. The one exception suggests that
release of dopamine is linked to the presence of clinical signs: in this
experiment, dopamine did not appear during the first, but appeared
during the second administration of tubocurarine; visible effects (twitches
and large deflexions in the electroencephalogram) were present only on
the second occasion (Fig. 2, a and b).














dTc Sx10"5 g/ml. dTc 5x10"5 g/ml.
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perfusing tubocurarine was compared with that of perfusing gallamine,
both drugs being used in a concentration of 10~4 g/ml. Figure 2 (c and d)
illustrates one of them, and shows that release occurred only during the
administration of tubocurarine. When the drugs were given in a reverse











dTc 10 4 g/ml. Gallamine 10 4 g/ml.
Fig. 2. Release of dopamine by short perfusions of a cerebral ventricle with tubo¬
curarine (dTc).
Dopamine (DA) determined in 30 min samples of artificial cerebrospinal fluid
perfused through the anterior horn of a lateral ventricle of the cat. The columns
represent concentrations in consecutive samples, expressed as ng/30 min, and not
corrected for recovery. Heavy bars: perfusion of ventricle with tubocurarine
5 x 10~6 g/ml. (a and 6), 10~4 g/ml. (c), and gallamine 10-4 g/ml. (d).
Whenever dopamine is released in the brain, it is subject to the action
of the enzymes monoamine oxidase and 0-methyl transferase and trans¬
formed into homovanillic acid. Any dopamine appearing in the ventricular
perfusate was thus just the 'over-spill' of what escaped such destruction.
The determination of the metabolite should therefore give a truer picture
of any release of dopamine and yield larger amounts of material. However,
the methods for fluorimetric estimation of homovanillic acid are very
much less sensitive than those available for dopamine, and it was not
clear whether the increase in sensitivity obtained by the modifications
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described under 'Methods' were sufficient for our purpose. Figure 3 shows
that it was. The two experiments illustrate that perfusates collected
during control periods contain measurable amounts of homovanillic acid,
whereas the concentration of dopamine in such samples had usually been







0 dTc 10~4 g/ml. dTc 10-" g/ml.
Fig. 3. Release of homovanillic acid by cerebroventricular perfusion with tubo-
curarine (dTc).
Homovanillic acid (HVA) determined in 30 min (a) or 45 min (6) samples of
artificial cerebrospinal fluid perfused through the left anterior horn of one lateral
ventricle of a cat. The columns represent concentrations in consecutive samples,
expressed as ng/min, and corrected for recovery. Heavy bars: perfusion of
ventricle with tubocurarine 10-4 g/ml.
tubocurarine was infused over a period of 1 hr; the concentration of
homovanillic acid rose to approximately twice the resting concentration,
stayed there for 2\ hr, and then began to fall. In the second experiment
(Fig. 3&), infusion lasted only 45 min, and the rise in homovanillic acid
elicited by tubocurarine persisted for 2J hr.
There were two main differences between the pattern of release of
dopamine and homovanillic acid. The first concerned the absolute values;
for dopamine these hardly exceeded 4 ng (5 ng if corrected for recovery)
in a collection period of half an hour, whereas for homovanillic acid they
reached 240 ng (corrected). The second was the duration of the accelerated
release which greatly outlasted the period of infusion for homovanillic
acid but not for dopamine.
DISCUSSION
The experiments have shown that perfusion of the cerebral ventricles
with (+ )-tubocurarine releases dopamine and its metabolite homovanillic
acid into the fluid bathing the caudate nucleus. Since the caudate nucleus
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of the lateral ventricle perfused in these experiments, it is clear that this
nucleus must be the source of the amine. It is not at all certain, however,
and not even likely, that the (+ )-tubocurarine exerted its action directly
on the caudate nucleus, since some of the drug diffuses to other parts of
the ventricular system during prolonged perfusion. Several observations
implicate the shivering and tremor elicited by intraventricularly admini¬
stered tubocurarine in this release of dopamine: another muscle relaxant,
gallamine, lacked both the capacity to release dopamine and to produce
shivering (or any other clinical signs), and tubocurarine itself failed to
release dopamine when shivering or tremor failed to appear. These findings
suggest, though they do not prove, that' spontaneous' release of dopamine
in experiments in which there was spontaneous shivering was due to the
shivering. Carmichael et al. (1962) have shown that the hypothalamus is
the site to which tubocurarine must penetrate if tremor or shivering is to
ensue; the activation of the caudate nucleus could thus be brought about
by a reflex originating in the hypothalamus. Since, however, tubocurarine
has many other motor and autonomic actions, it is quite possible that
activation of the caudate nucleus could have taken place through other
pathways.
Dopamine release lasted approximately as long as tubocurarine infusion,
whereas release of homovallic acid outlasted the infusion for a considerable
period. This observation is in keeping with observations made on the
release of homovanillic acid by various stimuli applied for a few minutes
only: the appearance of increased amounts of homovanillic acid rarely
lasted less than 60 min (J. Portig & M. Vogt, to be published). The
explanation appears to be the distance the metabolite has to travel if the
cells activated in the caudate nucleus are situated far away from the
ventricular surface. The same does not hold for dopamine, since most of
the amine would be destroyed if it had to diffuse through a thick layer of
tissue.
It would be of the greatest interest to know whether, and in what
direction, the release of dopamine modifies, or contributes to, the motor
response to tubocurarine infusion. The fact that tubocurarine-induced
tremor is suppressed by intraventricular injection of large doses of
dopamine (Carmichael et al. 1962) may or may not be relevant to the
events within the caudate nucleus.
This work was done during the tenure by P. J. Portig of a Fellowship from the Mental
Health Research Fund.
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The effect of tropolone on the formation of
3,4-dihydroxyphenylacetic acid and 4-hydroxy-
3-methoxyphenyIacetic acid in the brain of the mouse
G. F. MURPHY, D. ROBINSON* and D. F. SHARMAN*
Laboratory of Chemical Neurobiology, Allan Memorial Institute of Psychiatry, McGill
University, Montreal, Canada, and *Agricultural Research Council Institute of Animal
Physiology, Babraham, Cambridge
1. The development of a very sensitive and specific fluorimetric assay for
3,4-dihydroxyphenylacetic acid has made it possible to measure how inhibitors
of the enzyme catechol-O-methyl transferase affect the relative concentrations
of this acid and its O-methylated derivative 4-hydroxy-3-methoxyphenylacetic
acid (homovanillic acid) in the brains of mice treated with L-3,4-dihydroxy-
phenylalanine or probenecid.
2. It was found that tropolone and tropolone-4-acetamide reduce the concen¬
tration of homovanillic acid in the brains of the treated mice to an extent
dependent on the dose.
3. The concentration of 3,4-dihydroxyphenylacetic acid in the brain was
increased by the administration of tropolone or tropolone-4-acetamide but the
dose and response were not simply related to one another.
4. The results suggest that, in vivo, the formation of 3,4-dihydroxyphenyl¬
acetic acid is not always a simple alternative to the formation of homovanillic
acid when the enzyme catechol-O-methyl transferase is inhibited.
The ability of some compounds to inhibit the enzyme catechol-O-methyl trans¬
ferase (COMT) in the central nervous system in vivo has been studied by Carlsson,
Lindqvist, Fila-Hromadko & Corrodi (1962), and by Carlsson, Corrodi & Waldeck
(1963), who found that such compounds cause a fall in the concentration of 4-
hydroxy-3-methoxyphenylethylamine (methoxytyramine) in the brains of mice treated
with L-3,4-dihydroxyphenylalanine (l-DOPA) and a monoamine oxidase inhibitor.
The activity of the enzyme in the brains of living mice has also been measured by
Ross & Haljasmaa (1964a,b) with a radioisotopic method.
The development of a very sensitive specific fluorimetric assay for 3,4-dihydroxy¬
phenylacetic acid (Sharman, Poirier, Murphy & Sourkes, 1967) has enabled us to
study the ability of drugs to inhibit catechol-O-methyl transferase in the central
nervous system. To do this we have observed the effects of such drugs on the
relative concentrations of 3,4-dihydroxyphenylacetic acid and its methylated deriva¬
tive homovanillic acid, in the brains of mice treated with l-DOPA or probenecid.
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Methods
The following chemicals and reagents were used: homovanillic acid (Calbio-
chem); 3,4-dihydroxyphenylacetic acid (L. Light & Co. Ltd. ; recrystallized from
benzene); l-3,4-dihydroxyphenylalanine (l-DOPA ; Calbiochem.); Tris (hydroxy-
methyl) aminomethane (Tris; L. Light & Co. Ltd.); l-cysteine hydrochloride
(Hopkin & Williams Ltd. ; recrystallized from ethyl alcohol); Tropolone (2-hydroxy-
2:4:6-cycloheptatriene-l-one ; Aldrich Chemical Co. Inc.; recrystallized from light
petroleum); Tropolone-4-acetamide (A. B. Hassle ; recrystallized from dilute acetic
acid); 1,2-diaminoethane distilled three times and kept at 4° C ; n-butyl acetate
distilled once and washed once with water. All other reagents and chemicals were
of analytical reagent quality except for hydrochloric acid which was of micro-
analytical reagent quality. Glass distilled water was used throughout.
Female albino mice weighing 15-35 g were used. Drugs were injected intra-
peritoneally, dissolved in 0-9% (w/v) sodium chloride solution, except for l-DOPA
which was dissolved in sterile distilled water.
Dissection and extraction of tissues
The mice were stunned and then decapitated. The brain was rapidly removed
and placed on a glass plate in an ice bath. In the experiments in which DOPA was
injected, the brain stem was divided at the posterior border of the hypothalamus
and all of the tissue rostral to the section, but excluding the olfactory lobes, was
extracted. The tissue from one mouse was sufficient for the analysis of both
dihydroxyphenylacetic acid and homovanillic acid. In the investigations on normal
mice, the striatal region was dissected out (Sharman, 1966) and the tissue from three
mice combined for the estimation of both the acids. The tissue samples were homo¬
genized in 2 ml. of ice cold 01 N hydrochloric acid in a cooled, all glass homogenizer.
The homogenate was transferred to a polypropylene or cellulose nitrate centrifuge tube
(7 ml. capacity) and the homogenizer washed twice with 1 ml. of ice cold distilled
water, the washings being combined and mixed with the homogenate. The centri¬
fuge tube was then dipped into liquid nitrogen so that the homogenate was frozen.
The frozen homogenate was placed in a refrigerator at 4° C until all the tissue
samples to be extracted had been homogenized. The homogenates were then
allowed to thaw at room temperature and concentrated perchloric acid (012 ml.;
specific gravity, 1-72) was added to and mixed with each sample. Solid potassium
chloride was then added in an amount just in excess of that required to saturate
the homogenate, which was then thoroughly mixed. This procedure removes the
perchlorate ion as insoluble potassium perchlorate while leaving the solution acid.
The procedure is endothermic and this helps to keep the homogenate cold, also
ensuring a good precipitation of the potassium perchlorate. The homogenate was
then centrifuged at 0° C for 5 min with a radial acceleration at the tip of the tube of
147,000 m sec-2 (15,000 g). The clear supernatant was transfered to a glass
stoppered test tube (15 ml. capacity) and a few crystals of potassium chloride were
added to ensure that the solution was saturated. n-Butyl acetate (10 ml.) was
added and the tube shaken by hand for 5 min. The tube was centrifuged at room
temperature for 1 min to separate the two layers and two portions (4-5 ml. each) of
the n-butyl acetate extract were taken. One portion was added to 2 ml. of Tris
solution (6 g/1. in distilled water) contained in a glass stoppered test tube (10 or 15
ml. capacity). The other was added to a 2-2 ml. portion of a mixture of 35 ml. water,
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1 ml. 2 N hydrochloric acid and 1-5 ml. of 1,2-diaminoethane, also in a glass
stoppered test tube. The tubes were cooled in ice, shaken for 3 min and then
centrifuged for 1 min. The butyl acetate layers were discarded. Homovanillic acid
was estimated in the Tris extract and dihydroxyphenylacetic acid in the 1,2-
diaminoethane extract.
Estimation of homovanillic acid
Homovanillic acid was estimated fluorimetrically essentially as described by
Anden, Roos & Werdinius (1963). Three portions (0-6 ml. each) of the Tris extract
were taken. To one of them was added a known amount of homovanillic acid
(usually 0T pg) and to another 0-2 ml. of a freshly prepared, solution of cysteine
(1 mg/ml.). The latter tube served as a blank and the former enabled the develop¬
ment of the fluorescence to be checked and gave a standard for the calculation of the
amount of homovanillic acid present. Potassium ferricyanide (1 ml. of 20 mg/1. in
5 n ammonium hydroxide) was then added to each tube and mixed. After exactly
4 min, 0-2 ml. of the cysteine solution was added to the two tubes which contained no
cysteine and the contents of all tubes were mixed thoroughly. The fluorescence of
the solutions was then measured in an Aminco-Bowman spectrophotofluorometer.
The activating light wavelength was 315 mp and the fluorescence light wavelength
was 430 mju. An interference filter with maximum transmission at 426-2 m/i and a
band width of 9-9 m/a. and 44% transmission (Grubb Parsons type G.P.) was placed
in the fluorescent light path. Slits 5 mm wide were placed, immediately adjacent to
the cuvette, in both the activating and fluorescent light paths. This arrangement
yielded the smallest blank readings in comparison with the fluorescence developed
from homovanillic acid.
Estimation of 3,4-dihydroxyphenylacetic acid
Two samples (10 ml. each) of the 1,2-diaminoethane extract were taken. To one
of them was added a known amount of authentic 3,4-dihydroxyphenylacetic acid
(usually 0-1 pg in a volume of 0-01 ml.). The solutions were then heated in a water
bath at 60° C for 20 min in the dark. At the end of this time the tubes were cooled
in an ice bath and hydrochloric acid (0-3 ml. of a 1:1 v/v dilution of concentrated
hydrochloric acid (36% w/v) in distilled water) was added and mixed. The tubes
were left in the ice bath for 10 min and neutralized by the addition of 1,2-diamino¬
ethane (0-3 ml. of a 1:9 v/v dilution in distilled water). The fluorescence of the
solution was immediately measured in an Aminco-Bowman spectrophotofluorometer.
The activating light wavelength was 385 mp and the fluorescence light wavelength
was 450 mp. (uncorrected for any errors in the instrument). A Corning 3389 glass
filter was placed in the fluorescence light path.
Recovery experiments
The recovery of authentic homovanillic acid and 3,4-dihydroxyphenylacetic acid
was tested by adding amounts ranging from 0-1 pg to 2 pg to tissue homogenates
and extraction and estimation as described above. For homovanillic acid the mean
recovery was 70% ±2-3% (s.e.m.), in eighteen tests, and for 3,4-dihydroxyphenyl¬
acetic acid the mean recovery was 65% ± 1-6% (s.e.m.), in seventeen tests.
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Results
Notes on the fluorimetric assay of 3,4-dihydroxyphenylacetic acid
The present method for the estimation of this acid is an improvement on previous
methods in two respects. First, the fluorescence intensity of the derivative is higher
and second, the reaction is more specific for 3,4-dihydroxyphenylacetic acid.
The changes in the fluorescence characteristics are illustrated in Fig. 1. The
yellow fluorescence (maximum wavelength 540 m/x) which develops when 3,4-dihy¬
droxyphenylacetic acid is condensed with 1,2-diaminoethane (Valk & Price, 1956)
disappears on acidification and is replaced by a green fluorescence of lower intensity
at a shorter wavelength (490 m/x when activated at 395 m/x). As the solution is
neutralized with ethylene diamine, this latter fluorescence at first increases in
intensity, and then a second, more intense, blue fluorescence suddenly appears (maxi¬
mum at 450 m/x; wavelength of maximum activation, 385 m/x). As more of the base
is added, the fluorescence at 490 m/x gradually decreases and eventually disappears,
but the intensity of the fluorescence at 450 m/x is only slightly increased. The con¬
ditions selected were those which, in model experiments, were found to give
reproduceable results.
The fluorescence at 450 m/x appears to be specific for 3,4-dihydroxyphenylacetic
acid and some closely related compounds which have an acid function. For example,
if the reaction is carried out on 3,4-dihydroxyphenylalanine (DOPA) or a-methyl-
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fig. 1. Characteristics of the fluorescence derived from 3,4-dihydroxyphenylacetic acid. The
reaction was carried out as described in the text using 0-2 /tg of the acid. Where necessary the
volume of the sample was adjusted to 1-6 ml. with water for each scan. (1) The character¬
istics of the fluorescence derived from 3,4-dihydroxyphenylacetic acid when activated at 405 m/x.
(A) After condensation with 1,2-diaminoethane ; (B) After the addition of hydrochloric acid.
(2) Activation wavelength 385 m/x. (C) As 1 (B). (3) Activation wavelength 385 m/t. (D)
After the addition of 1,2-diaminoethane solution. The scans in (3) were recorded at one
tenth of the amplification used for 1 and 2.
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If these two amino-acids are first acetylated to give the 0,0,N-triacetyl derivatives,
converting the amino group to a neutral amide group, then a blue fluorescence
develops. 3,4-Dihydroxymandelic acid yields only a very small amount of fluore¬



















flc. 2. Effect of tropolone and tropolone-4-acetamide on the concentration ( + s.e.m.) of homo-
vanillic acid on the brains of mice treated with l-DOPA. © ©, Mice treated with l-DOPA
(100 mg/kg) and tropolone for 1 hr ; O 0-, mice treated with l-DOPA (100 mg/kg) and
















fig. 3. Effect of tropolone and tropolone-4-acetamide on the concentration ( + s.e.m.) of 3,4-
dihydroxyphenylacetic acid in the brains of mice treated with l-DOPA. © ©, Mice treated .
with l-DOPA (100 mg/kg) and tropolone for 1 hr. Q O, mice treated with l-DOPA (100
mS/kg) and tropolone-4-acetamide for 1 hr.
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The method, in common with many other fluorimetric methods, suffers from the
difficulty of determining accurately the blank fluorescence. The fluorescence derived
from extracts of cerebral cortex of rabbits and mice was slightly higher than that
derived from the reagents alone. This increased fluorescence was found to be
equivalent to 3,4-dihydroxyphenylacetic acid in a concentration of 0-03 pg/g tissue
when approximately 0-5 g of brain tissue was extracted. In the present experiments
the reagent blank has been used in the calculation of the concentration of 3,4-dihy¬
droxyphenylacetic acid in the tissues from experiments in which l-DOPA was ad¬
ministered, because the error introduced by doing this is negligible. In the estimation
of the endogenous 3,4-dihydroxyphenylacetic acid, however, the values might be
over-estimated by about 10% if the reagent blank is used. It has not been proved
that the fluorescence derived from the cortex is due to the presence of 3,4-dihydroxy¬
phenylacetic acid, so a correction for the fluorescence from the tissue has been












fig. 4. Effect of tropolone and tropolone-4-acetamide on the concentrations (±s.e.m.) of
homovanillic acid and 3,4-dihydroxyphenylacetic acid in the striata of mice treated with
probenecid. All mice received probenecid (200 mg/kg intraperitoneally) and were killed after
1*5 hr. ©, Control homovanillic acid ; C——C, homovanillic acid after tropolone ; <•> <•>,
homovanillic acid after tropolone-4-acetamide; O, control 3,4-dihydroxyphenylacetic acid;
9 3, 3,4-dihydroxyphenylacetic acid after tropolone ; <> O, 3,4-dihydroxyphenyl¬
acetic acid after tropolone-4-acetamide. The two regression lines for the fall in the concentra¬
tion of homovanillic acid with the two drugs do not deviate significantly from parallel.
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Effect of tropolone and tropolone-4-acetamide on the concentration of
homovanillic acid and 3,4-dihydroxyphenylacetic acid in the mouse brain
After treatment with L-DOPA
Two groups of mice were injected with l-DOPA (100 mg/kg intraperitoneally),
followed immediately by an intraperitoneal injection of tropolone or tropolone-
4-acetamide in the test group. One hour later the mice were killed, the brains
removed and analysed for their content of homovanillic acid and 3,4-dihydroxy¬
phenylacetic acid. The effect of different doses of the two tropolone compounds on
the concentration of homovanillic acid is shown in Fig. 2 and the effect on the
concentration of 3,4-dihydroxyphenylacetic acid is shown in Fig. 3.
Figure 2 shows that both drugs reduce the concentration of homovanillic acid,
1 hr after the administration of l-DOPA, and that the reduction bears a linear
relation to the logarithm of the dose of the drug used. Figure 3 shows that the
concentration of 3,4-dihydroxyphenylacetic acid at first increases with increasing
doses of tropolone, but that with the higher doses of both tropolone and tropolone-
4-acetamide the concentration of the acid tends to fall. A comparison of the abilities
of tropolone and tropolone-4-acetamide to reduce the concentration of homovanillic
acid shows that, on a weight basis, tropolone is 6 5 times as active as tropolone-4-
acetamide. No homovanillic acid could be detected when tropolone was injected
in a dose of 100 mg/kg or more.
In normal mice treated with probenecid
Normal mice were injected with tropolone or tropolone-4-acetamide intraperi¬
toneally. Immediately afterwards, they were given probenecid (200 mg/kg intra¬
peritoneally) to prevent the egress of acid metabolites from the brain (Neff, Tozer &
Brodie, 1964 ; Sharman, 1966).
The animals were killed 1-5 hr later and the striata dissected out and analysed
for homovanillic acid and 3,4-dihydroxyphenylacetic acid. The striata from mice
treated only with probenecid (200 mg/kg intraperitoneally ; 1-5 hr previously) were
examined at the same time. The experiment was designed as a four-point assay to
compare the effects of the two tropolone compounds on the concentrations of the
two acid metabolites. The result is illustrated by Fig. 4 which shows that both
tropolone and tropolone-4-acetamide reduce the concentration of homovanillic acid
in mice treated with probenecid and that tropolone is 3-5 times as active as
tropolone-4-acetamide in this test.
Discussion
The enzyme, catechol-O-methyl transferase (COMT), is of importance in the
metabolism of dopamine in the central nervous system because the major metabolic
product of this amine in the brain appears to be homovanillic acid. The inhibition
of this enzyme by tropolone derivatives was postulated and confirmed by Belleau &
Burba (1961, 1963), who also showed that these substances could block sympathetic
j8-receptors, though this observation was not confirmed by Ross & Flaljasmaa
(1964b).
Tropolone and related compounds have been used in studying the effect of inhibi¬
tion of COMT on the metabolism of radioactive catecholamines in the brain
(Goldstein, 1964), but there have been few comparisons of the ability of different
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substances to inhibit the enzyme in the central nervous system of living animals.
Carlsson, Corrodi & Waldeck (1963) examined a series of compounds, including
tropolone-4-acetamide, by determining the dose of each substance which would
reduce the cerebral concentration of 4-hydroxy-3-methoxyphenylethylamine
(methoxytyramine), without reducing the cerebral concentration of dopamine, in
mice treated with l-DOPA and the monoamine oxidase inhibitor, nialamide. Ross
& Haljasmaa (1964b) have measured the COMT activity in supernatants obtained
after centrifuging homogenates of brains obtained from mice treated with tropolone
derivatives and other compounds. A dose of tropolone-4-acetamide 500 mg/kg
was required for these effects. This dose was found by Carlsson, Corrodi & Waldeck
(1963) to reduce the concentration of methoxytyramine to below 12% of its normal
value and by Ross & Haljasmaa (1964b) to reduce the COMT activity in brain
extracts by 50%. The present experiments show that tropolone-4-acetamide pre¬
vents the accumulation of homovanillic acid after l-DOPA, presumably as a result
of the inhibition of COMT, at dose levels much lower than 500 mg/kg, and that
tropolone itself is more active than tropolone-4-acetamide.
In mice treated with l-DOPA, the administration of small doses of tropolone
causes a reduction in the concentration of homovanillic acid with a concomitant
increase in the concentration of 3,4-dihydroxyphenylacetic acid. The increase in
the latter is larger than the decrease in the former and suggests that the rate constant
for the removal of 3,4-dihydroxyphenylacetic acid from mouse brain is smaller than
that for the removal of homovanillic acid; in other words, it is more difficult for
3,4-dihydroxyphenylacetic acid to get out of the mouse brain than it is for homo¬
vanillic acid. After higher doses of tropolone derivatives there is apparently some
inhibition of the accumulation of 3,4-dihydroxyphenylacetic acid. The tropolone
compounds will inhibit the hydroxylating enzymes involved in the biosynthesis of
catecholamines, tropolone-4-acetamide being less active than a-propyldihydroxy-
phenylacetamide (Carlsson et. ai, 1963), but there is no evidence to show that they
will inhibit DOPA-decarboxylase, the enzyme involved in the formation of dopa¬
mine from l-DOPA. It may be that the larger doses of tropolone interfere with
the transport of l-DOPA or its metabolites in the brain. The tropolones can also
chelate divalent metal ions (Bryant, Fernelius & Douglas, 1953) and thus the higher
concentrations may interfere with many metabolic reactions and processes.
It can be concluded that observations on cerebral metabolism of catecholamines
made in vivo with doses of tropolone compounds in excess of 100 mg/kg should
not, in the mouse, be referred simply to the inhibition of COMT.
The present results show that quite small doses of tropolone and tropolone-4-
acetamide will reduce the concentration of homovanillic acid in the striatum of
normal mice, not treated with l-DOPA, but given probenecid to prevent the active
transport of acid metabolites out of the brain. The reduction in the concentration of
homovanillic acid again, is directly proportional to the logarithm of the dose of the
COMT-inhibitor. In this test, tropolone-4-acetamide was more active relative to
tropolone than in the first test, and it can be inferred that the test using probenecid-
treated mice gives a better assessment of the inhibition of COMT at the sites where it is
normally acting. In this experiment the increase in 3,4-dihydroxyphenylacetic acid
was smaller than the fall in homovanillic acid and was similar for all the doses of
the tropolones. This is unlikely to be a result of an accelerated removal of 3,4-dihy¬
droxyphenylacetic acid because of the probenecid treatment, which was intended to
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block the active transport of acid metabolites from the brain. The finding suggests
that in the normal mouse the formation of 3,4-dihydroxyphenylacetic acid is not a
simple alternative to the formation of homovanillic acid in the metabolism of dopa¬
mine in the striatum, but if the test is to be used as a method for examining the
ability of compounds to inhibit catechol-O-methyl transferase, there should be no
decrease below the normal concentration of 3,4-dihydroxyphenylacetic acid, because
this would indicate an interference in the metabolism of dopamine elsewhere in the
metabolic pathway.
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Turnover of amines using probenecid to
block egress of metabolites
D. F. SHARMAN
Agricultural Research Council Institute of Animal Physiology, Babraham, Cambridge,
England
In 1964 Neff, Tozer & Brodie described a specialized transport system for the
removal of 5-hydroxyindol-3-ylacetic acid (5-HIAA), an acid metabolite of 5-
hydroxytryptamine (5-HT) from the brain of the rat. The presence of such a system
in this species was deduced from the observation that when rats were given
probenecid there was an increase in the concentration of 5-HIAA in the brain.
Probenecid is a competitive inhibitor of acid transport in the renal tubules and
is thought to act by interfering with the formation of an intermediate complex
involved in the transport of acids through the renal tubular cell.
An active transport system for the removal of acid metabolites from the brain is
also present in the mouse (Sharman, 1566) and the pigeon (Ahtee, personal com¬
munication) but not in the rabbit (Werdinius, 1967, 1968) and is also concerned
with the removal of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid;
HVA), an acid metabolite of 3,4-dihydroxyphenylethylamine (dopamine) (Sharman,
1966 ; Werdinius, 1966) from the brain. The concentration of another acid meta¬
bolite of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) is, however,
unaffected when probenecid is administered to mice (Sharman, unpublished).
The presence of such an active transport system in the rat and the mouse and
the possibility of its inhibition by probenecid has enabled studies to be made on
the rates at which acid metabolites of monoamines are formed in the brain. Neff,
Tozer & Brodie (1967) have shown that the rate at which 5-HIAA accumulates in
the brain, after a maximally effective dose of probenecid, is similar to the rates at
which 5-HT and 5-HIAA are synthesized in normal and reserpine-treated rats. It
should be emphasized at this point that although the rate of accumulation of an
acid metabolite after treatment with probenecid can, in some circumstances, be
shown to be similar to the rate of metabolism of the parent monoamine and to the
rate of formation of the acid itself, this need not always be so. The possibility of
an alternate pathway for the metabolism of the monoamine and an alternative route
for the disposition of the acid must not be ignored. Neff, Tozer & Brodie (1967)
have obtained evidence that these possibilities do not occur in their experiments
on 5-HIAA in the rat brain and that the accumulation of 5-HIAA can be taken as
a measure of the rate of turnover of 5-HT. In the rat, the accumulation of 5-HIAA
after a maximally effective dose of probenecid is linear for at least 90 min and in
the mouse for at least 60 min.
Estimated rates of accumulation, after probenecid, of 5-HIAA in the brain of
the rat are 0.40 «g/g per hr (Neff, Tozer & Brodie, 1967) and 0.32 jxgtg per hr
(Diaz, Ngai & Costa, 1968) and in the mouse brain 0.54 jj-glg per hr. It has been
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shown in rat brain that reserpine (Neff, Tozer & Brodie, 1967) and ether anaesthesia
(Diaz, Ngai & Costa, 1968) increase the rate of accumulation of 5-HIAA after
probenecid, which indicates an increased rate of turnover of 5-HT.
The application of similar methods to the study of the rate of metabolism of
catecholamines in the brain has proved to be more difficult. The presence in the
brain of an acid metabolite of noradrenaline, the concentration of which can be
increased by the administration of probenecid has yet to be demonstrated. The
effect of probenecid on the acid metabolites of dopamine has, however, proved
useful in studying drug-induced changes in dopamine metabolism in the striatum
of the mouse (Sharman, 1966 ; Sharman, 1967).
The quantitation of the turnover rate of dopamine from studies on the accumula¬
tion of homovanillic acid is not as simple as for 5-HT because there are alternative
pathways for the metabolism of dopamine. Also in preliminary experiments on
the mouse striatum the molar turnover rate of dopamine, calculated from the fall
in the concentration of this amine in the striatal tissues of mice treated with
a-methyl-p-tyrosine, was approximately twice the molar rate of accumulation of
homovanillic acid after a maximally effective dose of probenecid. By regarding
the active transport system as two enzymic processes in a non-reversible chain
(Sharman, 1967) and by partially inhibiting the system with probenecid, it was
possible to study whether a drug-induced increase in the concentration of homo¬
vanillic acid in the striatal tissues of the mouse was due to an increase in the rate
of formation of the acid, to interference with the active transport system or to
retention of the acid at a site where the active transport system was not operative.
It seems from such experiments that the homovanillic acid can be present in the
striatal tissue in at least two compartments. One of these compartments reflects
the homovanillic acid which is in the process of being actively transported out of
the brain and another contains homovanillic acid which does not have immediate
access to the active transport system. The finding that the concentration of DOPAC
is unaffected by probenecid is further evidence in support of this hypothesis
(Sharman, unpublished) showing that acid metabolites can be formed at a site where
the active transport system does not act. Because of the possibility that homo¬
vanillic acid is present at two separate sites in the brain tissue, the application of
simple enzyme kinetics to the results obtained after partial inhibition of the active
transport by probenecid must be reconsidered, because it was assumed that all the
homovanillic acid in the tissue was immediately involved in the active transport
system. If, however, changes in the rate of formation of homovanillic acid are
reflected in an increase in the concentration of homovanillic acid which is distributed
in a constant proportion between the compartments, then the simple approach will
still hold. In all the drug-induced increases in the rate of formation of homo¬
vanillic acid so far examined, the relative increase in homovanillic acid induced by
a dose of probenecid has only rarely exceeded the relative increase induced by the
same dose of probenecid in normal mice, whereas the normal relative increase would
be expected to be exceeded in all cases if only the homovanillic acid in the process of
being actively transported was affected when the rate of synthesis of homovanillic
acid is increased. There have been several instances where the probenecid-induced
relative increase in homovanillic acid in the striatum of drug-treated mice has been
less than in normal mice, indicating that the drug treatment had caused a retention
of homovanillic acid in the tissue or that an equilibrium situation had not been
attained.
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With the apparently simpler situation which prevails for the metabolism of 5-HT,
the presence of two or more compartments for 5-HIAA should also be examined.
Diaz, Ngai & Costa (1968) have shown that the rate of synthesis of 5-HIAA is
increased threefold in rats anaesthetized with ether but that the concentration of
5-HIAA in the brain was increased only 1.7 times. This implies that at a higher
concentration of 5-HIAA the active transport system is more efficient, but it is
also possible that only a part of the normal concentration of 5-HIAA is involved in
the active transport process.
The administration of 2-amino-tetralin to mice results in a reduction in the con¬
centration of 5-HIAA in the brain (Robinson & Sharman, 1966). The results of
an experiment in which the effect of probenecid alone and in combination with
this drug will serve to illustrate the method of studying the rate of formation of
5-HIAA. Figure 1 shows that after treatment with 2-amino-tetralin the rate of
accumulation of 5-HIAA induced in the mouse brain by a maximally effective dose
of probenecid is approximately half that seen with normal mice. This result
fig. 1. Effect of 2-aminotetralin on the accumulation of 5-hydroxyindol-3-ylacetic acid
(5-HIAA) in the brain of the mouse after treatment with probenecid. O O. Concentration
of 5-HIAA in the brains of mice given probenecid (200 mg/kg i.p.) at time 0 ; A ▲, con¬
centration of 5-HIAA in the brains of mice given 2-aminotetralin (30 mg/kg i.p.) 60 min before
time 0 ; © ©, concentration of 5-HIAA in the brains of mice given 2-aminotetralin (30
mg/kg i.p.) 60 min before time 0 and probenecid (200 mg/kg i.p.) at time 0. Concentrations
are drawn+ S.E.M.; each point is the mean of at least seven determinations.
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suggests that the fall in 5-HIAA concentration after 2-amino-tetralin is a reflection
of a reduced rate of formation of the acid.
It can be concluded that the use of probenecid to inhibit the active transport of
acid metabolites of monoamines out of the rodent brain will prove to be a most
useful aid in the study of the metabolism of monoamines in the brain, but it must
be remembered that the effect of probenecid can only be used as an index of the
rate of synthesis or arrival of an acid metabolite at a site where the active transport
system can function.
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The noradrenaline content of the heart and spleen was investigated in normal
mice and in mice treated with drugs. A modification of the methods of Bertler,
Carlsson & Rosengren (1958) was used for extraction, and of v. Euler & Floding (1955)
for fluorimetric estimation of the amine. In normal mice the mean noradrenaline
content of the heart was 0.55 /'-g/g and that of the spleen 0.26 /<g/g fresh tissue.
Iproniazid (100 mg/kg), nicotine (0.1 mg/kg) and histamine (0.5 mg/kg), given 1 and
3 hr before killing the mice, did not significantly change the concentration of nor¬
adrenaline in the heart. Neither did nicotine and histamine, administered 1 hr
before death, significantly alter the noradrenaline content of the spleen. The rapid
changes in the catechol amine content of mouse tissues reported with these drugs
by De Schaepdryver & Preziosi (1959) were not observed. In contrast, reserpine
(2.5 mg/kg), methyl reserpate methyl ether (1 mg/kg), and methyl 18-epireserpate
methyl ether (2 mg/kg) caused severe depletion of noradrenaline from the heart
and spleen of the mice.
Of the numerous reports on the normal catechol amine content of mammalian
tissues few concern mice. The effect of drugs on the amine stores in mice has
also been studied very little. In 1959 De Schaepdryver & Preziosi, using adsorption
of adrenaline and noradrenaline on aluminium oxide, elution by sulphuric acid and
fluorimetric estimation, analysed the catechol amine concentrations of the suprarenal,
heart, liver and spleen in normal mice. They found that a number of drugs rapidly
deplete the amines from these tissues. Thus, 1 hr after the intraperitoneal injection
of nicotine (0.1 mg/kg) or iproniazid (100 mg/kg) complete loss of both amines from
the heart was observed. Similarly, 1 hr after administration of nicotine or histamine
(0.5 mg/kg), no noradrenaline was detected in the spleen. Very rapid recovery of
both cardiac and splenic noradrenaline to normal and to levels above normal was
observed within a few hours. Even after reserpine, recovery of the cardiac nor¬
adrenaline was nearly complete in 48 hr. However, experiments of several authors
(Carlsson, Rosengren, Bertler & Nilsson, 1957 ; Muscholl & Vogt, 1958 ; Paasonen
& Krayer, 1958) have shown in other species that, after depletion by reserpine, it
took many days for the concentration of tissue noradrenaline to recover. These
results suggested that, in contrast to other species, the stores of noradrenaline in
mouse tissues are labile and easily affected by drugs. Other species differences in
the metabolism and storage of catechol amines have been recently demonstrated by
Sanan & Vogt (1962).
s*
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The present study was made in order to investigate further what appeared to be
unusual behaviour of the tissue catechol amines in the mouse and to repeat the
experiments of De Schaepdryver & Preziosi (1958) by using another method of
estimation. The noradrenaline content of the heart and spleen was estimated in
normal mice and in mice treated with iproniazid, nicotine, histamine, reserpine and
two of its analogues.
METHODS
Animals and drugs. Albino mice of both sexes (predominantly male) were used. The
body weight of the animals ranged from 20 to 40 g. The animals were kept in groups of
10 or 20 at room temperature. Food in pellets and tap-water were allowed ad libitum.
Special precautions were taken to minimize the biological variations related to the origin
of the animals. The majority of the experiments were carried out on one breed of mice reared
in the laboratories ; for the remaining experiments animals from a single strain were obtained
from a dealer. The organs of a group of five or six mice were pooled, since this number
provided sufficient tissue for an accurate estimation of noradrenaline. The groups were made
as uniform as possible in respect of body weight and sex.
The following drugs were used: iproniazid phosphate (Marsilid, Roche Products),
nicotine hydrogen tartrate (British Drug Houses), histamine acid phosphate (British Drug
Houses), reserpine (Serpasil, Ciba), methyl reserpate methyl ether hydrochloride and its 18-epi
isomeride (Su-8842 and Su-9064, Ciba). The doses of nicotine and histamine are expressed
in terms of the base and those of all other drugs as weight of the salts.
All drugs were dissolved in an isotonic solution of sodium chloride and injected intra-
peritoneally in a volume of 0.5 ml./20 g body weight. Controls were injected with the same
volume of sodium chloride solution.
The animals were killed by decapitation and exsanguinated. The hearts were dissected as
rapidly as possible. The blood and the blood clots were removed by blotting on filter paper.
Before excising the spleens, electrical stimulation of the splenic nerves (square waves of
100 msec duration, 12/sec, 6 V) was carried out for a few sec in an attempt to induce
contraction of the organ. \
General procedure. Immediately after their removal the tissues were weighed and homo¬
genized in 0.1 n hydrochloric acid (2 ml./g tissue) in the presence of a few mg ascorbic acid.
The homogenate was diluted with about twice its volume of water. The proteins were pre¬
cipitated by adding 1 vol. 0.8 n perchloric acid. The further treatment of the extract was
essentially the same as described by Bertler et al. (1958). The main characteristic of this
method is the absorption of the catechol amines on the cation exchange resin Dowex-50x8
in a column. The elution was done by gravity, and 10 ml. of 1.2% hydrochloric acid was
used. The eluates were analysed fluorimetrically for noradrenaline with an Aminco-Bowman
spectrophotofluorimeter. The trihydroxyindole method of von Euler & Floding (1955) was
used in a somewhat modified way: the reaction (oxidation with potassium ferricyanide and
rearrangement with alkali) was performed in the dark and the pH of the m acetate buffer
was 6.5 (Sharman, 1960). Von Euler & Lishajko (1961) improved the original method by
addition of ethylene diamine to the mixture of sodium hydroxide and ascorbic acid. In the
majority of the estimations, ethylene diamine was used but was incorporated in the sodium
hydroxide solution, since this was added separately from ascorbic acid, as suggested by
Crawford & Law (1958).
The samples were activated at 400 mp, and the resulting fluorescence was read at 500 mp.
The catechol amines in the extracts were read against a standard noradrenaline solution treated
in the same way as the sample. The results were expressed as /'g of noradrenaline base.
Extract blanks were obtained after allowing a portion of the eluates to fade for 7 min in the
presence of potassium ferricyanide and sodium hydroxide and adding ascorbic acid afterwards.
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A polished Araldite rod was used as a standard for the calibration of the spectrophoto-
fiuorimeter. The sensitivity was checked and corrected if necessary before each reading.
All solutions for the fluorimetric analysis were made with deionized water. Also, all glass¬
ware was rinsed with deionized water in order to prevent possible interference by some
fluorescent material contaminating the ordinary distilled water.
Test for sensitization or masking. To 1 ml. of each eluate a known amount of noradrenaline
was added. The fluorescence was developed in the usual way, and the increase in fluorescence
above that obtained with 1 ml. of eluate only was measured. This increase should theoretically
be identical with the fluorescence produced by the added amount of noradrenaline in pure
solution. Any deviation from the expected reading would disclose either masking or intensifi¬
cation of the reaction by some material in the tissue. Masking was hardly ever found, but
the fluorescence produced in the extracts was sometimes slightly higher than in pure solution ;
the difference never exceeded the equivalent of 2.0 ng noradrenaline.
Recovery. The recovery was checked in every single experiment. For this purpose two
portions of 3 ml. each were pipetted off from the homogenates which had been diluted with
water to either 6.5 or 7 ml. To one of these portions 0.1 pg of noradrenaline was added.
The recovery was determined by comparing the fluorescence of the two portions. The mean
recoveries were of the order of 80%.
Sensitivity. Because of these various controls, the fluorescence was measured on about
3/70th of the original homogenate, as seen from the following plan:
6 hearts (spleens) Dilution
homogenized with twice —to
their weight of 0.1 n HC1 6.5 or 7 ml
A and B each yielded 10 ml. eluates, which were used as follows:
2 ml. for duplicate estimation on 1 ml. each ;
2 ml. for duplicate check on masking or sensitization (1 ml. eluate + known amount of nor¬
adrenaline) ;
1 ml. for faded (extract) blank.
If 1 g of tissue is worked up, reliable readings can be obtained by this procedure down to a
tissue concentration of noradrenaline of 0.1 pg/g. Estimations of lower concentrations are
only approximate.
RESULTS
The noradrenaline content of the heart and spleen in normal mice. The animals
referred to here as " normal" are either untreated mice or controls injected with
0.9% sodium chloride solution. The noradrenaline content of the heart and spleen
for these is summarized in Table 1. The penultimate column shows the individual
concentrations, means, standard deviations and standard errors of the mean,
corrected for recovery. The percentage recovery will be found in the preceding
column.
The coefficient of variation was not significantly changed when the concentrations
were expressed as pg noradrenaline/100 g body weight instead of pg/g fresh tissue.
No consistent relationship was found between body weight and noradrenaline con¬
centration. Since estimations of noradrenaline concentrations below 0.1 pg/g tissue
have a low degree of accuracy, the second decimal in the table is only an approxi¬
mation.
^ 3 ml. =A (test)
% 3 ml. + 0.1 pg
\ noradrenaline
= B (recovery)
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Table 1
NORADRENALINE CONTENT OF THE HEART AND SPLEEN IN NORMAL MICE
s.d.=standard deviation. s.e.=standard error of the mean
Total Total Noradrenaline Noradrenaline,
No. of body wt. of Re¬ /Xg/g tissue,
animals wt. in
Tissue
tissue /xg/g /xg/100 g covery
%
corrected
Group and sex g in mg tiss. body wt. for recovery Remarks
1 6c? 183 Heart 860 0-45 0-21 63 0-71
n 6<? 166 Heart 850 0-37 0-18 65 0-57 No
3 6<? 231 Heart 1046 0-52 0-23 92 0-56 treatment
4 6<? 237 Heart 1072 0-53 0-24 87 0-61
Mean 204 957 0-47 0-21 76-7 0-61
s.d. 0-07 0-026 0-07
s.e. 0-035 0-013 0-03
5 63 229 Heart 1006 0-56 0-24 96 0-58
6 5 <? 223 Heart 936 0-59 0-25 71 0-83
7 6 c? 214 Heart 904 0-39 0-16 60 0-65
8 6<? 233 Heart 1163 0-59 0-29 70 0-84 Saline-
9 6 $ 194 Heart 914 0-59 0-27 108 0-55 treated
10 6 5 185 Heart 845 0-84 0-37 95 0-88 controls
11 6 ? 186 Heart 890 0-72 0-34 88 0-82
12 6c? 176 Heart 895 0-43 0-21 69 0-61
Mean 205 944 0-59 0-28 82-1 0-72
s.d. 0-14 0-07 0-13
s.e. 0-05 0-03 0-05
Overall mean 0-55 0-26 80-3 0-68
s.d. 0-14 0-06 0-13
s.e. 0-04 0-02 0-04
1 6 $ 194 Spleen 943 0-29 0-13 100 0-29
2 6 ¥ 186 Spleen 1263 0-21 0-13 82 0-25 Saline-
3 6 $ 188 Spleen 860 0-33 0-15 103 0-32 treated
4 5 ¥ 147 Spleen 690 0-38 0-17 69 0-55 controls
5 6c? 195 Spleen 979 0-26 0-12 65 0-40
6 6c? 171 Spleen 1006 0-17 0-09 75 0-22
7 6<? 147 Spleen 922 0-16 0-09 53 0-30
Mean 176 952 0-26 0-12 78-1 0-33
s.d. 0-08 0-03 0-11
s.e. 0-03 0-01 0-04
The mean for the noradrenaline content of the heart of the untreated mice was
0.47 /xg/g tissue with a standard deviation of +0.07 (Table 1). The corresponding
figures for the saline-treated controls were 0.59 + 0.14 /xg/g, and the mean of both
groups 0.55 + 0.14 /xg/g. The difference between the two groups becomes smaller
(and non-significant) when correction is made for recovery (Table 1, penultimate
column).
The spleen was only analysed in saline-treated mice. The mean noradrenaline
concentration in seven groups was 0.26 + 0.08 ,«g / g tissue. This figure is lower
than that obtained by De Schaepdryver & Preziosi (0.686 /xg/g tissue). In order
to obtain the highest concentration possible, the splenic nerves were stimulated
for a few sec so as to reduce the spleen volume ; not much contraction was, however,
observed, probably because the spleen was already contracted as a result of the
exsanguination.
The results both for the heart and spleen show considerable variations which are
reduced by correcting for recovery. Consistent differences between the two sexes
were not found, but an occasional group of female mice had a slightly higher nor¬
adrenaline content of their spleens.
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The noradrenaline content of the heart and spleen of the mouse after administra¬
tion of drugs. The effects of the drugs studied are presented in Table 2. These
drugs might be conveniently divided into two groups. Firstly, iproniazid, nicotine
and histamine, and, secondly, reserpine and two of its analogues—methyl reserpate
methyl ether and methyl 18-epireserpate methyl ether. The effect of reserpine
served to confirm that the method would demonstrate a depletion of catechol amines
if this were to occur.
Table 2
NORADRENALINE CONTENT OF THE HEART AND SPLEEN OF THE MOUSE AFTER
TREATMENT WITH DRUGS
Total Total Noradrenaline
No. of body wt. of Duration
animals wt. tissue Dose of drug of exp. fig/g ftg/100 g Recov-
Group and sex in g Tissue in mg (mg/kg) (hr) tiss. body wt. ery %
1 6 c? 214 Heart 1002 ) 1 0-54 0-25 87
2 6 c? 252 Heart 1002 [ Tnr ■ 1nn 1 0-64 0-25 80
3 6 c? 217 Heart 894 f Ipoiai' 100 1 0-31 0-12 100
4 6 <? 227 Heart 981 ) 3 0-60 0-26 85
5 6 ? 190 Heart 863 1 1 0-74 0-33 134
6 6 $ 185 Heart 891 I Nicotine 0., 1 0-66 0-31 77
7 5 $ 141 Heart 659 ( NlC0tlne>0 1 \ 0-76 0-35 92
8 6 c? 180 Heart 832 ) 3 0-50 0-22 70
9 6<? 165 Heart 978 ) Hktamine 0.c 1 0"35 0-20 62
10 6<? 154 Heart 765) histamine, u o j Q.48 0.23 ?g
11 6 c? 239 Heart 917 Reserpine, 2-5 18 0-013 0-005 58
12 6 <? 235 Heart 1058 Su-8842, 1 2 0-03 0-01 93
13 6 <? 194 Heart 1052 Su-8842, 1 2 0-03 0-01 80
14 6<? 242 Heart 1264 Su-9064,2 2 0-03 0-01 136
1 5 9 145 Spleen 708 Nicotine, 0-1 1 0-34 0-16 105
2 6<? 180 Spleen 797 Nicotine, 0-1 3 0-30 0-12 68
3 6 c? 165 Spleen 1160 Histamine, 0-5 1 0-15 0-10 63
4 6 <? 194 Spleen 960 Su-8842, 1 2 Less than 0-01 61
Table 2 shows that iproniazid, nicotine and histamine in the doses used did not
produce significant changes in the noradrenaline content of the heart and spleen in
the course of 1 or 3 hr.
In contrast with this, a single injection of reserpine provoked in 18 hr a profound
fall in the noradrenaline content of the heart. Similarly, the two reserpine analogues,
methyl reserpate methyl ether and its 18-epi isomeride, caused severe loss of nor¬
adrenaline from heart and spleen. In confirmation of Robison, Lucas, MacPhillamy,
Barrett & Plummer (1961), the action of these compounds was found to be very fast,
negligible amounts of the amine being left in the tissues after as little as 2 hr. The
behavioural and autonomic effects of the doses used were less marked than those
of reserpine, 2.5 mg/kg. There was obvious sedation and reduced reactivity to
external stimuli, closure of the eyelids and tremor.
DISCUSSION
As Udenfriend (1959) stated, specificity and sensitivity are the most important
criteria in the choice of a chemical method for the estimation of catechol amines.
The specificity of the present method is based on the combination of selective
adsorption and elution with a characteristic fluorescence. Of the catechol amines
which might be mistaken for noradrenaline, isoprenaline has never been found in
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the tissues examined, while adrenaline is present in such small amounts that it
cannot seriously affect the results. The fluorescence derived from dopamine with
this method is less than 1 % of that derived from noradrenaline (Crawford & Law,
1958).
The sensitivity of the method is sufficient to measure accurately 0.1 jig nor¬
adrenaline in 1 g of fresh tissue, and is, therefore, adequate for the estimation of
noradrenaline in 1 g of normal heart which is about 5 times that figure. Since the
concentration of adrenaline in all mammalian species examined, including the rat,
is only a few per cent, of that of noradrenaline, it was obvious that reliable figures
for the adrenaline content of the organs of mice could not be expected with this
method. In addition, it is known that the concentration of adrenaline in tissues
supplied with sympathetic nerves varies much more than that of noradrenaline. No
attempt was therefore made to estimate any adrenaline in the tissues analysed.
As a precaution, recoveries were carried out in each estimation to check on
accidental losses. Though, on the average, the recovery was of the order of 80%,
the variation of the losses suggests that the precision is greatly increased by esti¬
mating the recovery from each homogenate.
The noradrenaline content of the heart of normal mice found in the present
work (overall mean 0.55 /xg/g) is in good agreement with the figures reported by
De Schaepdryver & Preziosi (1959) and by Porter et cd. (1961).
The concentration in the spleen of normal mice, however (0.26 /xg/g), was signifi¬
cantly lower than that found by De Schaepdryver & Preziosi (0.69 /xg/g). In order
to stabilize the weight of the spleen by expelling as much blood as possible, electrical
stimulus was applied for a few sec to the splenic pedicle in the present experiments.
It is most unlikely that this should have reduced the noradrenaline content of the
splenic tissue, since Vogt (1954) has shown that stimulation of the superior cervical
sympathetic nerve for 2 hr does not change the noradrenaline content of the ganglion.
The reason for the lower figure may lie in a strain difference.
After reserpine and two of its analogues, the noradrenaline content of the heart
and spleen fell to values so low that they were not significantly different from zero.
In this the present results agree with those of De Schaepdryver & Preziosi with
reserpine. When, however, iproniazid, nicotine and histamine were injected, and
the tissues examined 1 and 3 hr later, the results obtained were at variance with
those of De Schaepdryver & Preziosi (1959). These authors found no noradrenaline
in the heart after iproniazid and nicotine, and none in the spleen after nicotine and
histamine, whereas the foregoing experiments gave normal concentrations for the
noradrenaline in all these instances. It is very difficult to explain these discrepancies.
Our conclusion is that the noradrenaline content of the mouse organs is not changed
more readily than that of other species and that the stores are just as stable in the
mouse as in the rabbit or cat.
Nicotine and histamine are drugs which deplete catechol amines from the adrenal
gland by a direct action on the medullary tissue. They are also known to cause
stimulation of sympathetic ganglia. The present experiments with these drugs show
that such stimulation is not accompanied by a depletion of the amines from their
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peripheral storage sites. This is in agreement with the findings of Muscholl (1961)
on the effect of nicotine and dimethylphenylpiperazinium iodide on cat atria, and of
Sanan & Vogt (1962) with the latter drug on sympathetic ganglia.
The work was- done while one of us (S. V.) was holding a Scholarship from the British
Council, whose help is gratefully acknowledged. We wish to thank Ciba Laboratories Limited
for a gift of Serpasil; Ciba Pharmaceutical Products, Inc., for gifts of Su-8842 and Su-9064 ;
and Roche Products Limited for a gift of Marsilid.
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Estimations have been made of the amounts of adrenaline, noradrenaline and
5-hydroxytryptamine released by iontophoresis from micropipettes. In most experi¬
ments, the amount released was linearly related to the total electrical charge, but the
transport numbers for different pipettes, filled with samples of the same solutions
of adrenaline or of noradrenaline, varied substantially. Two pipettes containing
noradrenaline failed to release any appreciable amounts of the drug. The transport
number of 5-hydroxytryptamine was relatively constant (mean, 0.14).
The iontophoretic method of applying sympathomimetic drugs to neurones in
the central nervous system is being used more and more extensively (Curtis & Davis,
1962 ; Bradley & Wolstencroft, 1962 ; Krnjevic & Phillis, 1963a, b). It is therefore
of interest to know how much drug is released from a micropipette by iontophoresis.
Studies, made with pipettes containing acetylcholine chloride, have shown that the
average fraction of the total current carried by ionized acetylcholine (its transport
number) in such pipettes is not very different from that observed with a large volume
of solution, but there was a substantial variation in behaviour between one pipette
and another (Krnjevic, Mitchell & Szerb, 1963).
It is preferable to study the iontophoretic release of drugs by currents which are
at least similar in magnitude to those used in experiments on nerve cells. Inevitably
only very small amounts of drugs are thus available for estimation. We have now
examined the iontophoresis of adrenaline, noradrenaline and 5-hydroxytryptamine,
for which adequately sensitive methods of assay were available.
METHODS
The micropipettes consisted of five Pyrex glass tubes sealed together and pulled out to a
fine tip, as described by Krnjevic & Phillis (1963a). They were similar to those used in
previous studies of cerebral cortical neurones (Krnjevic & Phillis, 1963a, b). The compound
tips had outside diameters of 6 to 12 //.
In the present experiments, only one of the barrels was filled with a concentrated solution
of a drug, the others containing merely water. The solutions were prepared 48 hr before the
experiments to allow time for diffusion to the tips. The concentrations of drugs were as
* Beit Memorial Fellow.
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follows: 0.13 M-5-hydroxytryptamine creatinine sulphate (May & Baker); 0.75 M-adrenaline
acid tartrate (British Drug Houses); and 1.7 M-noradrenaline (British Drug Houses) acidified
with concentrated hydrochloric acid. All three solutions had a pH between 3 and 4.
The pipettes were held vertically, with the tip dipping in 1.0 ml. of 150 mM-NaCl, to which
was added either a trace of ascorbic acid (about 10 mg/100 ml.) to preserve 5-hydroxytrypt-
amine, or hydrochloric acid (giving a final concentration of 2 dim) to preserve the catechol
amines.
The iontophoretic currents were measured by a series galvanometer, with an accuracy of
1 nA (10~° A), and there was a 50 M12 resistor in series with the micropipette to reduce
fluctuations in the current. The latter was kept at 100 nA in all experiments, well within the
range of currents used when testing nerve cells. Four to six different periods of release (lasting
up to 10 min) were tried with each micropipette, so that the relation between the release and
the total electrical charge could be examined over a substantial range of times. Samples of
fluid were also collected during periods when the drugs were allowed to diffuse out spon¬
taneously, to estimate the magnitude of any spontaneous leak.
All samples were assayed within 2 to 3 hr and, for controls, several solutions of known
concentration were handled in the same way to test for any possible loss of drug or
contamination during handling ; none could be detected.
Estimations. Noradrenaline and adrenaline were estimated fluorimetrically as described by
Sharman, Vanov & Vogt (1962), but a Locarte filtei fluorimeter was used. For noradrenaline,
the primary filter was an LF/2 and the secondary an Ilford No. 625 ; for adrenaline the primary
filter was a Corning 3880 with a half standard thickness Corning 3113, and the secondary a
Chance OY4. The accuracies of this method are about +10% in the upper range of concen¬
trations for noradrenaline and about ±5% for adrenaline. The lower limits of accurate
estimation are about 50 and 20 pmole for noradrenaline and adrenaline respectively. Hence,
the lowest values in our results are only very approximate, being liable to errors approaching
+ 100%.
5-Hydroxytryptamine was estimated by its fluorescence in 3 n-HCI (Udenfriend, Bogdanski
& Weissbach, 1955) using an Aminco-Bowman spectrofluorimeter. The lower limit of
estimation was about 10 pmole.
RESULTS
In all, twelve multibarrelled micropipettes were used, four containing adrenaline,
four noradrenaline and four 5-hydroxytryptamine solution.
The amount of iontophoretic release of drug was plotted against the electrical
charge after making due correction for any spontaneous leakage of drug. The
general relation between the release of drug and the charge was obtained from the
slopes of lines drawn through the experimental points. Examples of such graphs
are shown in Figs. 1 and 2. The effective transport number was calculated by
multiplying the slope (expressed in mole/coulomb) by 96,500.
Adrenaline
The values of the transport numbers were 0.13, 0.14, 0.20 and 0.37 (mean, 0.21).
The full range of slopes is illustrated by the lines in Fig. 1. It can be seen that there
was relatively little scatter of points obtained with any one pipette, and that all the
lines, when extrapolated, went through or near the origin.
The marked difference between the slopes was associated with corresponding
variations in tip diameter, electrical resistance and, especially, in the amount of
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Electrical charge (fiC)
Fig. 1. The relationship between iontophoretic release of adrenaline (ordinate, pmole) and electrical
charge (abscissa, /^coulomb) for three different micropipettes containing adrenaline acid
tartrate. The current was 100 nA. Straight lines were positioned by eye.
spontaneous leak of adrenaline. Thus the smallest rate of release was from a pipette
with a 7 fi tip (overall outside diameter) and a resistance much greater than 100 Mft,
and with a spontaneous leak of only 0.3 pmole/min ; whereas the steepest slope
was given by a 12 /r diameter pipette, with a tip resistance of 70 MSI and a leak
of 25 pmole/min.
Noradrenaline
Two micropipettes allowed current to flow without any difficulty; the values of
the transport numbers were 0.34 and 0.37 and the spontaneous leakage was 0.5 to
1 pmole/min. The experimental points obtained with one of these pipettes are
shown in Fig. 2 (o—o).
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Electrical charge (/xC)
Fig. 2. The relationship between iontophoretic release (ordinate, pmole) of noradrenaline and of
5-hydroxytryptamine and electrical charge (abscissa, iticoulomb). O O and © ©:
release of noradrenaline from two micropipettes containing noradrenaline hydrochloride.
•—■—■ • : release of 5-hydroxytryptamine from another pipette containing 5-hydroxytryptamine
creatinine sulphate. The iontophoretic current was 100 nA in all instances. Straight lines
were positioned by eye.
The other two pipettes did not behave so satisfactorily: current did not flow
regularly because of a large and variable increase in the tip resistance. Hence much
larger voltages had to be applied to keep the current flow at 100 nA (about 100 V
instead of the usual 10 V). Moreover, no spontaneous leak of drug could be detected,
so any leak was probably less than 0.1 pmole/min. These two pipettes did not
release noradrenaline in a way clearly related to the iontophoretic current. One of
them was tested on two different occasions: the first time there was only a minimal
release of noradrenaline, which apparently did not vary with the amount of charge ;
on the second occasion the release apparently increased somewhat with the charge
(points ©—© in Fig. 2). However, as all these estimates were at the lower limit
of sensitivity of the method, it is not certain that there was any significant release
of noradrenaline. The transport number was probably in the range of 0.0 to 0.07.
The other pipette giving only a doubtful release of noradrenaline gave a transport
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number in the range 0.0 to 0.02 ; but, after several applications of a high voltage
(with reversal of the polarity from time to time), the same pipette appeared to conduct
a current more readily, and the value of the transport number rose to 0.17 (this
same procedure applied to the other pipette did not change its behaviour). In this
instance there was no obvious correlation between tip diameter or resistance and
the transport number.
5-Hydroxytryptamine
The four pipettes containing the 5-hydroxytryptamine solution behaved in the most
consistent manner. A typical result is indicated in Fig. 2 (• — •). The four
values of the transport numbers were 0.10, 0.13, 0.14 and 0.18 (mean, 0.14). The
spontaneous leak of drug was usually 1 to 2 pmole/min.
DISCUSSION
The most significant result of the present experiments is the demonstration of
substantial variations in the effective transport number determined when a similar
current flows through samples of the same solution of a drug in different micro-
pipettes, even though the latter were prepared at the same time and from similar
glass tubing. This result was shown, for instance, by the variations in the release
of adrenaline from the pipettes containing solutions of adrenaline acid tartrate.
The mean value of the transport numbers for adrenaline was 0.21, which is only
about two-thirds of that for the release of acetylcholine from solutions of acetyl¬
choline chloride (Krnjevic et al., 1963). The lower mean value and the scatter of
results with adrenaline may be due to variations in ionization of the acid Tartrate
in the tip of the pipette.
The micropipettes containing 5-hydroxytryptamine showed least variation in
transport numbers, which were consistently relatively low. This result supports
the suggestion that the creatinine component in solutions of 5-hydroxytryptamine
creatinine sulphate probably carries one-half of the iontophoretic current (Curtis &
Davis, 1962). However, it does not seem safe to assume on this basis that 5-hydroxy¬
tryptamine has double the potency of other drugs, as these (such as adrenaline) may
have a similar transport number.
The experiments with noradrenaline presented a special problem, since the micro¬
pipettes either released a relatively large amount of drug or practically none. Use
of such pipettes giving extremely low values of transport number could be very
misleading when testing nerve cells since, although the micropipettes would be
conducting the appropriate current, hardly any noradrenaline would leave their tips.
It must be supposed that under these conditions the tip behaves as a semipermeable
membrane (perhaps because it is blocked by some contaminating particle) which
allows the passage of hydrogen or chloride ions but not those of noradrenaline.
Evidently one cannot assume that iontophoresis is a strictly quantitative method
of application of drugs when comparing different compounds, and it is clearly
essential to make observations with several pipettes before drawing any general
conclusions about the effectiveness of any drug.
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Porter, Totaro & Stone (1963) have reported that a single injection of 6-hydroxydopamine
(2,4,5-trihydroxyphenylethylamine) lowered the noradrenaline content of the mouse heart
by more than 50% for longer than 25 days. Porter et al. (1963) proposed that this prolonged
action was due to destruction of the noradrenaline binding sites by the 6-hydroxydopamine.
However, since 6-hydroxydopamine is very similar to noradrenaline in its chemical
properties (Senoh & Witkop, 1959) it was possible that the 6-hydroxydopamine or some
metabolite replaces the noradrenaline in the heart tissue and is then bound there, preventing
the resynthesis or replacement of the lost noradrenaline.
In order to investigate this question a method was devised to isolate and measure the
6-hydroxydopamine content of tissue samples, and so to see whether its persistence in the
tissues could explain its action on the storage of noradrenaline. The functional state of
the nervi accelerantes was tested at different time intervals after the administration of
6-hydroxydopamine, and the effect of the drug on the release of catechol amines from the
adrenal medulla was examined.
METHODS
Adult male and female mice, young female guinea-pigs, and kittens and puppies of either sex were used
in these experiments. 6-Hydroxydopamine was injected intraperitoneally or intravenously as the hydro-
bromide; all doses of 6-hydroxydopamine and other amines are expressed in terms of the bases.
Cardiac nerve stimulation. Kittens were anaesthetized with ether followed by intravenous chloralose
(80 mg/kg) and the chest was opened under artificial ventilation. In some kittens the adrenal glands were
removed before opening the chest; in many, the blood pressure was measured by a mercury manometer
connected to the carotid artery. The right stellate ganglion was exposed and the strand of postganglionic
nerves going to the heart was placed on shielded electrodes. Rectangular pulses of 1 msec duration from a
Grass SD5 stimulator were used at a frequency of 15 shocks/sec; the voltage applied was usually 20 V.
The heart rate was measured from the electrocardiogram recorded on a Grass Polygraph.
Perfusion of adrenal glands. Adrenal glands of puppies were perfused by gravity at 35° C with Locke
solution saturated with 95% oxygen and 5% carbon dioxide. The perfusion cannula was tied into the
superior mesenteric artery. The dissection was carried out as previously described (Vogt, 1951), but the
isolated segments of aorta and vena cava to which the left adrenal gland was attached were excised from
the body together with the adrenal gland and placed on a perforated platform resting in a funnel. The
* Beit Memorial Research Fellow. Present address: Wellcome Research Institute, University of
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6-hydroxydopamine was freshly dissolved in bicarbonate-free Locke solution to make a 0.2% solution.
Of this solution, 0.2 ml. was slowly infused by means of a precision syringe fitted to a narrow polyethylene
tube which opened into the tip of the arterial cannula. In this way it was possible to give the drug without
addition of reducing chemicals to prevent its destruction.
Catechol amine estimations. Mice were stunned and bled to death. Guinea-pigs and kittens were
anaesthetized with chloroform or chloralose and bled to death. The hearts and other tissues were removed,
blotted dry and stored for less than 3 hr at —16° C. In the kitten experiments only the atria of the heart
were used; mouse hearts were handled as groups of four to six. Heart tissues were frozen in liquid nitrogen,
crushed while frozen and then homogenized with twice their weight of 0.1 n-hydrochloric acid; brain tissues
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Fig. 1. Elution pattern of noradrenaline ( ), 6-hydroxydopamine ( ) and dopamine ( ) from
a Dowex 50 X-8 ion-exchange resin column (2.5 x 0.4 cm) using 0.4 n- and 2 n-hydrochloric acid.
acid, and the amines were extracted by passing the deproteinized extract, after adjusting to pH 4 with potas¬
sium carbonate, through a column of Dowex 50 X-8 ion-exchange resin (2.5 x 0.4 cm) (Bertler, Carlsson
& Rosengren, 1958). The column was washed with 4 to 6 ml. of water. Noradrenaline was eluted with
10 ml. of 0.4 n-hydrochloric acid, and other catechol amines were removed with 8 ml. of 2 n-hydrochloric
acid (Fig. 1). When separation of the catechol amines was to be carried out by paper chromatography
they were eluted from the column with 8 ml. of 2 n-hydrochloric acid.
Noradrenaline in the first eluate was determined fluorimetrically after oxidation by ferricyanide (Euler
& Lishajko, 1961; for details see Sharman, Vanov & Vogt, 1962). The catechol amines in the second eluate
were estimated fluorimetrically after acetylation (Laverty & Sharman, 1964) by condensation with ethylene-
diamine; 4 ml. of column eluate, after treatment with 0.3 ml. of acetic anhydride followed by excess of
sodium bicarbonate, were heated for 20 min at 65° C with 0.5 ml. of a mixture of 3 vols of ethylenediamine
and 2 vols of 2 n-hydrochloric acid. The reaction mixture was cooled, saturated with sodium chloride and
extracted with 3 ml. of isobutanol. The fluorescence of the organic phase was measured.
The quantitative measurements of the catechol amines were carried out on a Locarte filter fluorimeter.
For noradrenaline the filters used were primary, Chance OX1, and secondary, Ilford Bright Spectrum 625.
For catechol amines after ethylenediamine condensation the primary filter was a combination of Corning
3389 and Corning 5113 (half standard thickness); the secondary filters were Ilford Bright Spectrum 623
and Ilford Bright Spectrum 625 (see later).
For further purification by paper chromatography, the column eluate was treated with acetic anhydride
and sodium bicarbonate and the total acetylated amines were extracted from aqueous solution with
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dichloromethane; the dichloromethane extract was evaporated almost to dryness and the concentrated
extract was applied to alkali-washed Whatman No. 50 paper (Sharman, 1963). The developing solvent
was a modification of the system used for steroids (Eberlein & Bongiovanni, 1955) and consisted of the
organic phase from a mixture of petroleum ether (boiling point, 80 to 1C0° C), water and terf.-butanol
(8:8: 3). The paper was equilibrated in the presence of the aqueous phase for 12 to 18 hr and a descend¬
ing chromatogram was developed for 24 to 48 hr. Authentic catechol amines were acetylated and run on
each chromatogram and visualized by heating the paper after spraying with a five-fold dilution of the
ethylenediamine-hydrochloric acid mixture described above. The chromatograms of tissue extracts were
cut into 1.5-cm lengths and each piece was eluted with 4 ml. of water. The catechol amines were estimated
fluorimetrically after condensation with ethylenediamine as described above.
In the experiments on kittens and guinea-pigs, the small quantities of noradrenaline present in the superior
cervical and stellate ganglia were measured biologically on the pithed rat, following separation of the amines
by paper chromatography using a phenol-hydrochloric acid solvent (Vogt, 1954). Because 6-hydroxy-
dopamine and noradrenaline are " isographic " (Senoh & Witkop, 1959), any 6-hydroxydopamine present
in the extract would be found on the chromatogram with the noradrenaline. However, since the pressor
activity of noradrenaline is about 3,000-times that of 6-hydroxydopamine, the amount which might
conceivably have been present in the tissue extract was far below threshold dose in the bioassay.
Separation and estimation of6-hydroxydopamine. 6-Hydroxydopamine gave no fluorescent product when
subjected to the ferricyanide oxidation method used for noradrenaline and adrenaline; 1 fig of 6-hydroxy¬
dopamine gave less fluorescence than 1 ng of noradrenaline. Using the iodine oxidation technique of
Carlsson & Lindqvist (1962), 1 fig of 6-hydroxydopamine gave a fluorescence equivalent to less than that
of 30 ng of dopamine but, when condensed with ethylenediamine, it formed a fluorescent product of similar
intensity and wavelength to that of dopamine.
After acetylation, condensation of catechol amines with ethylene diamine gave a greater fluorescence
intensity than before (Laverty & Sharman, 1964). The same held for 6-hydroxydopamine. In isobutanol
the acetylated 6-hydroxydopamine derivative had similar fluorescence characteristics to the acetylated
noradrenaline derivative, but different ones from those of the acetylated dopamine derivative (Laverty &
Sharman, 1965).
Separation of 6-hydroxydopamine from other catechol amines was attempted using both column and
paper chromatography. The elution pattern of 6-hydroxydopamine from Dowex 50 X-8 resin using hydro¬
chloric acid is compared in Fig. 1 with those of noradrenaline and dopamine. It will be seen that the
6-hydroxydopamine is eluted predominantly in the dopamine eluate (the 2 N-hydrochloric acid eluate);
any 6-hydroxydopamine eluted with the noradrenaline in the 0.4 N-hydrochloric acid eluate did not interfere
with the estimation of noradrenaline by the ferricyanide-oxidation technique. The total recovery of amine
was for noradrenaline 89% from 0.2 fig, for 6-hydroxydopamine 90% from 5 fig, and for dopamine 82%
from 2 fig.
On paper, 6-hydroxydopamine is " isographic " with noradrenaline (Senoh & Witkop, 1959). In order
to separate the two amines, the acetyl derivatives were formed and run in a descending paper chromatogram
with the solvent system described above for catechol amines.
In this solvent system, acetylated noradrenaline, adrenaline, 6-hydroxydopamine and dopamine were
separated (Fig. 2), though there was, in some experiments, a tendency for the tail of the dopamine spot to
overlap the 6-hydroxydopamine spot. The mean recovery of amines after acetylation, extraction with
dichloromethane and chromatography was for noradrenaline 71% from 0.2 to 1.0 fig, for adrenaline 68%
from 1 fig, for 6-hydroxydopamine 49% from 1 to 5 fig, and for dopamine 63% from 0.2 to 1.0 fig.
Since both column and paper chromatography separated the 6-hydroxydopamine and dopamine from
the noradrenaline, a method was required for the measurement of 6-hydroxydopamine in the presence of
dopamine. After condensation with ethylenediamine the fluorescence spectra of acetylated dopamine
and 6-hydroxydopamine were sufficiently different to make a differential estimation feasible. With an
Ilford Bright Spectrum 623 filter, the fluorescence intensity per fig of dopamine was approximately twice
that of 6-hydroxydopamine whereas, using an Ilford Bright Spectrum 625 filter, it was approximately
six-times that of 6-hydroxydopamine. Using these filter sets it was possible to determine with reasonable
precision quite small amounts of one amine in the presence of the other (Table 1).
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Fig. 2. Separation of the acetylated derivatives of noradrenaline ( ), adrenaline ( ), 6-hydroxy-
dopamine and dopamine ( ) on Whatman No. 50 paper using a petroleum ether, water
and tert-butanol (8:8:3) solvent system. The chromatogram was developed downwards for 24 hr,
and then cut into 1-cm strips.
Table 1
THE ESTIMATION OF DOPAMINE AND 6-RYDROXYDOPAMINE IN MIXTURES
The amines were acetylated, condensed with ethylenediamine and the amounts measured fluorimetrically





A. Sample in 4 ml. ofwater
200 220 2 -33
200 213 5 -22
200 196 10 7
200 201 50 42
100 98 100 135
100 96 100 114
50 47 200 185
50 52 500 476
25 22 500 462
10 10 500 419
100 96 500 476
Sample added to 4 ml. ofeluate
100 88 300 324
100 92 300 290
100 90 300 302
100 93 300 302
100 106 300 323
100 102 300 316
100 99 300 332
RESULTS
Effect of 6-hydroxydopamine on catechol amine concentrations in mouse tissues. In a
preliminary experiment on two groups of three mice each, it was found that 16 hr after
an injection of 6-hydroxydopamine (6.7 mg/kg, intraperitoneally) the noradrenaline content
of the hearts was reduced from 0.42 to 0.16 /xg/g; there was no observable change in the
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noradrenaline content of the brain, spleen or lung, nor in the dopamine content of any of
these four tissues. In all further experiments on mice, only the noradrenaline and 6-hydroxy-
dopamine contents of the hearts were measured.
Two strains of mice were used, one for the experiments involving intraperitoneal injec¬
tions of 6-hydroxydopamine and dopamine, the other for the intravenous experiments.
They were found to differ in the initial noradrenaline concentration of their hearts. The
results are summarized in Fig. 3,a. It will be seen that the noradrenaline content of the
i.o
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Fig. 3. The concentration in heart tissue of noradrenaline (a) and 6-hydroxydopamine or dopamine (6)
following the injection of 10 mg/kg of 6-hydroxydopamine (O, intraperitoneal^; •, intravenously)
or 10 mg/kg of dopamine (A , intraperitoneally). The means and standard deviations given for control
values (zero time) were obtained using six groups of five mice each; other points represent the means
from two or more such groups.
mouse heart fell rapidly following the injection of 6-hydroxydopamine (10 mg/kg) by
either route, the fall being almost complete at 1 hr after the injection. The level of nor¬
adrenaline recovered very slowly, and was still quite low, particularly in the intravenously
injected group, as long as 14 days after the injection. However, with a dose of 6.7 mg/kg
intraperitoneally, the noradrenaline content of the heart was back to 70% of its initial value
at 17 hr. After injection of dopamine (10 mg/kg), used for comparison, there was no
significant change in the noradrenaline content of the heart.
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Estimation of 6-hydroxydopamine concentrations in mouse heart by differential fluori-
metry. After injection of 6-hydroxydopamine its concentration in the heart rose to
over 1 pg/g 15 min after the injection, and then fell steeply, being almost back to control
values at 1 hr (Fig. 3,b). The values of 6-hydroxydopamine given for control hearts probably
represent a background fluorescence from undetermined materials rather than an actual
tissue content of 6-hydroxydopamine, because no 6-hydroxydopamine could be detected
in control hearts following further purification by paper chromatography. Small amounts
of materials having fluorescence characteristics similar to those of 6-hydroxydopamine
were detected on the paper in places other than those occupied by known catechol amines.
The tissue concentration of injected dopamine was measured in order to compare the
time course of its accumulation in, and disappearance from, tissue with that of 6-hydroxy-
dopamine. The uptake of dopamine by the heart was not as complete as the uptake of
6-hydroxydopamine, the tissue containing only 0.6 pg/g 15 min after the injection. The
tissue content of dopamine fell at a slightly slower rate than that of 6-hydroxydopamine,
and had not returned to control values 2 hr after the injection.
With a lower dose of 6-hydroxydopamine (6.7 mg/kg, intraperitoneally), the amount in
the heart 1 and 17 hr after the injection was similar to that following 10 mg/kg.
The recovery of 6-hydroxydopamine, added to a tissue sample and carried through the
column extraction procedure, was rather variable; the mean recovery in five experiments
in which 1 pg of 6-hydroxydopamine was added to tissue was 60%. The recovery of
dopamine (0.5 pg) in similar experiments was 73%. All figures given are uncorrected for
recovery.
It was noticed that many animals killed 15 and 30 min after an injection of 6-hydroxy¬
dopamine had a pronounced red coloration of their urine. No such colour was seen in
control animals or in animals injected with dopamine.
Detection of 6-hydroxydopamine and metabolites in mouse hearts after paper chromato¬
graphy. In order to confirm the results obtained by differential fiuorimetry, treated hearts
were extracted for amines by ion-exchange chromatography and the amines in the column
eluates were then acetylated, extracted with dichloromethane and separated on a paper
chromatogram. After elution, condensation with ethylenediamine was carried out and
the fluorescence plotted. Pooled extracts from 13 to 20 mouse hearts were used. An equal
number of hearts from uninjected controls was analysed simultaneously: in none of the
three experiments was there any 6-hydroxydopamine found. The amount detectable by the
present technique was less than 30 ng; allowing for an approximate total recovery of 30%,
this would place an upper limit on the tissue concentration of 6-hydroxydopamine in mouse
hearts at 0.04 pg/g. It was possible in these experiments to detect the presence of adrenaline
and dopamine in some extracts of mouse hearts; the amounts were too small to be
measured accurately but were of the order of 0.03 pg/g for adrenaline and 0.01 pglg for
dopamine.
The hearts of mice which had been treated with 6-hydroxydopamine 15 min and 16 hr
before being killed were extracted and analysed. At 15 min after injection of 6-hydroxy-
dopamine, at a time when the noradrenaline content was only slightly lower than that of
the control hearts, there was a fluorescence peak on the chromatogram (Fig. 4) correspond¬
ing to approximately 1.1 pg of 6-hydroxydopamine. This amount represents a tissue
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Fig. 4. Fluorescence scan of chromatograms from extracts of hearts. ( ) Control mice, ( ) mice
killed 15 min after intraperitoneal injection of 6-hydroxydopamine (10 mg/kg). The extracts were
from approximately 3 g ofheart and chromatograms were developed downwards for 48 hr in a petroleum
ether, water and /ert.-butanol (8:8:3) solvent. Control spots of known catechol amines run in
parallel were found at, for noradrenaline (NA) 5 to 6 cm, 6-hydroxydopamine (HD) 11 to 12 cm,
and dopamine (D) 14 cm from the origin. The fluorescer.ce is measured in arbitrary units.
concentration similar to that obtained by direct differential fluorimetry. The chromatogram
from mouse hearts 16 hr after the injection of 6-hydroxydopamine showed a pronounced
fall in the noradrenaline content from the control values, but no detectable 6-hydroxy¬
dopamine peak.
Since, therefore, residual 6-hydroxydopamine did not appear to replace the noradrenaline
of the heart, two experiments were carried out in which a search was made for any other
phenolic or indolic bases which might have been formed as metabolites of 6-hydroxydop-
amine. Groups of about twenty mice were killed 3 hr after intraperitoneal injection of
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Fig. 5. The depletion of the noradrenaline from kitten hearts by 6-hydroxydopamine. The doses used
were 10 mg/kg intraperitoneally ( A), 20 mg/kg intravenously (O), and 30 mg/kg intravenously (•).
The results are calculated in terms of the percentage of the noradrenaline content of hearts from
litter-mate controls; the noradrenaline content (mean and standard deviation) of the hearts of eight
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They were scanned with ultraviolet light, but no absorbing spots were seen. A portion of
the chromatogram was then sprayed with diazotized p-nitroaniline to detect any phenolic
compounds, and the other portion with Ehrlich's p-dimethylaminobenzaldehyde reagent
to look for indoles. No difference from strips prepared from control hearts was seen;
these tests are not sensitive to less than microgram quantities.
The effect of 6-hydroxydopamine on the kitten and guinea-pig heart and on other tissues.
The injection of 6-hydroxydopamine into kittens caused a profound and prolonged fall
in the noradrenaline content of the heart (Fig. 5), of similar degree and time-course as that
observed in mice. However, the 6-hydroxydopamine content of the hearts of the treated
animals fell more slowly, being 1.6 pg/g 1 hr after intraperitoneal administration of 10
mg/kg, but undetectable 21 hr after injection. When 30 mg/kg were given intravenously,
some 6-hydroxydopamine (0.1 pg/g) was found 4.5 hr later.
Relaxation of the nictitating membrane was seen when large doses of 6-hydroxydopamine
had been injected 6 hr or more previously; therefore the noradrenaline content of the
superior cervical ganglia was estimated in these experiments. No significant changes were
seen (Table 2). Neither was there any change in the noradrenaline content of stellate
ganglion of the cat examined 18 hr after the highest dose; it was 5.1 pg/g which is even
Table 2
THE EFFECT OF 6-HYDROXYDOPAMINE ON THE NORADRENALINE CONTENT OF




Litter No. (mg/kg) Duration cervical ganglia Hypothal:
1 Control 3-6 2-3
30 4-5 hr 3-1 0-7
30 18 hr 3-2 1-1
2 Control 4.4 1-6
20 20 hr 4.4 0-6
3 Control — 1-3
Control ■— 1-9
30 8 days — 0-7
30 8 days •— 1-2
30 8 days — 1-3
higher than the average normal figure (Muscholl & Vogt, 1958). The noradrenaline content
of the hypothalami of the kittens treated with 20 or 30 mg/kg of 6-hydroxydopamine was
found to be lowered significantly up to 24 hr after injection (Table 2). The single low figure
8 days after the injection was that of a cat which had developed a severe infection.
The functional state of the sympathetic nerves leading to the heart was tested in a series
of kittens. In six control experiments stimulation of the right nervi accelerantes caused an
average increase of heart rate of 16% from a mean rate, after vagotomy, of 235 beats/min.
When 6-hydroxydopamine was injected while records were being made, acceleration of the
heart by stimulation of the cardiac nerves was immediately abolished. However, in one cat,
which had not been adrenalectomized, the heart rate rose spontaneously by 25% (to 342) in
the course of the next 90 min. A smaller rise of 10% occurred in an adrenalectomized cat
following the intravenous, injection of 6-hydroxydopamine; since it only developed slowly,
it was not responsible for the immediate failure of nerve stimulation to increase heart rate.
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In four kittens that had been injected with 10 mg/kg of 6-hydroxydopamine either 1 or 7
days previously, stimulation of the cardiac sympathetic nerves caused a mean increase in
heart rate of 11%. However, when the dose was increased to 20 to 30 mg/kg, even 8 days
later stimulation of the cardiac nerves did not accelerate the heart or raise the blood pres¬
sure. In one experiment in which the heart failed to respond to nerve stimulation after
treatment with 6-hydroxydopamine, an intravenous injection of noradrenaline caused a
prolonged increase in heart rate of 20%. There was no correlation between the ability
of the heart to respond to nerve stimulation and the noradrenaline content of the heart.
Experiments in guinea-pigs gave similar results to those obtained in mice and kittens,
in that 6-hydroxydopamine depleted the heart and spleen of noradrenaline without affecting
the noradrenaline content of the sympathetic ganglia (Table 3). Yet comparison with
Table 3
EFFECTS OF 6-HYDROXYDOPAMINE IN THE GUINEA-PIG


























































Fig. 3 shows certain differences: 16 hr following intraperitoneal injection of 10 mg/kg of
6-hydroxydopamine, only a small fall in the noradrenaline content of the heart had occurred
in the guinea-pig, and the 6-hydroxydopamine did not disappear from the heart as rapidly
as in the mouse.
The release of catechol amines from the adrenal gland by 6-hydroxydopamine. The effect
of 6-hydroxydopamine on the storage mechanism of adrenomedullary amines was investi¬
gated in the isolated perfused adrenal gland of the dog. A dose of 0.27 mg infused over a
period of 75 to 100 sec caused an immediate and reversible increase in the release of both
noradrenaline and adrenaline into the perfusate collected over a 2-min period (Table 4).
There was no damage to the gland which was seen to revert to a lower secretion rate after
the end of the infusion and to respond subsequently to stimulation by tyramine hydro-
Table 4
MEDULLARY AMINES RELEASED BY THE ISOLATED PERFUSED ADRENAL GLAND OF
THE DOG IN RESPONSE TO AN INFUSION OF 0-27 mg OF 6-HYDROXYDOPAM1NE
Noradrenaline released
Adrenal Before During
weight infusion infusion Increase





0-25 53 90 70 300 500 67
0-28 45 138 206 300 500 67
0-41 50 120 140 450 1,100 144
558 R. LAVERTY, D. F. SHARMAN and MARTHE VOGT
chloride, prenylamine or dimethylphenylpiperazinium iodide. The flow through the
adrenal gland was not affected by the drug. The percentage methylation (adrenaline as
percentage of the total amines) was not or very little changed during stimulation by the
drug.
DISCUSSION
The present experiments confirm those of Porter et al. (1963) concerning the prolonged
action of 6-hydroxydopamine on the noradrenaline content of the mouse heart. The action
of this drug has a rapid onset, but even after a single injection the effect lasts for more than
1 week in both mice and kittens. We have also shown in guinea-pigs and kittens that
6-hydroxydopamine has no appreciable action on the noradrenaline content of sympathetic
ganglia; our findings differ from those in dogs (Stone, Stavorski, Ludden, Wenger, Ross,
Totaro & Porter, 1963) with 6-aminodopamine in that a high dose of 6-hydroxydopamine
(20 to 30 mg/kg) depleted the hypothalamic noradrenaline in cats. Thus 6-hydroxydopamine
appears to have selective effects on different parts of the peripheral and central nervous
system.
6-Hydroxydopamine not only lowers the noradrenaline content of heart tissue but also
releases catechol amines from the dog adrenal medulla (Table 4). This effect explains the
rapid increase in heart rate seen in anaesthetized kittens immediately following an intra¬
venous injection of 6-hydroxydopamine, an effect which was reduced but not abolished by
adrenalectomy. In dogs, also, 6-hydroxydopamine caused a prolonged increase in heart
rate (Stone et al., 1963).
It has been suggested that 6-hydroxydopamine might be a naturally occurring amine,
at least in the rat (Senoh, Creveling, Udenfriend & Witkop, 1959). Our experiments using
a paper chromatographic separation failed to show any 6-hydroxydopamine in untreated
mouse hearts. This does not, however, eliminate the possibility that quantities not detect¬
able by our methods may occur, particularly in tissues rich in dopamine.
A number of phenylethylamine derivatives are thought to lower noradrenaline concentra¬
tion in tissues by direct replacement of the noradrenaline; tyramine (Schumann & Philippu,
1962), a-methylnoradrenaline (Maitre & Staehelin, 1963) and dopamine (Harrison, Levitt
& Udenfriend, 1963) have all been shown to replace noradrenaline stoichiometrically.
However, it is obvious from our experiments that, except during the first hour after injec¬
tion, there is not sufficient 6-hydroxydopamine present in the tissue of mice and kittens to
replace the lost noradrenaline. Since 6-hydroxydopamine disappeared so rapidly from the
tissue, it was possible that a metabolic product was formed which was responsible for its
action. However, no basic metabolite could be detected in extracts from treated mouse
hearts. This may have been due to the metabolites being acidic or neutral, chemically
unstable and thus lost during extraction, or being present only in small quantities. Such a
metabolite would be unlikely to act as a replacement for a considerable quantity of nor¬
adrenaline for periods of longer than a week. 6-Hydroxydopamine does not affect uptake
of noradrenaline into the rat heart so that it appears not to act in the tissue like a
sympathomimetic amine (Iversen, 1964).
It is possible that only small amounts of 6-hydroxydopamine need be present to release,
and to maintain the depletion of, stored noradrenaline. Such small amounts may persist in
6-HYDROXYDOPAMINE ON TISSUES 559
tissues, as do small amounts of reserpine (Maggiolo & Haley, 1964) and guanethidine
(Bisson & Muscholl, 1962). Some other mode of action than replacement must then be
postulated.
The fact that the noradrenaline content of heart remains depressed after a single injection
of 6-hydroxydopamine for many days has been interpreted (Porter et al., 1963) as permanent
damage to the binding sites in the heart. This view is supported by the demonstration of
rapid disappearance of the compound from the tissues and our inability to find any persist¬
ing metabolite. 6-Hydroxydopamine is a strong reducing agent, very unstable and forming
red oxidation products readily. It is, therefore, not unlikely that its metabolic path is totally
different from that of sympathomimetic amines and that it causes irreversible damage to
receptor sites by virtue of its great chemical reactivity.
In addition to damage to storage mechanisms in the heart, there is functional failure of
transmission at sympathetic endings of several organs. In the heart, this occurs immediately
after an intravenous injection, when depletion has not yet had time to develop, and is still
present a week later, when the noradrenaline content of the heart is reduced by about 50%
at most. Furthermore, relaxation of the nictitating membrane was seen at periods ranging
from 6 hr to 3 days after an injection of 6-hydroxydopamine (30 mg/kg); in the earlier
part of the experiment, it was probably overshadowed by release of amines from the
adrenal medulla. Yet the noradrenaline content of the superior cervical ganglia was normal,
as was, indeed, that of the stellate ganglion at a time when impulse transmission to the heart
was abolished. A similar lack of correlation between block of transmission and depletion
of tissue noradrenaline was seen in the dog by Stone et al. (1963). It is possible to explain
these observations on a multiple-pool concept of storage of tissue noradrenaline, by
assuming a complete depletion of the readily available noradrenaline without necessarily
a complete depletion of more firmly bound stores. However, they could be explained equally
well by assuming that 6-hydroxydopamine has a bretylium-like action on adrenergic nerves.
This hypothesis would be more consistent with the observations that the noradrenaline
content of the stellate and other ganglia, from which the adrenergic neurones originate, is
normal when the peripheral nerve ending is no longer releasing noradrenaline.
SUMMARY
1. A single injection of 6-hydroxydopamine (10 to 30 mg/kg) lowered the noradrenaline
content of mouse, kitten and guinea-pig hearts for a period ranging from less than 1 hr
to more than 1 week.
2. Methods for the isolation and fluorimetric estimation of 6-hydroxydopamine in
tissue were developed. Ion-exchange chromatography, alone or followed by paper chroma¬
tography, was used for separation of 6-hydroxydopamine from catechol amines. The
6-hydroxydopamine did not remain in the heart of the mouse for more than 1 hr after the
injection.
3. No bases which might have been metabolites of 6-hydroxydopamine were detected
in the heart 3 hr after injection of the drug.
4. In kittens and guinea-pigs, 6-hydroxydopamine did not lower the noradrenaline
content of the superior cervical or stellate ganglia; large doses (20 to 30 mg/kg) reduced
the hypothalamic noradrenaline in kittens.
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5. Large doses of 6-hydroxydopamine in kittens abolished the increase in heart rate due
to stimulation of the cardiac postganglionic sympathetic nerves; smaller doses (10 mg/kg)
reduced this response. No correlation was found between the response to nerve stimulation
and the noradrenaline content of the heart.
6. 6-Hydroxydopamine released noradrenaline and adrenaline from the isolated perfused
adrenal gland of the dog.
7. The prolonged and specific depletion of noradrenaline from peripheral stores is not
due to replacement by 6-hydroxydopamine. Other possible mechanisms of action are
discussed.
We are grateful to J. E. McEwen, F.I.S.T., for his skilful help in the noradrenaline estimations. We
would like to thank Dr C. S. Miller (Merck Sharp & Dohme Research Laboratories Inc.) for a gift of
6-hydroxydopamine.
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The noradrenaline content of the caudate nucleus of the rabbit
(Received 14 September 1964)
In a recent paper (Matsuoko, Yoshida and Imaizumi, 1964) it was stated that there is a high nor¬
adrenaline concentration (0-85 pglg) in the rabbit caudate nucleus. In all species previously examined
the caudate nucleus has been found to contain high concentrations of dopamine, but hardly any nor¬
adrenaline. In order to ascertain whether there existed an interesting species difference between the
rabbit and other mammals, we estimated the noradrenaline in the caudate nucleus of adult rabbits
(weight 2-5-3 kg) by three different methods: (1) a bioassay on the pithed rat's blood pressure
following paper chromatographic separation of the catecholamines (Vogt, 1954), (2) a fluorimetric
assay by a method comparable to that used by Matsuoko et al. (1964) consisting of adsorption of the
amines on a column of resin followed by oxidation of the eluate by ferricyanide to form a fluorescent
compound (von Euler and Lishajko, 1961), and (3) a fluorimetric method in which the amines in the
eluate from the column were acetylated, chromatographed on paper and the fluorimetry was carried
out on the eluate from the paper after condensation with ethylene diamine (Laverty and Sharman,
1965). Table 1 shows the results obtained with the three methods; the results of method 3, in which
the losses are greater, have been corrected to 70 per cent recovery which is the recovery achieved in
methods 1 and 2.
Table 1.—Noradrenaline content estimated by different methods in
the caudate nucleus of the rabbit
pg/g fresh tissue
Method 1 Method 2 Method 3
Experiment 1 < 0025 0-33 0-045
Experiment 2 0017 018 0-027
It is evident from the Table that method 2 gives much higher figures than methods 1 and 3. A
likely explanation is that there exists, in the rabbit caudate nucleus, a substance which is not
noradrenaline but which is adsorbed on strong cation exchange resins and gives a fluorescent com¬
pound with ferricyanide. It is probable that Matsuoko et al. (1964) encountered such a phenomenon
in their extracts. Recently a similar difficulty has arisen in our laboratory in assays of noradrenaline in
the rat hypothalamus; the figures obtained were 50 per cent higher with method 2 than with methods
1 and 3.
The discrepancies might also be due to the presence in the tissues of fluorescent material which
loses its fluorescence on the addition of ferricyanide and alkali, and causes the "faded blanks", used
for reference, to be too low.
Agricultural Research Council D. F. Sharman
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[From the Proceedings of the Physiological Society, 20-21 September, 1968
Journal of Physiology, 200, 33-35P]
Gas chromatographic evidence for the presence of glycol meta¬
bolites of catecholamines in brain tissue
By D. F. Sharman. A.B.C. Institute of Animal Physiology, Babraham,
Cambridge
It has been shown hy Rutledge & Jonason (1967) that rabbit brain
slices can metabolize noradrenaline in vitro to 3,4-dihydroxyphenyl-
ethyleneglycol (DOPEG) and 4-hydroxy-3-methoxyphenylethyleneglycol
, i ^ ^
SP BHC MOPEG derivative
Fig. 1. Gas chromatogram record of: 1. Extract of rabbit hypothalamus. 2. Extract
of rabbit cerebral cortex to which authentic 4-hydroxy-3-methoxyphenylethyl-
eneglycol (MOPEG) had been added. 3. Extract of rabbit cerebral cortex. 4.
Authentic MOPEG derivative. SP, solvent peak. BHC, Benzene hexaehloride used
as a reference compound. The gas chromatogram was developed on a 180 cm
column of 3-8 % s.e. 30 on silanized Diatoport S (60-80 mesh). Column tempera¬
ture 135° C; detector temperature 180° C; pulse interval 50 ^see; carrier gas argon:
5 % methane; gas flow 30 ml./min at 1-7 kg/cm2.
[p.t.o.
2
(MOPEG). Schanberg, Schildkraut, Breese & Kopin (1968) have reported
that the ethereal sulphate conjugate of MOPEG was present in normal
rat brain but were unable to detect the free compound.
DOPEG and MOPEG can be converted to heptafluorobutyric esters
which can be separated by gas chromatography and measured by the
electron capture detector. It was found that acetylation of the phenolic
hydroxyl groups, before the esterification of the alcoholic hydroxy groups
with heptafluorobutyric anhydride, yielded compounds with MOPEG and
DOPEG which were more easily separated from the solvent peak of the
gas chromatogram and which can be easily crystallized to form reference
standards. Chromatograms developed with extracts prepared from rabbit
and mouse hypothalamus have shown peaks with the same relative reten¬
tion time as the compounds derived from authentic MOPEG and DOPEG.
Figure 1 illustrates the evidence for the presence of very small amounts
of free MOPEG in an extract of the hypothalamus of the rabbit.
The general procedure is applicable to the estimation of those catechol¬
amines and their metabolites which contain primary or secondary alco¬
holic hydroxyl groups.
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Summary
1. A gas chromatographic method using electron capture
detection is described .for the estimation of those
catecholamines and their metabolites which possess one or
two free alcoholic hydroxy1 groups. It is based on
acetylation of phenolic hydroxyl and primary and secondary
amino groups in aqueous solution, extraction into a water
immiscible solvent and esterification of alcoholic hydroxyl
groups with heptafluorobutyric anhydride.
2. The method has been successfully applied to the
detection and estimation of free 4-hyd.roxy-3-methoxyphenyl-
ethyleneglycol (MOPEG) and free 3»4-dihydroxyphenyl-
ethyleneglycol (DOPEG) in hypothalamic brain tissue.
3. Although it was possible to measure noradrenaline
and normetanephrine by the same method in pure solution,
crude tissue extracts could not be used, despite their
suitability for estimating the glycol metabolites.
Introduction
In 1963) Mannarino, Kirshner and Nashold showed that
when DL- _ noradrenaline was injected into the lateral
cerebral ventricle of the cat, it was metabolised in the
brain to 4-hydroxy-3~methoxyphenylethyleneglycol (MOPEG) and
3,4-dihydroxyphenylethyleneglycol (DOPEG). Glowinski, Kopin
and Axelrod (1965) injected tritiated noradrenaline into the
cerebral ventricles of the rat and also found that the major
part of the deaminated metabolites formed in the brain con¬
sisted of MOPEG. The presence of a sulphate conjugate of
MOPEG in normal rat brain was reported by Schanberg,
Schildkraut, Breese and Kopin (1968) but these authors were
unable to detect the free glycol in this species. Recently
Schanberg, Breese, Schildkraut, Gordon and Kopin (1968) have
described the determination of MOPEG in brain tissue and
cerebrospinal fluid using the method described for urine by
Wilk, Gitlow, Clarke and Paley (1967). In this method a
trifluoroacetyl derivative of MOPEG is formed and measured
by gas chromatography using the electron capture detector.
The formation of acetyl and perfluoroacyl derivatives
as the basis of methods for the estimation of catecholamines
and their metabolites has been described by Brooks and
Horning (19^4), Horning, Horning, Yanden Heuvel, Knox,
Holmstedt and Brooks (1964) and Wilk, Gitlow, Franklin and
Carr (1964)- The ma.in problem in applying these methods to
biological samples lies in the difficulty of extracting
small quantities of catecholamines and their metabolites
from tissues and then achieving the anhydrous conditions
required for the introduction of perfluoroacyl and acetyl
groupings without excessive losses.
Chattaway (1931) showed that phenolic hydroxyl groups
and amino groups could be acetylated very easily in dilute
aqueous alkaline solution. This reaction was used by Welsh
(1955)? Hagopian, Dorfman and Gut (1961) and Laverty and
Sharman (1965) as a step in the isolation of catecholamines
and. their metabolites from aqueous solutions and tissue
extracts. The acetylated derivatives are more stable than
the parent compounds and thus can be brought more easily
to the anhydrous state. Alcoholic hydroxyl groups are not
acetylated under these conditions and are left free to form
a perfluoroacyl derivative. This paper describes the use
of these steps in an approach to the problem of estimating
catecholamines and their metabolites in tissues and body
fluids by gas chromatography.
Materials and Methods








4-hydroxy-J-methoxyphenylethanol (prepared by reduction of
4-hydroxy-3-methoxyphenylacetic acid with lithium aluminum
hydride);
Y-benzene hexachloride (Shell);
Heptafluorobutyric anhydride. Prepared from heptafluoro-
butyric acid (Minnesota Mining and Manufacturing Co. Ltd.)
by heating under reflux with phosphorus pentoxide (1 mol.
heptafluorobutyric acid : 1.5 moles PqO^) ^or 5 hr.
Distilled three times B.P. 108°C (uncorrected);
Dichloromethane. May & Baker Ltd. Distilled three times;
Tetrahydrofuran. Hopkin & Williams. Distilled fresh in
small quantities as required;
Acetic anhydride. British Drug Houses Ltd.. Distilled
twice; stored at 4°C;
Methanol. James Burrough Ltd. Purified by distillation
from KOI! and then redistilled;
Hexane. Hexane fraction, Hopkin & Williams. Distilled
twice.
All other chemicals were of analytical reagent quality.
Double distilled water was used throughout.
Extraction of tissues
The tissues were removed rapidly after killing the
animals and homogenised in ice-cold 0.1N-hydrochloric acid
(4 ml. acid for up to 0.5 g tissue). Concentrated
perchloric acid (72fo w/v), 0.2 ml., was added for each
4 ml. of homogenate and mixed thoroughly. . Solid potassium
chloride was then added in a slight excess of the amount
required for saturation. The homogenate was then
centrifuged with a tip radial acceleration of 147000 ms~^
(15000 X g) for 5 min at 0°C. The clear supernatant was
transferred to a glass stoppered test tube and mixed with
0.3 ml. acetic anhydride. A slight excess of sodium
bicarbonate was then added in small portions with mixing,
allowing the effervescence to subside between additions.
The solution was then extracted twice with 10 ml. portions
of dichloromethane which were dried by filtering through
anhydrous sodium sulphate. The extract was evaporated to
a small volume, under a stream of dry nitrogen, in test
tubes standing in holes in an electrically heated aluminium
block at 60°C. The concentrated extract was then trans¬
ferred to a 75 mm X 8 mm borosilica.te glass test tube and
evaporated to dryness at 60°C under a stream of dry
nitrogen.
Formation of heptafluorobutvrate esters
The sample was dissolved in a small volume (20 -
200 pi.) of tetrahydrofuran. One quarter of this volume
of heptafluorobutyric anhydride was then added and mixed.
The mixture was allowed to stand at room temperature for
5-10 min and then evaporated to dryness under a stream of
dry nitrogen at 60°C. The gas flow and heating were con¬
tinued for 15 min after the liquid had disappeared. The
formation of the acetyl-heptafluorobutyryl derivatives is
thought to proceed as shown in Fig. 1.
Gas chromatography
This was carried out on both Model 400 and Model 402
F & M Scientific Corporation gas chromatographs using in the
former a U-shaped column 180 cm X 3 ram i.d. packed with 3*8/£
SE-30 on silanized Diatoport S (60 - 80 mesh). This column
had been conditioned at 300°C for 12 hr and then used at
230°C for several months for the analysis of steroid
compounds. The Model 402 was fitted with a new 120 cm X
4 mm i.d. column of 3>8% SE-30 on Diatoport S conditioned by
heating at 300°C for 12 hr.
The carrier gas was argon containing 5i° methane. A
tritium foil electron capture detector was used with both
instruments.
The derivatives were dissolved in hexane or in a hexane
solution of y-benzene hexachloride of known concentration
for injection into the gas chromatograph. The extracts
prepared from tissues were dissolved in volumes of 0.1 -
0.5 ml. of which 0.5-2 pi. were injected.
Results
The formation of heptafluorobutyryl derivatives of nor¬
adrenaline and some catecholamine metabolites
1. 4-Hydroxy-3-methoxyphenylethyleneglycol (MOPEG).
MOPEG was separated from the piperazine in the
commercially available salt by dissolving in water, adding
hydrochloric acid to bring the pH to 1 - 2 and extracting
three times with five volumes of diethyl ether. The ether
extracts were dried with anhydrous sodium sulphate and
evaporated under a stream of nitrogen, yielding an oily
residue. The heptafluorobutyryl derivatives of both MOPEG
and. acetyl-MOPEG were prepared from known amounts of MOPEG.
Pig. 2 illustrates the separation of these two derivatives
on the gas chromatogram and shows that the fully hepta-
fluorobutyrated derivative did not give a response larger
than the acetyl-heptafluorobutyryl derivative when these
were prepared by the methods described here.
2. Acetyl-heptafluorobutyryl derivatives were pre¬
pared from 1-noradrenaline, d,l-4-hydroxy-3-methoxyphenyl-
ethanolamine (normetanephrine), MOPEG, DOPEG and 4-hydroxy-
3-methoxyphenylethanol. The derivatives of noradrenaline,
MOPEG and DOPEG were crystallised at -17°C from hexane. The
uncorrected melting points of these derivatives were:
acetyl-heptafluorobutyryl MOPEG, white crystals 75-5 - 76°C:
acetyl-heptafluorobutyryl DOPEG, white crystals 71 - 72°C;
acetyl-heptafluorobutyryl noradrenaline, white needles,
93°c.
The retention times of these derivatives relative to
Y-benzene hexachloride under differing conditions for
chromatography are given in Table 1. Each can be separated
from the others on a 3»8$ SE-30 column. However, the
relative retention time of the noradrenaline derivative is
too long at column temperatures below 150°C to allow the
measurement of small amounts of noradrenaline and at higher
temperatures the response from the derivative of MOPEG tends
to overlap with that of the benzene hexachloride, the
reference compound. The hexane solutions of the acetyl-
heptafluorobutyryl derivatives of MOPEG, DOPEG, nor-
i
metanephrine and noradrenaline were stable for several
months at -17°C if care was taken not to allow water to
condense inside the vessels holding the solutions when
portions were taken out. The crystalline derivatives were
not very stable unless kept under hexane at -17°C.
The quantitative estimation of MOPEG and DOPEG
The principle of the method has been described for the
estimation of steroid compounds by Vandenheuvel, Hinderks,
Nixon and Layng (19^5)» Wisniewski and Umbreit (19^5) and "by
Heap, Holzbauer and Newport (1966); it is based on the ratio
of the sizes of the responses of two substances, a and b
which have different retention times. If the ratio of the
sizes of the two responses is proportional to their relative
concentrations in a mixture of the two substances and the
total amount present in the sample of one of them is known
then the total amount of the other substance present in the
sample can be calculated from the equation
A = x B x C
KJd
where A = Total amount of substance a present in the
sample,
RA = Size of response to a in the sample,
RB = Size of response to b in the sample,
B = Amount of substance b present,
C = Ratio — of responses to equal amounts of a and b.
a
The last term in the equation is obtained by calcula¬
tion .from the responses observed when samples each contain¬
ing known amounts of the derivatives both of authentic A
and of authentic B are tested on the gas chromatogram.
In the present experiments benzene hexachlorid_e was
selected as the reference compound to be added to the
extracts. Pig. 3 shows that the ratios of the heights of
the response peaks obtained with the acetyl-heptafluoro-
butyryl derivatives of MOPEG and DOPEG and y-henzene
hexachloride are suitable for such estimations since the
peak height ratios are proportional to the concentration
ratios. When peak height ratios were replaced by ratios of
areas of the peaks (calculated by triangulation) the
variance of the relation between concentration ratio and
response ratio was higher because two measurements were
required for each area estimation.
Recoveries
Authentic MOPEG was added to tissue homogenates in
quantities ranging from 10 - 50 ng to show that any MOPEG
present in samples would be detected on the gas chromato¬
gram. In the earlier experiments it was difficult to
estimate MOPEG accurately without having the crystalline
derivative to obtain accurate standard, measurements. In two
experiments with the procedure finally adopted in which
crystalline standards were used the recovery of MOPEG was
64$ and 69$ and of DOPEG 67$ and 78$.
The presence of MOPEG and DOPEG in the hypothalamus
Hypothalamic tissues of the mouse, rabbit and cat were
extracted and the extracts treated to form acetyl-hepta-
fluorobutyryl derivatives. The gas chromatographic record
obtained with an extract of mouse hypothalamus is shown in
Pig. This shows that the extract of mouse hypothalamic
tissue gives response peaks similar to those of authentic
derivatives of MOPEG and DOFEG. The retention times rela¬
tive to that of the response due to y-benzene hexachloride
are identical with those obtained with the acetyl-hepta-
fluorobutyryl derivatives of MOPEG and. DOPEG. The responses
correspond, in this experiment, to a concentration in the
tissue of MOPEG 0.04 pg/g a-nd DOPEG 0.05 pg/g (uncorrected
for recovery). Similar peaks were seen on the recordings
obtained with the extracts of rabbit (Sharman, 19&9) and cat
hypothalamus.
Further evidence for the identity of the substances giving
rise to the peaks on the chromatograph record
a) Hydrolysis of the acetyl derivative of MOPEG.
As shown in Fig. 2 the responses of the heptafluoro-
butyryl derivatives of MOPEG and acetyl-MOPEG are easily
distinguished. The acetyl group on the phenolic hydroxyl of
MOPEG, introduced during the extraction procedure, can be
removed by dissolving in an alkaline aqueous solution. After
evaporation to dryness the MOPEG can then be treated to
yield the completely heptafluorobutyrylated derivative. A
dichloromethane extract containing the acetylated deriva¬
tives was prepared from rabbit hypothalamus and from rabbit
brain cortex to which MOPEG had been added. Each of these
was divided into two equal portions and the four samples
evaporated to dryness. To one of each pair of samples was
add.ed 0.1 ml. of concentrated ammonia solution and after
5 min these were again evaporated to dryness. All four
samples were then treated with heptafluorobutyric anhydride
in tetrahydrofuran as described and the final extracts
examined by gas chromatography. A peak corresponding with
that given by acetyl-heptafluorobutyryl MOPEG was observed
with the two extracts that had not been treated with ammonia.
The other two extracts showed a. response at the retention
time corresponding to that of heptafluorobutyryl MOPEG but
the size of the response was difficult to estimate as it
coincided with the sharp rising phase of another peak on the
chromatogram and was observed as a shoulder on this peak.
b) Paper chromatographic separation of the acetyl
derivatives before gas chromatography.
A dichloromethane extract containing the acetylated
derivatives was prepared from 1.1 g of mouse hypothalamus.
One tenth of this extract was taken, evaporated to dryness,
treated to form the acetyl-heptafluorobutyryl derivatives
and examined on the gas chromatograph. Peaks corresponding
with those obtained with acetyl-heptafluorobutyryl deriva¬
tives of both MOPEG and DOPEG were obtained similar to those
in Pig. 4. The remainder of the methylene dichloride
extract was evaporated to a volume of approximately 0.3 ml.
This was applied toal.5 cm wide lane: of Whatman No. 50
filter paper for chromatography which had been washed with
2N-sodium hydroxide and distilled water as described by
Sharman (1963). A descending chromatogram was run using a
modification of the Bush solvent system C (Bush, 1952). The
solvent system was toluene s methanol : water : ethyl
acetate in the proportions 10 : 5 ' 5 ' 2 and the chromato-
gram was developed, for 2.5 hr at 27°C after equilibrating
overnight. After development, the chromatogram was dried
and cut up into 1 cm long portions each of which was eluted.
by intermittent shaking with 1 ml. of methanol which was
left in contact with the paper for 1 hr. The pieces of
paper were removed, the eluates evaporated to dryness and
then treated to form the acetyl-heptafluorobutyryl deriva¬
tives. They were then examined by gas chromatography. The
result is illustrated in Fig. 5- This shows that those
responses on the gas chromatogram at relative retention
times similar to those of the acetyl-heptafluorobutyryl
derivatives of MOPEG and DOPEG, are only obtained from
regions of the chromatograms where acetyl-MOPEG and acetyl-
DOPEG are found.
Noradrenaline and normetanephrine
The estimation of these two substances after formation
of their acetyl-heptafluorobutyryl esters using gas
chromatography is theoretically possible since good
responses are obtained when aqueous solutions of either are
subjected to the extraction and estimation procedures
described for MOPEG and DOPEG.
In practice, the application of the method to measure¬
ment of noradrenaline and normetanephrine in tissues has met
with technical difficulties. When gas chromatograms of
extracts of mouse and rabbit hypothalamus were developed at
140°c and below, a response with a relative retention time
similar to that given by the acetyl-heptafluorobutyryl
derivative of normetanephrine was observed. However, when
the derivative prepared from authentic normetanephrine was
added to such extracts, the retention time of the response
given by the added normetanephrine derivative could just be
distinguished from that of the response seen with the
extract alone. Preliminary experiments on eluates from the
appropriate regions of the chromatogram used to obtain the
results described in Pig. 5 yielded responses, the retention
times of which approximated to those of the acetyl-hepta¬
fluorobutyryl derivatives of noradrenaline and nor¬
metanephrine; but it has not yet been possible to confirm or
disprove the identity of these retention times with those of
the authentic derivatives. These results indicate that
simple extraction procedures are not suitable for the
estimation of the two amines by gas chromatography of their
acetyl-heptafluorobutyryl derivatives. Moreover the nor¬
adrenaline and normetanephrine derivatives are relatively
insoluble in hexane which adds to the difficulties in
applying the method as given here.
Sensitivity of the method
Pig. 4 shows the responses given by amounts of
authentic derivatives corresponding to 50 x lO-^ g MOPEG
and 100 x 10""''2 g DOPEG. The responses given by the deriva¬
tives of normetanephrine and noradrenaline were, respective¬
ly, at least 20 times and 100 times smaller than that given
by the derivative of MOPEG.
Stability of the final extracts
The final hexane extract prepared from a sample of
rabbit hypothalamus was tested for its content of acetyl-
heptafluorobutyryl MOPEG three times over a period of four
days. The extract was kept at -17°C between the tests. On
the first day the content of MOPEG was estimated to be J.6
ng, on the second 9-7 and 9-8 ng and on the fourth d.ay
8.2 ng.
The concentration of MOPEG and DOPEG in the hypothalamus
Table 2 shows the concentration (uncorrected for
recovery) of MOPEG and DOPEG estimated to be present in the
hypothalamus of several species.
Discussion
A technique for the estimation of certain catechol¬
amines which contain a secondary alcoholic hydroxyl group
and of some of their metabolites has been developed 'using a
double esterification procedure. The first, an acetylation
in aqueous solution, converts the compound into derivatives
which are soluble in a water-immiscible organic solvent and
the second, the introduction of one or more heptafluoro-
butyryl groups, forms derivatives which can be detected by
electron capture. The method has proved to be extremely
sensitive for the glycol metabolites of noradrenaline.
Although it is theoretically possible to use a similar
procedure for noradrenaline and adrenaline and their
methoxylated amine metabolites, technical problems have
arisen which no doubt can be overcome by further purifica¬
tion of extracts of tissues.
The method for the estimation of the glycol metabolites
measures the free glycols present in the tissues and yields
values for the concentrations of DOPEG and MOPEG which are
not very different in the three species examined.
Schanberg, Breese, Schildkraut, Gordon and Kopin (1968)
have also used a perchloric acid protein precipitation with
results indicating that there is little if any hydrolysis
of conjugated MOPEG during this procedure. Preliminary
experiments have shown that the simple extraction procedure
used here is difficult to apply after treatment of brain
extracts with a sulphatase because of the presence of
contaminants in the enzyme preparation. Whether the
present method is more sensitive than the method of Wilk
et. al. (1967) will only be decided by a direct comparison
but the sensitivity given by these authors (91,000 mm^ for
10~9 moles) for the response to trifluoro-acetylated MOPEG
can be compared with approximately 5,000,000 mm^ for 10~^
moles, a typical response with the present method.
In addition to confirming the presence of free MOPEG
in the central nervous system, the present results show
that free DOPEG is also present, a result predicted by
experiments on the metabolism of radioactive noradrenaline
in the brain.
























SpeciesMOPEGng/gDOPEGp.g/ Rabbit Mouse Cat0.045 0.047 0.159 0.049 0.048 0.049 0.077 0.040 0.048 0.018 0.017Estimatedinduplic t portionsofsame homogenate.
Presentbutnoestimated becauseofla kstandard. 0.030 0.120 0.126 0.048 0.054 0.047 0.029 0.022 0.018



























Fig. 1. The formation of acetyl-heptaflnorohutyryl
derivatives of DOPEG and MOPEG.
Solvenl-peA HF8M X'Q"C A-HFBM
Fig. %. Gas chromatogram tracings of the fully heptafluoro-
hutyrated derivative of 4-hydroxy-3-methoxyphenylethylene
glycol (MOPEG) and the acetyl-heptafluorobutyryl deriva¬
tive of MOPSG.
The responses were obtained, with mixtures containing
Y BHC and derivatives of MOPEG in the proportions given in
parentheses.
y-BHC - Y-Benzenehexachloride (4 parts)
HFBM - Heptafluorobutyryl MOPEG (=7 parts MOPEG)




Flash heater temperature 160°C
E.C. detector temperature 180°C
Gas flow 100 ml./min at 1.4 kg/cm^ pressure
E.C. detector pulse interval 50 psec
Column 180 cm x J mm 3.8/0 SE-30
Fig. 3- The ratio of the peak heights of the responses
to Y-benzene hexachloride and the acetyl-heptafluorobutyryl
derivatives of MOPEG and DOPEG plotted against the ratio of
their concentrations in mixtures.
(The concentrations of the derivatives of the glycols
are expressed as the concentration of the parent glycol).
A-HP*
-y_B H C M0PEG
IFig. 4- &as chromatographic record of an extract of mouse
ihypothalamus.
lUpper tracing: Mouse hypothalamic extract (from 0.103 g
tissue) to which 1.25 ng y-benzene hexachloride had been
added.
Lower tracing: Responses to derivatives of authentic MOPEG
and. DOPEG. Ratio of concentrations BHC : MOPEG : LOPEG =
200 : 250 : 500 ng/ml.
Column temperature 140°C; flash heater temperature 180°C;
Detector temperature 170°C; Carrier gas flow 60 ml./min
(Argon: ^fo me thane) (no purge gas) Pulse interval 150 psec.
Retention times relative to that of y-benzene hexachloride
observed with the extract used for the above record (Mean
± s.e.m. from three observations).

















* B^C | DOPEG
Fig. 5- Gas chromatographic records obtained with eluates
from a paper chromatogram of an extract of mouse
hypothalamus.
The catecholamines and their metabolites on the tissue
were acetylated and separated as indicated on the paper
chromatogram by the reference compounds shown in the diagram.
The chromatogram was cut into small pieces as indicated by
the transverse lines and each piece eluted with methanol.
The eluates were evaporated and treated to form hepta-
fluorobutyryl derivatives.
No response peaks at retention times relative to that
of Y-benzene hexachloride corresponding with those of
acetyl-heptafluorobutyryl MOPEG and acetyl-heptafluoro-
butyryl DOPEG were observed with eluates from regions of
the chromatogram other than those shown.
The conditions for gas chromatography were similar
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